Tag Archive: Monsanto


New Evidence Of Controlled Demolition On 9/11

http://www.prisonplanet.com/new-evidence-of-controlled-demolition-on-911.html

International Center for 9/11 Studies
Thursday, September 2, 2010

The International Center for 9/11 Studies has secured the release of hundreds of hours of video footage and tens of thousands of photographs used by the National Institute of Standards and Technology (NIST) for its investigation of the collapse of the World Trade Center Twin Towers and Building 7. This material is being released to the Center under the Freedom of Information Act, in response to a lawsuit the Center filed against NIST.

The Center filed a FOIA Request with NIST on January 26, 2009, seeking production of “all of the photographs and videos collected, reviewed, cited or in any other way used by NIST during its investigation of the World Trade Center building collapses.” Following several unsuccessful attempts to get NIST to even acknowledge receipt of the Request, the Center was forced to file a lawsuit on May 28, 2009. Shortly after the lawsuit was filed, the Request was assigned a reference number, and NIST began periodically releasing batches of responsive records. To date, the Center has received over 300 DVDs and several external hard disk drives that contain responsive records – more than 3 terabytes of data so far – and NIST has indicated that additional records will be released in the future.

We are currently looking at the best ways to distribute these materials to interested researchers and journalists around the world. It has taken NIST more than 8 months so far to produce a partial archive of photographs and videos in their possession, but we hope to be more efficient in our efforts. Because of the huge volume of data, we are working on a wiki-style website to facilitate review and discussion of any interesting items that are discovered by researchers.

Justin Keogh, our Chief Technical Officer, is preparing the website and materials for release. The first batch of materials we are releasing is a group of video clips sent to us on an external hard disk drive labeled “NIST WTC Investigation Cumulus Video Clips.” We believe NIST entered these clips into a searchable database called the Cumulus database, and used them as the basis for the investigation and reports. Researchers may be interested to see which video clips NIST determined were important to its investigation, and compare these clips to the raw footage we release at a later date. Justin will be posting more details about the data release in the next week or two. Any questions about the FOIA Request, lawsuit, or data release should be submitted via the Contact Us page at the Center’s website:http://www.ic911studies.org/Contact_Us.html

Although the Center has extremely limited resources with which it can review this mountain of data, several interesting items have already been discovered. Below are five items the Center has uncovered so far. The items below have not been altered from the original provided by NIST, except in three cases where a short section of footage was extracted from a much longer video. Otherwise, no alterations have been made to the video or audio. For the best viewing experience, you should watch all of the videos below in the highest resolution available. We will supplement the list below in the coming days and weeks.

1. Video Footage of Explosion Before Collapse

In the video below, at about the 0:59 mark, a high-pressure explosion occurs in one of the Twin Towers, below the impact zone, while the building is still standing.

In the final report on the collapse of the Twin Towers issued by NIST, it appears to attempt an explanation for this explosion by suggesting it is a smoke puff resulting from a pressure pulse inside the building, perhaps from a collapsing wall or ceiling, or sudden opening of a door. (See NCSTAR1-5A, p. 52) However, as can be seen from the screen capture below, it isn’t merely smoke and dust being ejected. There appears to be a massive object being ejected along with the explosion.

WTC Explosion

2. Audio Evidence of Explosions During Collapse

Several videos released to the Center have clear audio tracks that contain distinct sounds of explosions occurring at the World Trade Center. These audio tracks provide support to the many eyewitness statements referring to explosions occurring when the buildings collapsed. Explosions can be heard at the initiation of the South Tower collapse in the following two videos. The explosions are clear enough at normal volumes, but turning your speaker volume up a bit can help provide a full appreciation of the sound.

The video below contains distinct sounds of explosions occurring throughout the collapse of the North Tower. The native audio track is at very low volume, so your speakers should be turned up enough to hear the explosions. (Please be careful to turn your volume back down after watching this video.)

In the next video, a loud, low-frequency boom can be heard just before the east penthouse of WTC 7 falls.

David Chandler will soon be publishing a video that contains a more in depth analysis of this footage, including audio enhancements of the explosion.

3. Visual Evidence of Explosions During Collapse

Several videos also have clear visible explosions that occur above the airplane impact/collapse zone in the South Tower. In the video below, the collapse begins at about the 3:45 mark. If you watch the corner of the South Tower nearest the camera, at a point about halfway between the airplane impact zone and the top of the building, you will see puffs of smoke and a flash at about the 3:49-3:50 mark. The corner of the building also appears to lose structural support (or “kink”) at this same location. These are the obvious result of explosive charges severing the steel structure at the near corner.

In the next video, a similar phenomenon can be seen, but from a different angle and not quite as clearly.

The video below is raw footage from a news outlet of the South Tower exploding. Explosions can be seen ahead of the collapse front. The newscaster even calls it a “huge explosion.”

http://www.prisonplanet.com/new-evidence-of-controlled-demolition-on-911.html

Phthalates

by Kenneth J. Edwards, Jr., VP Alken-Murray Corp.

Phthalates, prominently used in many industries, including plastics, belong to a family of chemical compounds which are based on a benzene ring, to which is attached a pair of carbonyl groups in consecutive positions on the benzene ring.

Commentary & examples:

A benzene ring consists of a backbone of 6 carbons and 6 hydrogens. This structure can be represented as if it was alternating between 1,3,5-cyclohexatriene (a) and 2,4,6-cyclohexatriene (b), but the truth is that the extra electrons are not localized over the double bonds between the carbons. Single hydrogen atoms would also be associated with each carbon represented in the drawing. In reality, the electrons of the benzene ring are gathered into doughnut shaped clouds above and below the ring. Therefore, a simplified representation was adopted by chemists to represent the six carbons and their implicit six hydrogens, as a six sided figure (each point represents a carbon atom), and a circle in its center (the doughnut shaped electron cloud) (c)

Phthalates-1.gif

Carbons which are double-bonded to an oxygen are called a "carbonyl" group. Thus, (d)has a carbonyl group which has a carbon on one side and an "R" group on the other side. "R" is used as a generic representation of an organic molecule or simply an atom, to enable chemists to make generalizations about families of chemicals which have certain parts of their chemical structure in common, except for the "R" group. (e) is the simplified version of (d).

All phthalates follow the pattern shown by (f), where R1 and R2 may represent various atoms or functional groups. The most common and simplest phthalate is phthalic acid(g). I find phthalic acid is of special interest. If one of the OH groups is neutralized with potassium hydroxide, to give an OK, instead of OH, the resulting compound is called potassium hydrogen phthalate. This compound is used as a pH 4.00 reference, to calibrate pH meter electrodes. It has exceptional buffering abilities and changes its pH very little with significant temperature variation.

Phthalates 2.gif

(h) is still considered a member of the phthalate family because of the portion of the molecule shown in red.

Phthalates3.gif

Phthalic anhydride (i) and phthalimide (j) also belong to the phthalate family in spite of the fact that both carbonyl groups share an atom between them.

Phthalates4. gif

Those of our bacteria which can degrade phthalates should be able to degrade at least the phthalate portion of the molecules shown in g, h, i and j.

See the University of Minnesota Biocatalysis-Biodegradation pathway for Phthalates, to see the mechanism for biodegrading Phthalates.

 

 

 

Phthalates, Alkylphenols, Pesticides, Polybrominated Diphenyl Ethers, 
and other Endocrine-Disrupting Compounds in 
Indoor Air and Dust

http://www.mindfully.org/Pesticide/2003/Phthalates-Indoor-Air-Dust13sep03.htm 

Environmental Science & Technology (online) 13sep03

Ruthann A Rudel, * , † David E Camann, ‡ John D Spengler, § Leo R Korn , | and Julia G Brody †
† Silent Spring Institute, ‡ Southwest Research Institute, § Harvard University School of Public Health, | University of Medicine and Dentistry of New Jersey, * Corresponding author phone: (617)332-4288; fax: (617)332-4284; e-mail: rudel@silentspring.org
Silent Spring Institute, 29 Crafts Street, Newton, Massachusetts 02458, Southwest Research Institute, 6220 Culebra Road, P.O. Box 28510, San Antonio, Texas 78228-0510, Environmental Science and Engineering Program, Harvard University School of Public Health, Landmark Center, 401 Park Drive, Boston, Massachusetts 02115, and Division of Biometrics, University of Medicine and Dentistry of New Jersey, School of Public Health, 335 George Street, Liberty Plaza, Suite 2200, New Brunswick, New Jersey 08903-2688
Chemicals identified as endocrine-disrupting compounds (EDCs) have widespread consumer uses, yet little is known about indoor exposure. We sampled indoor air and dust in 120 homes, analyzing for 89 organic chemicals identified as EDCs. Fifty-two compounds were detected in air and 66 were detected in dust. These are the first reported measures in residential environments for over 30 of the compounds, including several detected at the highest concentrations. The number of compounds detected per home ranged from 13 to 28 in air and from 6 to 42 in dust. The most abundant compounds in air included phthalates (plasticizers, emulsifiers), o-phenylphenol (disinfectant), 4-nonylphenol (detergent metabolite), and 4-tert-butylphenol (adhesive) with typical concentrations in the range of 50- 1500 ng/m3. The penta- and tetrabrominated diphenyl ethers (flame retardants) were frequently detected in dust, and 2,3-dibromo-1-propanol, the carcinogenic intermediate of a flame retardant banned in 1977, was detected in air and dust. Twenty-three pesticides were detected in air and 27 were detected in dust, the most abundant being permethrins and the synergist piperonyl butoxide. The banned pesticides heptachlor, chlordane, methoxychlor, and DDT were also frequently detected, suggesting limited indoor degradation. Detected concentrations exceeded government health-based guidelines for 15 compounds, but no guidelines are available for 28 compounds, and existing guidelines do not consider endocrine effects. This study provides a basis for prioritizing toxicology and exposure research for individual EDCs and mixtures and provides new tools for exposure assessment in health studies.

Introduction

Current widespread interest in a range of health effects potentially associated with endocrine-disrupting compounds (EDCs) has made exposure assessment for these compounds a priority. Studies of potential health effects associated with EDCs have been hampered by lack of information about the major sources of exposure to EDCs. Furthermore, because many EDCs act additively through a common mechanism of action or have antagonistic or other interactive effects by operating at different points in cell signaling systems, consideration of exposure to mixtures is critical in studies of health effects (1-7). These questions are particularly important in relation to indoor environments, which have been identified as an important source of chemical exposures (8-11). People spend a large fraction of their time indoors, and indoor sources of chemicals, coupled with limited ventilation and slow chemical degradation processes, cause increased pollutant concentrations indoors. In fact, indoor air specifically has been described as “one of the most serious environmental risks to human health” (8).

Many high production volume chemicals—including some already identified as EDCs—have consumer uses (e.g., in plastics, detergents, and other household and consumer products) that make them potentially important indoor contaminants. While a number of comprehensive exposure studies have been conducted or are underway to characterize residential exposures to selected contaminants, particularly volatile organic compounds, pesticides, and polyaromatic hydrocarbons (PAHs), these studies have been limited to a small number of compounds and have focused on characterizing exposure pathways and sources (12-18). We were unable to locate exposure data for many of our compounds of interest, including alkylphenols, parabens, polybrominated diphenyl ethers (PBDEs), and many of the estrogenic phenolic compounds such as bisphenol A. We located only one (unpublished) study of substantial size that has characterized phthalate concentrations in indoor air (18).

The primary objective of this study is to provide an assessment of household exposure to a broad suite of organic chemicals that have been identified as EDCs. Indoor air and dust were selected for analysis because many EDCs are used in consumer products and building materials (6, 19), so these chemicals would be expected indoors. Indoor air has been identified as an important source of chemical exposure, while house dust has been demonstrated to be an important exposure pathway in young children (20). Dust also provides a record of chemicals that have been used in the home historically since degradation processes indoors are typically slow (21).

The chemicals targeted for analysis included phthalates, alkylphenols, pesticides, parabens, PBDEs, PAHs, polychlorinated biphenyls (PCBs), and other estrogenic phenols such as bisphenol A. These compounds were selected if there was evidence that they were EDCs, if they were reported to be present in commercial products or building materials, and/ or if they were compatible with one of two analytical methods being used for these samples. We previously reported on the selection of target compounds and methods for measuring them in air and dust (22).

This paper describes the analytical results for indoor air and house dust samples from 120 homes on Cape Cod, MA. Air and dust samples were analyzed for 89 target chemicals, many identified as EDCs. The large number of homes provides insight into population distributions of exposure to target compounds, and the large number of analytes provides insight into typical mixtures of EDCs to which people are exposed. Table 1 provides an overview of the study design. In addition to the air and dust samples, we collected a urine sample from a resident of the home and a detailed questionnaire about product use and home construction. We also used a geographic information system (GIS) to estimate the relative exposure at each home from historical wide-area pesticide use (23). Finally, air samples were extracted, and total estrogenic activity was determined using an MCF-7 cell proliferation assay (E-SCREEN) (24). Relationships across these measures will be reported separately. This household exposure study was conducted as part of a case-control epidemiologic study of breast cancer on Cape Cod, MA (25).


TABLE 1. Number of Analytes and Related Data Collection by Chemical Group for Samples Taken in 120 Homes on Cape Cod, MAa

			no. of				related
			analytes			data collection
chemical group 		dust 	air 	urineb 	interviewb  GIS-basedb
pesticides 		38 	39 	13 	+ 	    +
alkylphenols 		7 	7 		~ 
phthalates 		10 	9 	8 	~ 
PCBs, PAHs, PBDEs 	10 	10 		~ 
parabens 		3 	3
other estrogenic	18 	20
   phenols and misc.
estrogenic activity		+
 (E-SCREEN MCF-7 bioassay)b

a+, data of this type were collected in this study.
~,  limited questions related to sources of these compounds were included in the interview.
b   These data will be reported in subsequent papers.

Methods

Participant Selection. Eligible women were either breast cancer cases or age-matched controls, were currently alive and residing on Cape Cod, and had lived in their home at least 10 yr at the time of the sampling. To enhance variability across subjects and improve the precision of estimates of upper and lower percentiles of exposure distributions for pesticides, we oversampled individuals with higher and lower potential for pesticide exposure based on self-reported pesticide use and a GIS-derived measure of historical wide area application of persistent pesticides. Sampling was conducted in two rounds of 60 homes per round, beginning in June 1999 and ending in September 2001. All sample collection and analyses were the same for both rounds, although minor changes were made to the target analyte list between rounds.

Sample Collection.

Air.         The 24-h indoor air samples of particulate <5 µm and vapor phase materials were collected using a quiet indoor flow-controlled model SP-280 pump (Air Diagnostics and Engineering, Harrison, ME) modified to collect three parallel 160-mm URG personal pesticide sampling cartridges (University Research Glassware, Chapel Hill, NC). Each URG cartridge contained an impactor-equipped inlet (10 µm at 4 L/min) followed by a glass cartridge that was fitted with a 25-mm quartz fiber filter followed by a 3.0-g bed of XAD-2 resin sandwiched between two 113/16 in. diameter polyurethane foam plugs. Preparation of the URG cartridges is described in our earlier paper (22). Pumps were operated at a constant flow rate of 20-24 L/min. Flow control valves were used to control flow rates for the three parallel URG cartridges so that two samples were collected at flow rates of 8-9 L/min, and a third was collected at 4 L/min. Actual flow rates were determined at the beginning and end of the 24-h sample collection period using a high high-flow Gilian Gilibrator primary standard flow calibrator (Environmental Monitoring Supply). The two URGs collected at the higher flow rate were used for extraction and analysis by the two analytical methods, while the third URG was used to collect duplicate or other samples. The total volume of air sampled ranged from 10 to 14 m3 for the primary samples and from 4 to 6 m3 for the duplicate samples.

On day 1 of sample collection, the pump was placed in a frequently used room of the home, such as the living room or family room, and the URGs were suspended so that the intakes were directeddownward4 ft from the floor. The pump was then calibrated and turned on. On day 2, the URGs were disconnected, and the flow was checked. URGs were stored at -4 °C and then shipped on dry ice to Southwest Research Institute (SWRI) in San Antonio, TX, where they were extracted and analyzed.

Dust.         Dust samples were collected using a Eureka Mighty-Mite vacuum cleaner, 9 amp, modified to collect dust into a 19 × 90 mm cellulose extraction thimble (Whatman Inc., Clifton, NJ). Because of the number of our target analytes associated with plastic materials, a custom crevice tool with a holder for the extraction thimble was constructed of PTFE Teflon so dust did not contact any plastic parts of the vacuum. Dust sample collection did not begin until the air sample collection was complete. Sample collection was accomplished by slowly and lightly drawing the crevice tool just above the surface of rugs, upholstery, wood floors, windowsills, ceiling fans, and furniture in each room. Sampling was conducted in the most frequently used rooms of the house, usually 4-5 rooms and including hallways. Unfinished/semifinished areas such as basements, attics, and garages were not sampled. Using this technique and collecting for 45-90 min, approximately4gof dust was collected per sample. Cellulose thimbles containing dust were removed and placed in precleaned, certified glass jars with Teflon-lined lids (Environmental Sampling Supply, Oakland, CA). Samples were stored at -4 °C until they were shipped overnight on dry ice to SWRI. Prior to extraction, dust was tapped out of the thimbles, weighed, and sieved to <150 µm. These samples were split into aliquots for extraction and analysis by each of the two methods. Fourteen samples were split into a larger number of aliquots, with and without spiking with target compounds to determine recovery efficiency. Final sample masses of aliquots used for extraction and analysis ranged from 0.047 to 1.6 g per method (median 0.385 g).

Chemical Analysis. Chemical analysis of air and dust samples was conducted at SWRI. Two GC/MS analytical methods were used to analyze a total of 88 target compounds in air and 86 compounds in dust samples (total of 89 different compounds). One method targets neutrally extracted pesticides, phthalates, PAHs, PBDEs, and PCBs. The second method, which requires derivitazation of the extract prior to analysis, targets alkylphenols—specifically 4-nonylphenol, 4-octylphenol, and their mono- and diethoxylates as well as parabens and other phenols and biphenyls identified as EDCs. The chlorpyrifos metabolite and degradation product 3,5,6-trichloropyridinol and the methoxychlor metabolite/ degradation product 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) and some chlorinated phenols were also included as target analytes of the phenols method. All target analytes are included in Supporting Information Tables S1 (air) and S2 (dust).

Neutrals/Phthalates Extraction and Analysis.         Each sieved (<150 µm) dust sample was spiked with the required amount of surrogate solution, 40 ng/mL p-terphenyl-d14, and/or matrix spike solutions (in hexane) depending on the actual size of the dust sample. The spiked dust samples were equilibrated for 30 min at room temperature and then Soxhlet extracted using 6% diethyl ether in hexane for 16 h. The extracts were concentrated to 10 mL, and a 1-mL aliquot was cleaned by running through a florisil column (elution with 20 mL 10% acetone in hexane). When less than 2 g of sieved dust was available, proportionately smaller amounts of surrogates were spiked, and extracts were concentrated to proportionately smaller volumes. The florisil eluent was concentrated to a final volume of 2 mL with 10% ether in hexane for analysis by GC/MS.

The contents of each URG (XAD-2/PUF/filter) were Soxhlet extracted for 16 h in 150 mL of 6% ether in hexane solution with 100 mL of surrogate solution of p-terphenyld14 at 2.0 ng/mL. After being cooled, if water was visibly present in any of the extracts, the extract was passed through a glass drying tube containing sodium sulfate. The extracts were concentrated to 2mL and quantitatively transferred to a 3.7-mL vial, and the final volume was adjusted using 10% diethyl ether in hexane.

Analysis for the neutral target analytes was performed using an Agilent 6890/5973 (or a Thermoquest MD800) GC/ MS in selected ion monitoring (SIM) mode. A 60 m × 0.25 mm i.d. DB-5MS column was used as the GC analytical column. The GC/MS instrument was scanned to monitor two or four selected ions per analyte. The base peak ion (or the second most intense peak if there was interference with the base peak) was used as the quantification ion for each compound (22). Quantification was performed using labeled PAHs as internal standards (naphthalene-d8, acenaphthened10, phenanthrene-d10, chrysene –d12, perylene-d12). The percent relative standard deviation (% RSD) of each analyte was maintained within 30% during the initial five-point standard calibration. A continuing calibration standard was processed at the beginning and end of each sequence of 15 samples. The percent difference of each analyte in the midlevel standard was generally maintained within 40% of the initial calibration value during continuing calibrations.

Phenols Extraction and Analysis.         Dust samples were extracted by acidifying with 1 mL of 1:1 sulfuric acid/water (after adding 2,4,6-tribromophenol as the surrogate standard and matrix spike solutions as required), equilibrating spiked samples for 30 min at room temperature, and extracting with three portions of 18 mL of optima-grade dichloromethane (DCM) (sonicated 10 min per extraction). The three extracts were combined and evaporated under nitrogen at less than 45 °C.

The contents of each URG (quartz filter/PUF/XAD-2) were extracted 3 times with 50 mL of optima-grade DCM, 10 min shaking per extraction (after adding 2,4,6-tribromophenol as the surrogate standard and matrix spike solutions as required). After each extraction, the DCM was decanted through a glass drying tube (1.5 in. diameter, 5 in. length, HGF Scientific, Inc., Stafford, TX) containing a glass wool plug. After the last extraction, the PUF was added to the drying tube to remove any residual DCM. The extracts were concentrated to 1.0 mL under nitrogen using a N-EVAP analytical evaporator at 35-40 °C. All glassware was washed with acidified DCM (3 mL of HCl/600 mL of DCM) prior to use.

Dust and air extracts were derivatized with N,O-bis-(trimethylsilyl) trifluoroacetamide (BSTFA) at 60 °C for 60 min. Analysis was performed using an Agilent 6890/5973 GC/MS system in SIM mode. A 30 m × 0.25 mm i.d. DB- 5.625 column was used as the GC analytical column. Quantification was performed using 3,4,5-trichlorophenol as the internal standard. A continuing calibration standard was processed at the beginning and end of each sequence of 15 samples. The percent difference of each analyte in the mid-level standard was maintained within 40% of the initial calibration value during continuing calibrations. QA/QC. Extensive QA/QC measures were conducted to ensure accuracy and reliability of measurements. Of particular concern was the possibility of field and laboratory contamination with ubiquitous target compounds in plastics and other common products, so a high proportion of blank samples was included in this study.

Air.         Potential sample contamination by target compounds was evaluated using both laboratory solvent and matrix (URG contents including quartz filter/PUF/XAD-2) blanks as well as field matrix blanks shipped to the laboratory with samples. Analysts were blinded to the identity of field blanks. A total of 36 neutrals and 35 phenols blank samples were analyzed along with the 120 field samples reported here. These included field blanks (n = 7), matrix blanks (n = 23), and solvent blanks (6 neutrals, 5 phenols). The nominal analyte reporting limit in this study was the analyte level in the lowest standard of the initial five-point calibration curve. When an interfering compound was present so that the presence of a target analyte at the detection limit was obscured, the reporting limit of the analyte was raised to the size of the false interfering peak. Method Reporting Limits (MRLs) are listed in Table 2 (detected analytes) and in Table S1 in Supporting Information (all analytes). Phthalates, alklyphenols, and bisphenol A were the only compounds detected in any blanks. Target analytes were reported as not detected in samples if they were present at less than the mean + 3 SD of the amount in blank samples.

Method performance was evaluated using matrix spike samples. Over the course of the sample collection, 16 phenols or 17 neutrals PUF/XAD-2 preparations were spiked with target compounds. Average recoveries ranged from 40% to 220%; data in tables and figures are qualified for any compounds with average recoveries less than 60% or greater than 150% or for compounds with highly variable recoveries (>50% of spikes outside the 60-150% recovery range). Full-scan confirmational analyses were performed on two air sample extracts to verify large quantifications of o-phenyl phenol, propoxur, and phthalates. In addition, the two air samples with highest concentrations of 2,3-dibromo-1-propanol were confirmed by full scan.

Duplicate air samples (field duplicates; n = 10) were also analyzed by both neutrals and phenols methods to characterize reproducibility. Percent differences for field duplicate samples were typically between 15 and 25%. For a few compounds, average percent differences between field duplicates were higher than 30% (carbaryl, 33%; piperonyl butoxide, 39%; pentachlorophenol, 42%; 2,3-dibromo-1- propanol, 41%). The analyte o-phenyl phenol was included as a target analyte in both analytical methods for air and for dust samples as another check of the reliability of these methods. Percent differences between measurements by the two methods averaged 31%, and the two measures were well correlated (Pearson correlation coefficient, 0.87), although the phenols method tended to report slightly lower values than the neutrals method for this compound.

Breakthrough was not specifically evaluated, however “sandwich” combinations of XAD-2 between two layers of PUF have been shown to efficiently trap semivolatile organic chemicals with vapor pressures up to 10-3 kPa (26), so we expect these target compounds to be efficiently trapped with this preparation.

Dust.         Potential sample contamination by target compounds was evaluated for dust samples by running 27 neutrals and 22 phenols solvent blanks. Matrix or field blanks are not readily available for house dust samples. Certain phthalates, nonyl- and octylphenol diethoxylate, and 2-sec-butylphenol were the only target compounds detected in solvent blanks. These target analytes were reported as not detected in samples if they were present at less than the mean + 3 SD of the blank samples.

Method performance (percent recoveries) was evaluated using matrix spiked (n = 14) samples. Average recoveries ranged from 40% to 220%.

Full-scan confirmational analyses were performed on nine dust sample extracts to verify large quantifications of bendiocarb, carbaryl, chlordane, chlorpyrifos, cypermethrin, DDT, methoxychlor, permethrin, piperonyl butoxide (PBO), propoxur, phthalates, PCB congeners, andPBDE99. The 2,3- dibromo-1-propanol detects were also confirmed by full-scan GC/MS of three dust samples.

Duplicate dust samples (laboratory splits; n = 4) were also analyzed to characterize reproducibility. Average percent differences between duplicates were less than 20% with the exception of carbaryl (59%), bis(2-ethylhexyl) adipate (30%), benz[a]anthracene (39%), benz[a]pyrene (40%), and piperonyl butoxide (22%).

Data Analysis. The unadjusted descriptive statistics were calculated using the standard formulas for simple random samples. Data below the limit of detection were set equal to zero, which will cause the sample mean to be biased low.

Adjusted geometric mean concentrations and confidence intervals were calculated for target compounds after adjusting for stratified sampling. To achieve this, data and detection limits were log transformed. If there were no data below the limit of detection in a stratum, the usual within stratum arithmetic mean and standard deviation were calculated. When there were data below the limit of detection in a stratum, the normal distribution maximum likelihood estimates for the mean and standard deviation, assuming left censoring at the log detection limit were calculated. If there were no values above the detection limit within a stratum, the previous estimate does not exist.

After the within strata estimates were obtained, the adjusted means and their standard errors were calculated using the standard formulas for stratified samples (27). Since the data were sampled separately from cases and controls and participants in the first round were limited to women over 65 yr, the sample is more complex than a stratified random sample from the nine exposure cells. However, for the purposes of summarizing the data, they were assumed to have the simple stratified structure.

The 95% confidence intervals for the adjusted means were calculated using a t-distribution, with the Satterthwaite approximation to the degrees of freedom. These confidence intervals assume a normal distribution within the population. Since this assumption is probably not true for this population, the confidence intervals should be regarded as only approximate. The mean, standard error, and confidence intervals were exponentiated back to the original scale of the concentration data. It is important to realize that the estimate of the geometric mean in the original scale is consistent for the median of a log-normal distribution rather than the mean. The confidence interval in the original scale should be interpreted as a confidence interval for the median of the concentration values.

Results and Discussion

Summary Statistics.  Summary data for all detected compounds are shown in Tables 2 (air) and 3 (dust), and Tables S1 and S2 in Supporting Information provide more detailed statistics and include target compounds that were not detected. Chemicals are divided into the following groups: (1) alkylphenols; (2) phthalates; (3) parabens; (4) PAHs, PCBs, and PBDEs; (5) pesticides; and (6) phenols and miscellaneous. The summary tables (Tables 2 and 3) show the number of samples tested for each detected analyte, the percent of samples with detectable levels, the method reporting limit, and the median and range for the raw data. Tables S1 and S2 in Supporting Information include additional descriptive statistics for the raw data (arithmetic mean, range of detects, and the median, 75th, and 90th percentile concentrations detected). In addition, Tables S1 and S2 (Supporting Information) present geometric means and confidence intervals for the data after (i) adjusting for stratification in the participant selection process based on self-reported and GIS-based opportunities for pesticide exposure and (ii) using maximum likelihood estimates with left censoring for nondetects. Comparison of the adjusted geometric means with the medians of the raw data show few differences, suggesting that the adjustments and parametric assumptions are in agreement with the raw results.

In all, 52 of 88 target compounds were detected in indoor air and 66 of 86 compounds were detected in house dust. The most frequently detected compounds were phthalates, which are ubiquitous in plastics, building materials, food packaging, and personal care products, and alkylphenols, which are impurities or degradation products of the alkylphenol polyethoxylates that are used in detergents and personal care products and as inert ingredients in pesticide formulations. Three phthalates were detected in air in 100% of homes, and three different phthalates were detected in dust in 100% of homes. Nonylphenol was also detected in air in 100% of homes. Other frequently detected chemicals in air and dust samples include methyl paraben, which is used in personal care products; PBDEs, which are flame retardants with properties similar to PCBs; and bisphenol A, which is a constituent of polycarbonate plastics. Pesticides detected in at least half the homes included DDT, methoxychlor, pentachlorophenol, permethrin, and the synergist piperonyl butoxide (PBO) (dust) and chlordane and pentachlorophenol (air). The disinfectant o-phenyl phenol was detected in air in 100% of homes and was detected in a majority of dust samples. The number of target chemicals detected per sample ranged from 13 to 28 for air samples (mean 19) and from 6 to 42 for dust samples (mean 26). Figures 1 and 2 show concentration distributions for the most commonly detected compounds in air and dust, grouped by chemical class; and chemicals and pesticides detected at highest concentrations are summarized in Table 4.

Most Abundant Compounds.

Phthalates.        Phthalates, many of which have been characterized as EDCs due to their ability to interfere with androgen action (28, 29), were detected at the highest concentrations in both air and dust, although different phthalates dominated the two media. In indoor air, diethyl phthalate (DEP) and di-n-butyl phthalate (DBP) were present at the highest concentrations. The 90th percentile concentrations in indoor air were 1560 and 426 ng/m3 for DEP and DBP, respectively. These are the same phthalates observed to be most abundant in human urine samples reported by theCDCfor a cross-section of U.S. adults (30). In dust, diethyl hexyl phthalate (DEHP) and butyl benzyl phthalate (BBP) were the chemicals detected at the highest concentrations. The 90th percentile concentrations for these phthalates in dust were 854 and 277 µg/g dust, respectively. In addition, high concentrations of an unidentified phthalate with >7 carbon chain were detected (approximate concentration range 4-800 µg/g), and this compound interfered with detection of diisononyl phthalate.

In the absence of data, most estimates of exposure to phthalates have concluded that inhalation is not an important route of exposure (29). However, the high indoor air concentrations detected here and the correspondence between phthalates abundant in air and urine suggest that inhalation exposures may be important. While exposure estimates based on ambient air concentrations may appear to be an insignificant portion of total exposure, actual exposure by inhalation is likely to be higher than would be estimated on the basis of ambient indoor air concentrations because phthalate-containing product use may result in personal air concentrations that are much higher than ambient concentrations.

Alkylphenols.        Alkylphenols, particularly 4-nonylphenol (4- NP) and its mono- and diethoxylates, were also among the most abundant compounds detected (4-NP 90th percentile in air, 230 ng/m3; NP2EO in dust, 18.9 µg/g) (see Tables 2 and 3 and Tables S1 and S2 in Supporting Information). In addition to being present at high concentrations relative to other compounds detected, 4-NP was detected in 100% of indoor air samples. These data provide the first evidence that 4-NP is an important contaminant of indoor air, although lower concentrations have been reported in outdoor air (31). This result contrasts with conclusions by others that 4-NP is not volatile and would be unlikely to be a significant air contaminant (32, 33). Nonylphenol, octylphenol, and their small ethoxylates have been identified as EDCs because of their ability to mimic estrogen action (24).

Parabens and Phenols.        Several other estrogenic compounds, presumably originating from consumer products, were commonly detected in air. These include the disinfectant o-phenyl phenol (90th percentile, 440 ng/m3), 4-tert-butyl phenol (90th percentile, 43ng/m3), and methyl paraben (90th percentile, 11 ng/m3).

Pesticides.        Pesticides detected at the highest concentrations include the currently used pesticide permethrin and the synergist piperonyl butoxide (PBO) in dust (Table 4). Other pesticides detected at relatively high concentrations include heptachlor, propoxur, chlordane, chlorpyrifos, and pentachlorophenol in air and methoxychlor, DDT, pentachlorophenol, chlorpyrifos, carbaryl, and propoxur in dust (Table 4, Figures 1 and 2). The 90th percentile concentrations for these pesticides ranged from 10 to 19 ng/m3 in air and from 1.7 to 17 µg/g in dust. The prevalence indoors of pesticides that have been banned or restricted for many years, such as DDT, chlordane, heptachlor, methoxychlor, dieldrin, and pentachlorophenol, suggests that degradation indoors is negligible. This observation is further supported by the abundance of DDT in dust relative to its degradation product DDE (Figure 2).

Brominated Flame Retardants.         PBDEs, which are flame retardants widely used in foams and other plastics, were detected in dust samples with a concentration distribution similar to the carcinogenic PAHs, benzo[a]pyrene, and benz- [a]anthracene (Figure 2), with 90th percentile concentrations ranging from 0.7 to 4.1 µg/g dust. We targeted tetra- and pentabrominated BDEs, which originate from polyurethane foams. PCBs, which have a similar mechanism of endocrine toxicity to PBDEs, were also detected in air and dust samples but at somewhat lower concentrations (Figure 2).

Another notable finding in this study was detects of the mutagen and carcinogen 2,3-dibromo-1-propanol (34) in both dust and air samples. This chemical is described as an intermediate in the production of the flame retardant TRIS (tris(2,3-dibromo-1-propyl)phosphate), which was banned in 1977, and also as a urinary metabolite of TRIS (34). We detected it in both indoor air (9% of 85 homes with detects and a wide range of concentrations with maximum of 200 ng/m3) and house dust (6% of 88 homes with maximum of 42.8 µg/g dust).

Toxicity Data and Implications. For over 30 EDCs that we detected in indoor air and dust, including alkylphenols, PBDEs, 2,3-dibromo-1-propanol, parabens, and some phenols (e.g., bisphenol A, 4-tert-butyl phenol), our measurements are the first that we know of in these media. In some cases, these are the first we are aware of in any media. The exposure data reported here provide a basis for prioritizing EDCs for more comprehensive toxicity testing and for assessing potential risks once toxicity testing is complete. The compounds listed in Table 4, for example, provide a starting point for prioritization based on chemical concentrations, and consideration of preliminary toxicity data would suggest prioritization of additional compounds, such as the brominated flame retardants.

Comparison with Available Government Risk Evaluations.        We sought to compare our detected concentrations with risk-based media concentrations that have been developed for air, and we compared our dust concentrations with residential soil risk-based concentrations, which are designed to protect a small child from toxicant exposure via soil ingestion. Of the measurements that we were able to compare with EPA risk-based concentrations (35, 36), measurements in our study exceeded risk-based concentrations in at least one home for DEHP, PCBs, DDT, chlordane, dieldrin, heptachlor, and lindane (dust and air) and for benzo[a]pyrene, benz- [a]anthracene, chlorpyrifos, dicofol, and pentachlorophenol (dust only). However, because these EPA guidelines do not consider endocrine effects, these comparisons are of limited usefulness. In addition, we were unable to locate any risk-based media concentrations for 28 of the chemicals that we detected in homes in this study, including alkylphenols, parabens, some phthalates and pesticides, and most of the phenolic compounds, so we cannot evaluate the potential health risks associated with the detected concentrations using these types of data. Given the evidence of exposure reported here for EDCs, it is important to note the limitations in available toxicity data so that further work in this area can be prioritized. Furthermore, given that we detected so many EDCs and others report that mixtures at sub-threshold concentrations act additively (4, 7), our results provide additional evidence that consideration of mixtures is important in assessing EDC exposure.

Indoor Sources.        For virtually all the target compounds where comparison data are available, levels detected in indoor air are higher than those reported by others for outdoor air (9, 12, 14, 22, 37, 38), confirming that most of these chemicals originate in household products and materials. For example, one study of outdoor air in urban New York/New Jersey reported that average levels of 11 nonylphenol isomers combined were in the range of 10 ng/m3 (31), while in our study the average concentration of 4-nonylphenol was 130 ng/m3. Median outdoor concentrations ofDBPwere reported to be 18 ng/m3 in a suburban California location (18) as compared with a median indoors in our study of 210 ng/m3. While environmental regulatory programs have traditionally focused on outdoor ambient air, surface water, drinking water, and hazardous industrial processes, little attention has been paid to the home environment.

Regional Variation.        Comparison of these data with other studies can provide insights about regional, demographic, and temporal patterns in exposure to these compounds. Where comparison data were available (primarily for pesticides, PCBs, PAHs, and some phthalates), levels detected in our study (on Cape Cod, MA) are similar to levels reported elsewhere—especially for air concentrations (9, 12-14, 18, 39-42). Some regional differences observed for dust levels were reported in ref 40. Briefly, dust concentrations of PAHs on Cape Cod appear lower than on Long Island, NY, but higher than in many other regions of the United States (Iowa; Seattle, WA; Los Angeles, CA); levels of PCBs in dust appear higher on Cape Cod than in Iowa and Los Angeles, CA, but similar to or lower than Seattle, WA; Detroit, MI; and Long Island NY; levels of pesticides in Cape Cod house dust appear higher than other regions for DDT, carbaryl, chlordane, methoxychlor, pentachlorophenol, and propoxur; and levels appear lower than other regions for diazinon and permethrin. For chlorpyrifos and o-phenyl phenol in dust, Cape Cod levels are higher than some regions and lower than others (40). Compared with PBDE levels in indoor dust reported from Germany (43) and the United Kingdom (44), PBDE levels reported here were 5-10 times higher. These comparisons must be interpreted with caution considering differences between studies in methods of sample collection and demographics of study populations.

Individuals with Highest Measurements.        As is typical for environmental measurement data, the exposure distributions for most analytes are highly skewed. Thus, the maximum concentration detected is often much higher than even the 90th or 95th percentiles. This finding suggests that (for each analyte) a small proportion of the population (e.g., 1%) receives substantially higher exposures than the majority. Since most health-based standards are derived to protect the 90th or 95th percentile-exposed individual in a population, these standards may not be adequately protective of the highest exposed1%of the population who have exposures that are substantially higher, sometimes by orders of magnitude. For example, the maximum air concentrations for DDT and diazinon were 58 and 61 times higher than the 90th percentile concentrations, respectively. In dust samples, maximum concentrations for diazinon, chlorpyrifos, and PCB 153 were 228, 122, and 89 times higher than 90th percentile concentrations, respectively. The flame retardant 2,3-dibromo-1-propanol, while it was detected in fewer than 10% of the homes, was detected over a very large concentration ranges the maximum detected concentrations in both air and dust were at least 200 times higher than the MRL.

Tools for Health Studies and Source Identification.        There is great interest in conducting epidemiologic studies to evaluate effects of exposures to EDCs, but limitations in exposure assessment tools have impeded progress. Our study was designed in part to develop improved exposure tools for EDCs and to address some key data gaps—for example, these data provide a basis for prioritizing the development of exposure biomarkers. Data on key sources of these compounds and factors that affect exposure levels allow for further development of exposure assessment and source reduction tools and provide insight into exposure characterizations in health studies that have already been completed.


FIGURE 1. Cumulative frequency distributions of measured levels of the most frequently detected chemicals in indoor air samples from 120 homes. Distributions are truncated at the reporting level, and concentrations are shown on a log scale on the x-axis. Footnotes for specific chemicals refer to notes in Table 2. Chemicals are grouped into classes: (a) PAHs, PCBs, and misc.; (b) pesticides; (c) alkylphenols; and (d) phthalates.

Concentration In Indoor Air (ng/m3)

Concentration In Indoor Air (ng/m3)

Concentration In Indoor Air (ng/m3)

Concentration In Indoor Air (ng/m3)


FIGURE 2. Cumulative frequency distributions of measured levels of frequently detected chemicals in indoor dust samples from 120 homes. Distributions are truncated at the reporting level, and concentrations are shown on a log scale on the x-axis. Footnotes for specific chemicals refer to notes in Table 3. Chemicals are grouped into classes: (a) PAHs, PCBs, PBDEs, and misc.; (b) pesticides; (c) alkylphenols; and (d) phthalates.

Concentration (micrograms/g dust)

Concentration (micrograms/g dust)

Concentration (micrograms/g dust)

Concentration (micrograms/g dust)


TABLE 2. Summary Data for Detected Chemicals in Indoor Air (ng/m3)a

					no. of
					homes		%
	chemical			sampled	MRLb	>RL	min	median	max
___________________________________________________________________________________
Alkylphenols and Alkylphenol Ethoxylates
	4-nonylphenol			120	3	100	21	110	420
	nonylphenol monoethoxylate	120	6	95	<RL	17	73
	nonylphenol diethoxylate	120	4	33	<RL	<RL	26
	nonylphenol ethoxycarboxylate 	30	18	7	<RL	<RL	18
	octylphenol monoethoxylate	120	10	93	<RL	8.6	50
	octylphenol diethoxylate	120	8	5	<RL	<RL	120
Phthalates
	diethyl phthalatec		120	75	100	130	590	4300
	di-n-butyl phthalated		120	21	100	52	220	1100
	benzyl butyl phthalate		120	31	44	<RL	<RL	480
	bis(2-ethylhexyl) phthalate	102	59	68	<RL	77	1000
	dicyclohexyl phthalate		102	2	21	<RL	<RL	280
	bis(2-ethylhexyl) adipate	120	3	99	<RL	9.0	66
	di-n-propyl phthalate		120	3	15	<RL	<RL	27
	diisobutyl phthalate		120	2	100	11	61	990
Parabens
	butyl paraben			120	4	8	<RL	<RL	3.2
	ethyl paraben			120	1	3	<RL	<RL	4.0
	methyl paraben			120	1	67	<RL	2.9	21
Polycyclic Aromatic Hydrocarbons (PAHs)	
	anthracene			90	1	1	<RL	<RL	3.7
	pyrene				90	1	27	<RL	<RL	3.4		
Polychlorinated Biphenyls (PCBs) and Polychlorinated Diphenyl Ethers (PBDEs)
	PCB 52				120	1	31	<RL	<RL	25
	PCB 105				116	1	3	<RL	<RL	3.6
	PCB 153	 	 	 	119	1	6	<RL	<RL	6.7
Pesticides
	4,4'-DDD			90	1	3	<RL	<RL	3.5
	4,4'-DDE			90	1	2	<RL	<RL	5.1
	4,4'-DDT			90	1	10	<RL	<RL	30
	bendiocarb			90	6	4	<RL	<RL	120
	carbaryl			120	2	11	<RL	<RL	22
	α-chlordane			120	1	51	<RL	0.10	61
	g-chlordane			120	1	53	<RL	0.22	83
	chlorothalonil			90	1	17	<RL	<RL	36
	chlorpyrifos			120	1	38	<RL	<RL	92
	3,5,6-trichloro-2-pyridinold	120	1	13	<RL	<RL	7.3
	diazinon			120	1	40	<RL	<RL	550
	dieldrin			90	2	4	<RL	<RL	3.0
	heptachlor			120	1	44	<RL	<RL	71
	lindane				90	2	1	<RL	<RL	110
	methyl parathiond		90	2	6	<RL	<RL	92
	pentachlorophenold		120	1	58	<RL	1.6	34
	cis-permethrin			120	1	3	<RL	<RL	3.7
	trans-permethrin		120	2	3	<RL	<RL	5.4
	o-phenylphenol			120	1	100	12	71	970
	  (neutrals method) 
	o-phenylphenol			120	1	100	9.8	70	590
	  (phenols method)
	piperonyl butoxide		90	1	6	<RL	<RL	110
	prometon			90	2	1	<RL	<RL	4.3
	propoxure			120	4	47	<RL	<RL	110
	trifluralind,f			90	1	10	<RL	<RL	23
Phenols and Miscellaneous
	2,3-dibromo-1-propanol		85	1	9	<RL	<RL	200
	2,4-dihydroxybenzophenoned	85	1	1	<RL	<RL	1.2
	4,4'-methylenediphenold		120	1	3	<RL	<RL	4.9
	4-tert-butylphenol		120	1	100	3.4	16	290
	p-phenylphenol			120	1	1	<RL	<RL	1.5
	2,4-dichlorophenol		120	1	28	<RL	<RL	6.0 
	4-nitrophenol			120	1	17	<RL	<RL	7.0	   

a  Additional summary statistics in Table S1 in Supporting Information. 
b  MRL is the   typical method reporting limit (RL) reported as median 
   reporting limit for nondetect samples. Some samples had higher or lower 
   RLs due to smaller or larger sample sizes, respectively, or due to 
   interferences. For chemicals with detects in all samples, MRL is derived 
   from matrix blank samples and assumes typical sample size (11.6 m3). 
   For chemicals detected in blanks, MRL is the mean + 3 SD of the levels 
   in matrix blanks and assumes typical sample size. 
c  Average of matrix spike recoveries was high (150-220%). 
d  Matrix spike recoveries were variable (>50% of spikes outside the range of 60-150%). 
e  Interference from XAD-2 breakdown affects propoxur identification and quantification. 
f  Average of matrix spike recoveries was low (40-60%).	 

TABLE 3. Summary Statistics for Household Dust Samples (µg/g)a

					no. of
					homes		%
	chemical			sampled	MRLb	>RL	min	median	max
___________________________________________________________________________________
Alkylphenols and Alkylphenol Ethoxylates
	4-nonylphenol			118	1	80	<RL	2.58	8.68
	nonylphenol monoethoxylate	118	2	86	<RL	3.36	15.6
	nonylphenol diethoxylate	118	2	86	<RL	5.33	49.3
	nonylphenol ethoxycarboxylate	30	3	93	<RL	2.12	9.45
	4-octylphenol			118	0.2	2	<RL	<RL	0.090
	octylphenol monoethoxylate	118	0.5	50	<RL	0.13	1.99
	octylphenol diethoxylate	118	0.2	69	<RL	0.306	2.12
Phthalates
	diethyl phthalate		119	4	89	<RL	4.98	111
	di-n-butyl phthalate		119	24	98	<RL	20.1	352
	benzyl butyl phthalatee		119	3	100	3.87	45.4	1310
	bis(2-ethylhexyl) phthalatee	101	8	100	16.7	340	7700
	dicyclohexyl phthalate		101	0.8	77	<RL	1.88	62.7
	bis(2-ethylhexyl) adipatec,d	119	0.4	100	0.935	5.97	391
	di-n-hexyl phthalate		119	0.1	76	<RL	1.1	30.6
	diisobutyl phthalate		119	1	95	<RL	1.91	39.1
Parabens
	butyl paraben			118	0.2	22	<RL	<RL	3.92
	methyl paraben			118	0.3	90	<RL	0.978	8.24
	ethyl paraben			118	0.2	9	<RL	<RL	2.18
Polycyclic Aromatic Hydrocarbons (PAHs)
	anthracene			89	0.2	13	<RL	<RL	3.05
	benz[a]anthracene		119	0.3	76	<RL	0.499	10.0
	pyrene				89	1.2	96	<RL	1.33	39.8
	benzo[a]pyrene			119	0.4	85	<RL	0.712	18.1
Polychlorinated Biphenyls (PCBs) and Polybrominated Diphenyl Ethers (PBDEs)
	PCB 52				119	0.2	8	<RL	<RL	15.7
	PCB 105				119	0.2	9	<RL	<RL	16.5
	PCB 153				119	0.2	16	<RL	<RL	35.3
	PBDE 47				89	0.4	45	<RL	<RL	9.86
	PBDE 99				89	0.4	55	<RL	0.304	22.5
	PBDE 100			89	0.3	20	<RL	<RL	3.40
Pesticides
	4,4'-DDD			119	0.2	9	<RL	<RL	0.718
	4,4'-DDE			119	0.2	13	<RL	<RL	0.738
	4,4'-DDT			119	0.3	65	<RL	0.279	9.61
	alachlor			119	0.3	1	<RL	<RL	0.221
	bendiocarbc,d			114	0.2	12	<RL	<RL	40.7
	carbarylc,d			119	0.4	43	<RL	<RL	34.4
	α-chlordane			119	0.3	39	<RL	<RL	9.97
	y-chlordane			119	0.3	41	<RL	<RL	10.6
	chlorothalonil			119	0.2	19	<RL	<RL	3.20
	chlorpyrifos			119	0.2	18	<RL	<RL	228
	3,5,6-trichloro-2-pyridinol	118	0.2	31	<RL	<RL	44.7
	cypermethrinc			119	1	5	<RL	<RL	172							
	diazinon			119	0.2	14	<RL	<RL	51.0
	dicofol (ketone form)		119	0.4	6	<RL	<RL	3.54
	dieldrin			119	0.4	12	<RL	<RL	4.89
	lindane				119	0.4	2	<RL	<RL	1.04
	heptachlor			119	0.2	3	<RL	<RL	0.549
	malathion			119	0.2	3	<RL	<RL	1.48	
	methoxychlor			119	0.5	54	<RL	0.240	12.9
	pentachlorophenol		118	0.3	86	<RL	0.793	7.96
	methyl parathion		119	0.3	3	<RL	<RL	0.992
	cis-permethrin			119	0.3	45	<RL	<RL	61.9
	trans-permethrin		119	0.4	53	<RL	0.387	98.0
	o-phenylphenol (neutrals method)119	0.4	67	<RL	0.283	1.67
	o-phenylphenol (phenols method)	118	0.3	73	<RL	0.303	2.40
	piperonyl butoxided		119	0.2	66	<RL	0.426	624
	prometon			119	0.3	1	<RL	<RL	0.095
	propoxurc			119	0.2	42	<RL	<RL	12.6

Phenols and Miscellaneous
	2,3-dibromo-1-propanol		88	0.2	6	<RL	<RL	42.8
	2,4-dihydroxybenzophenone	88	0.7	63	<RL	0.515	9.36
	3-biphenylol			118	0.2	2	<RL	<RL	0.170
	4,4'-biphenyldiold		118	0.3	6	<RL	<RL	3.89
	4,4'-methylenediphenol		118	0.2	7	<RL	<RL	0.934
	4-cumylphenol			118	0.2	3	<RL	<RL	0.542
	4-tert-butylphenol		118	0.2	5	<RL	<RL	1.12
	bisphenol Ad			118	0.2	86	<RL	0.821	17.6
	p-phenylphenol			118	0.2	5	<RL	<RL	2.40
	2,4-dichlorophenol		118	0.2	5	<RL	<RL	0.227
	4-nitrophenolc			118	0.4	42	<RL	<RL	4.25

a   Additional summary statistics in Table S2 in Supporting Information. 
b   MRL is the typical method reporting limit (RL) reported as median 
    reporting limit for nondetect samples. Some samples had higher or lower 
    RLs due to smaller or larger sample sizes, respectively, or due to interferences. 
    For chemicals with detects in all samples, MRL is derived from solvent blank 
    samples and assumes typical sample size (0.38 g). For chemicals with detects 
    in solvent blanks, MRL is the mean + 3 SD of the levels in blanks and assumes 
    typical sample size. 
c   Average of matrix spike recoveries was high (150-220%). 
d   Matrix spike recoveries were variable (>50% of spikes outside the range of 60-150%). 
e   Spike recovery not determined.

TABLE 4. Most Abundant Chemicals

	Ten Chemicals with Highest 90th Percentile Concentrations

	air (ng/m3)a				dust (µg/g)a
	diethyl phthalate (1,600) 100		bis(2-ethylhexyl)phthalate (854) 100
	o-phenylphenol (440) 100		benzyl butyl phthalate (277) 100
	di-n-butyl phthalate (430) 100		di-n-butyl phthalate (43.9) 98
	4-nonylphenol (230) 100			nonylphenol diethoxylate (18.9) 86
	bis(2-ethylhexyl) phthalate (210) 68	bis(2-ethylhexyl) adipate (16.6) 100
	diisobutyl phthalate (150) 100		trans-permethrin (16.5) 53
	benzyl butyl phthalate (68) 44		piperonyl butoxide (15.1) 66
	4-tert-butylphenol (43) 100		diethyl phthalate (10.8) 89
	nonylphenol monoethoxylate (41) 95	nonylphenol monoethoxylate (8.55) 86
	bis(2-ethylhexyl) adipate (22) 99	cis-permethrin (7.04) 45						

	10 Pesticides with Highest 90th Percentile Concentrations

	air (ng/m3)a				dust (µg/g)a
	o-phenylphenol (440) 100		trans-permethrin (16.5) 53
	heptachlorb (19) 44			piperonyl butoxide (15.1) 66
	propoxur (16) 49			cis-permethrin (7.04) 45
	y-chlordaneb (12) 53			methoxychlorb (3.38) 54
	chlorpyrifos (12) 38			4,4'-DDTb(3.19) 65
	pentachlorophenolb (10) 58		pentachlorophenolb (2.42) 86
	diazinon (9.0) 40			chlorpyrifosb (1.87) 18
	α-chlordaneb (8.8) 51			carbaryl (1.72) 43
	chlorothalonil (3.4) 17			propoxur (1.70) 42
	3,5,6-trichloro-2-pyridinol (1.1) 13	bendiocarb (1.11) 12
	
	a  Percent detection in italics. 
	b  Indicates banned or restricted-use pesticide (at time of sample collection).	

Supporting Tables

http://pubs.acs.org/subscribe/journals/esthag/suppinfo/es0264596/es0264596si20030910_033657.pdf

Acknowledgments

The authors thank the following individuals for their substantial contributions to this effort: Nancy Ho, Jennifer Roberts Kachajian, Patricia Pajaron, and Christopher Swartz for coordinating and implementing the sample and field data collection; Wen Ye for data management and consulting on statistical issues; Jose Vallarino for customizing our sampling equipment; Alice Yau and Michelle Zuniga for chemical analytical support; and Karen Reece and Caitlin Willoughby for literature review and technical assistance in preparing the manuscript. We especially acknowledge the immeasurable contributions of Cheryl Osimo, Cape Cod outreach coordinator, and the women of Cape Cod who contributed their time and energy to participate in the sampling program. This research was funded by an appropriation of the Massachusetts Legislature administered by the Massachusetts Department of Public Health. Manuscript preparation was supported by the Boston Affiliate of the Susan Komen Breast Cancer Foundation, and the Susan S. Bailis Breast Cancer Research Fund.

Supporting Information Available

More detailed summary statistics for these data and a list of chemicals that were not detected in this study (Tables S1 and S2). This material is available free of charge via the Internet at http://pubs.acs.org.&#160;

Literature Cited

(1) U.S. Environmental Protection Agency. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report; U.S. Government Printing Office: Washington, DC, August 1998.

(2) Rudel, R. Environ. Health Perspect. 1997, 105, 655-663.

(3) National Research Council. Hormonally Active Agents in the Environment; National Academy Press: Washington, DC, 1999.

(4) Silva, E.; Rajapakse, N.; Kortenkamp, A. Environ. Sci. Technol. 2002, 36 (8), 1751-1756.

(5) Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Environ. Sci. Technol. 2002, 36 (6), 1202-1211.

(6) Daughton, C. G.; Ternes, T. A. Environ. Health Perspect. 1999, 107 (Suppl. 6), 907-937.

(7) Payne, J.; Scholze, M.; Kortenkamp, A. Environ. Health Perspect. 2001, 109 (4), 391-397.

(8) U.S. General Accounting Office. Indoor Pollution: Status of Federal Research Activities; GAO/RCED-99-254; U.S. Government Printing Office: Washington, DC, 1999.

(9) Whitmore, R. W.; Immerman, F. W.; Camman, D. E.; Bond, A. E.; Lewis, R. G.; Schaum, J. L. Arch. Environ. Contam. Toxicol. 1994, 26, 47-59.

(10) Colt, J. S.; Zahm, S. H.; Camann, D. E.; Hartge, P. Environ. Health Perspect. 1998, 106 (11), 721-724.

(11) Lioy, P. Environ. Health Perspect. 1995. 103 (Suppl. 3), 35-43.

(12) Gordon, S. M.; Callahan, P. J.; Nishioka, M. G.; Brinkman, M. C.; O’Rourke, M. K.; Lebowitz, M. D.; Moschandreas, D. J. Exposure Anal. Environ. Epidemiol. 1999, 9, 456-470.

(13) Pang, Y.; MacIntosh, D. L.; Camann, D. E.; Ryan, P. B. Environ. Health Perspect. 2002, 110 (3), 235-240.

(14) Robertson, G. L.; Lebowitz, M. D.; O’Rourke, M. K.; Gordon, S.; Moschandreas, D. J. Exposure Anal. Environ. Epidemiol. 1999, 9, 427-434.

(15) Robertson, G. L.; Krinsley, J.; O’Rourke, M. K.; Lebowitz, M. Epidemiology 1998, 9 (Suppl. 4), S132.

(16) Lebowitz, M. D.; O’Rourke, M. K.; Rogan, S.; Jin, S.; Gordon, S.; Moschandreas, D.; Needham, L. Epidemiology 1998, 9, S133.

(17) Wallace, L. J. Exposure Anal. Environ. Epidemiol. 1991, 1 (2), 157-192.

(18) Sheldon, L.; Clayton, A.; Keever, J.; Perritt, R.; Whitaker, D. PTEAM: Monitoring of Phthalates and PAHS in Indoor and Outdoor Air Samples in Riverside, California; California Environmental Protection Agency, Air Resources Board Research Division: Sacramento, CA, 1992.

(19) SRI International. Chemical Economics Handbook; SRI Consulting: Menlo Park, CA, 1995.

(20) Butte, W.; Heinzow, B. Rev. Environ. Contam. Toxicol. 2002, 175, 1-46.

(21) Roberts, J. W.; Budd, W. T.; Chuang, J.; Lewis, R. G. Chemical Contaminants in House Dust: Occurrences and Sources [Govt Reports Announcements & Index (GRA&I), Issue 24, 1993]; U.S. EPA, Atmospheric Research and Exposure Assessment Lab: Research Triangle Park, NC, 1993.

(22) Rudel, R. A.; Geno, P. W.; Sun, G.; Yau, A.; Spengler, J. D.; Vallarino, J.; Brody, J. G. J. Air Waste Manage. Assoc. 2001, 51, 499-513.

(23) Brody, J. G.; Vorhees, D. J.; Melly, S. J.; Swedis, S. R.; Drivas, P. J.; Rudel, R. A. J. Exposure Anal. Environ. Epidemiol. 2002, 12, 64-80.

(24) Soto, A. M.; Sonnenschein, C.; Chung, K. L.; Fernandez, M. F.; Olea, N.; Serrano, F. O. Environ. Health Perspect. 1995, 103 (Suppl. 7), 113-122.

(25) Silent Spring Institute. Investigating Breast Cancer and the Environment on Cape Cod: Research Protocol for the Cape Cod Breast Cancer and Environment Study Phase 2; Silent Spring Institute: Newton, MA, 1999.

(26) Lewis, R. G.; Gordon, S. M. Sampling for Organic Chemicals in Air. In Principles of Environmental Sampling; Keith, L. H., Ed.; ACS Professional Reference Book; American Chemical Society: Washington, DC, 1996; Chapter 23.

(27) Cochran, W. G. Samping Techniques, 3rd ed.; John Wiley & Sons: New York, 1977.

(28) Gray, L. E.; Ostby, J. S.; Mylchreest, E.; Foster, P. M. Toxicol. Sci. 1998, 42 (1S), 176.

(29) National Toxicology Program (NTP). NTP-CERHR Expert Panel Report on Butyl Benzyl Phthalate; U.S. Department of Health and Human Services, National Toxicology Program (NTP), Center for the Evaluation of Risks to Human Reproduction (CERHR): Alexandria, VA, 2000; 42 pp.

(30) Blount, B. C.; Silva, M. J.; Caudill, S. P.; Needham, L. L.; Pirkle, J. L.; Sampson, E. J.; Lucier, G. W.; Jackson, R. J.; Brock, J. W. Environ. Health Perspect. 2000, 108 (10), 979-982.

(31) Dachs, J.; van Ry, D. A.; Eisenreich, S. J. Environ. Sci. Technol. 1999, 33 (15), 2676-2679.

(32) Talmage, S. S. Environmental and Human Safety of Major Surfactants: Alcohol Ethoxylates and Alkylphenol Ethoxylates; Soap and Detergent Association/Lewis Publishers: Oak Ridge, TN, 1994; 374 pp.

(33) U.S. Environmental Protection Agency. RM-1 Document for para-Nonylphenol; Donald Rodier: Washington, DC, 1996.

(34) National Toxicology Program. Tenth Report on Carcinogens; U.S. Department of Health andHumanServices, National Toxicology Program: Research Triangle Park, NC, 2002.

(35) U.S. Environmental Protection Agency Region 3. Risk-Based Concentration Table, 1999; available at http://www.epa.gov/ reg3hwmd/risk/index.htm (accessed December 16, 2002).

(36) U.S. Environmental Protection Agency. Region 9: Superfund Preliminary Remediation Goals, 2002; available at http:// http://www.epa.gov/region09/waste/sfund/prg/index.htm (accessed December 16, 2002).

(37) Strandberg, B.; Bodder, N. G.; Basu, L.; Hites, R. A. Environ. Sci. Technol. 2001, 35 (6), 1078-1083.

(38) Kelly, T. J.; Mukund, R.; Spicer, C. W.; Pollack, A. J. Environ. Sci. Technol. 1994, 28 (8), 379A-387A.

(39) Rudel, R. Polycyclic Aromatic Hydrocarbons, Phthalates, and Phenols. In Indoor Air Quality Handbook; Samet, J., Spengler, J., McCarthy, J., Eds.; McGraw-Hill: New York, 2000.

(40) Camann, D. E.; Colt, J. S.; Teitelbaum, S. L.; Rudel, R. A.; Hart, R. M.; Gammon, M. D. Pesticide andPAHDistributions in House Dust from Seven Areas of USA; Society of Environmental Toxicology and Chemistry 21st Annual Meeting: Nashville, TN, November 2000.

(41) Currado, G. M.; Harrad, S. Environ. Sci. Technol. 1998, 32 (20), 3043-3047.

(42) Whyatt, R. M.; Camann, D. E.; Kinney, P. L.; Reyes, A.; Ramirez, J.; Dietrich, J.; Diaz, D.; Homes, D.; Perera, F. P. Environ. Health Perspect. 2002, 110 (5), 507-514. (43) Knoth, W.; Mann, W.; Meyer, R.; Nebhuth, J. Organohalogen Compd. 2002, 58, 213-216.

(44) Santillo, D.; Labunska, I.; Davidson, H.; Johnston, P.; Strutt, M.; Knowles, O. Consuming Chemicals: Hazardous Chemicals in House Dust as an Indicator of Chemical Exposure in the Home; Greenpeace Research Laboratories, Department of Biological Sciences, University of Exeter: Exeter, U.K., 2003; 17 pp.

Received for review December 20, 2002. Revised manuscript received May 16, 2003. Accepted June 18, 2003.

http://www.mindfully.org/Pesticide/2003/Phthalates-Indoor-Air-Dust13sep03.htm

 

 

 

The Estrogenic Activity of Phthalate Esters In Vitro

http://www.mindfully.org/Plastic/Estrogenic-Phthalate-Esters.htm

Environmental Health Perspectives v.105, n.8, Aug97

Catherine A. Harris, 1 Pirkko Henttu, 2 Malcolm G. Parker, 2 and John P. Sumpter 1

1 Department of Biology and Biochemistry, Brunel University, Uxbridge, Middlesex, United Kingdom

2 Molecular Endocrinology Laboratory, Imperial Cancer Research Fund, London, United Kingdom


Abstract

A large number of phthalate esters were screened for estrogenic activity using a recombinant yeast screen. A selection of these was also tested for mitogenic effect on estrogen-responsive human breast cancer cells. A small number of the commercially available phthalates tested showed extremely weak estrogenic activity. The relative potencies of these descended in the order butyl benzyl phthalate (BBP)>dibutyl phthalate (DBP)>diisobutyl phthalate (DIBP)>diethyl phthalate (DEP)>diisononyl phthalate (DINP). Potencies ranged from approximately 1 10 6 to 5 10 7 times less than 17ß-estradiol. The phthalates that were estrogenic in the yeast screen were also mitogenic on the human breast cancer cells. Di(2-ethylhexyl) phthalate (DEHP) showed no estrogenic activity in these in vitro assays. A number of metabolites were tested, including mono-butyl phthalate, mono-benzyl phthalate, mono-ethylhexyl phthalate, mono- n -octyl phthalate; all were found to be inactive. One of the phthalates, ditridecyl phthalate (DTDP), produced inconsistent results; one sample was weakly estrogenic, whereas another, obtained from a different source, was inactive. Analysis by gel chromatography-mass spectrometry showed that the preparation exhibiting estrogenic activity contained 0.5% of the ortho -isomer of bisphenol A. It is likely that the presence of this antioxidant in the phthalate standard was responsible for the generation of a dose-response curve–which was not observed with an alternative sample that had not been supplemented with o , p ´-bisphenol A–in the yeast screen; hence, DTDP is probably not weakly estrogenic. The activities of simple mixtures of BBP, DBP, and 17ß-estradiol were assessed in the yeast screen. No synergism was observed, although the activities of the mixtures were approximately additive. In summary, a small number of phthalates are weakly estrogenic in vitro . No data has yet been published on whether these are also estrogenic in vivo ; this will require tests using different classes of vertebrates and different routes of exposure. Key words : contaminated standards, estrogenicity, MCF-7, metabolites, phthalates, recombinant yeast screen, ZR-75.Environ Health Perspect 105:802-811 (1997).


Address correspondence to C.A. Harris, Department of Biology and Biochemistry, Brunel University, Uxbridge, Middlesex, UB8 3PH, U.K.

We are very grateful to the Natural Environment Research Council for funding this work (project no. RO5761). We thank BP Chemical Ltd., EXXON Chemical Ltd., and Monsanto Europe S.A., who supplied us with commercial preparations of phthalate esters, Rob Bos and Monsanto Europe S.A. for the provision of various metabolites, Dow Europe S.A. for the synthesis and donation of o , p ´-bisphenol A, and the Ministry of Agriculture, Fisheries and Food (Fisheries Laboratory) for the analysis of chemical standards. We also thank David Cadogan of ECPI for arranging for the chemical analysis of DTDP.

Received 18 February 1997; accepted 1 May 1997.


Introduction

In recent years there have been a plethora of publications discussing man-made estrogen-mimicking chemicals, the so-called xenoestrogens. Reports of declining semen quality ( 1 ) have been followed by hypotheses that this phenomenon may be linked to an increase in the exposure of humans to xenoestrogens, specifically in utero ( 2 ). Suspect chemicals originate from a variety of backgrounds, many being anthropogenic in origin, such as pesticides, detergents, and plasticizers. One of the earliest endocrine disruptors to be identified was the pesticide DDT, the effects of which are discussed by Fry and Toone ( 3 ). Other man-made chemicals have since been recognized as possessing estrogenic properties. For example, 4-nonylphenol is the degradation product of one group of nonionic surfactants, the nonylphenol polyethoxylates, and exposure to it has been demonstrated to induce estrogenic effects both in vitro ( 4 6 ) and in vivo ( 7 ). However, naturally occurring xenoestrogens–including phytoestrogens, such as coumestrol and genistein, and mycoestrogens, such as zearalenone–also exist; these may be found in plant food stuffs, to which humans have always been exposed ( 8 ).

Phthalates are just one of the many classes of chemicals that have been implicated as having estrogenic properties. Evidence of the estrogenic behavior of certain phthalates in vitro has previously been reported ( 9 11 ). Furthermore, an in vivo study has shown the adverse effects of butyl benzyl phthalate (BBP) on rat testes size and sperm production ( 12 ). A report concerning anin vivo multigenerational study investigating the reproductive toxicity of dibutyl phthalate (DBP) in Sprague-Dawley rats has recently been published. In this study, Wine et al. ( 13 ) found that a number of reproductive parameters were adversely affected by exposure to DBP administered via feed and that, critically, the second generation appeared more adversely affected than the first generation in that most of the F 1 males were infertile. The mechanisms underpinning these adverse reproductive effects are unclear presently, but one possibility is that some phthalates are estrogenic in vivo and hence disrupt normal male development.

Phthalates are essentially used as plasticizers in the production of polymeric materials such as polyvinyl chloride (PVC), imparting flexibility and workability, both during the manufacturing process and to the end product. When used in this way, they are not chemically bound to the product ( 14) and may therefore leach into the surrounding medium ( 15 ).

Table 1 – All the parent phthalate esters tested using recombinant yeast screen.

Phthalates are produced in extremely large volumes [the most widely used being di(2-ethylhexyl) phthalate (DEHP), at 400-500 thousand tons per annum in Europe alone; see Table 1] and have been identified in all environmental compartments. For example, they have been reported in water, sediment, air and biota sampled from the Gulf of Mexico ( 16 ), and river water and sewage effluent samples from the Greater Manchester area, United Kingdom ( 17 ). Food samples contaminated with phthalates have also been reported ( 18 21 ). The lipophilic nature of these chemicals indicates that fatty foods such as cream, cheese, and butter are most likely to be subject to contamination. Sharman et al. ( 21 ) discovered levels of up to 114 mg/kg total phthalate in cheese samples; however, the majority of samples contained 0.6-3.0 mg/kg DEHP and 4-20 mg/kg total phthalate. The authors suggested that these high levels might have arisen from environmental sources (for example, from the wrappers surrounding the cheese) rather than as a result of the diluted presence of the contaminant in the raw commodity, followed by its distillation in the fatty phase ( 21 ). Although these chemicals are no longer used in most direct contact food plastics and use in such materials has been regulated for many years based on toxicological data available and the fat content of the food concerned ( 22 ), it is possible that other sources of contamination during the manufacturing process, and from certain printing inks and adhesives used in packaging, may contribute to levels of phthalates found in more recently sampled foods ( 19 ).

The possibility of such extensively used chemicals as the phthalates having a detrimental influence on reproductive systems, of either humans or wildlife, clearly causes public concern, as is evident from the considerable media coverage of this issue. However, when phthalates are discussed, they are often mistakenly referred to as a single group of chemicals, with the assumption that they all have similar properties, for example estrogenic activity. In this paper we investigate the ability of individual phthalate esters to produce an estrogenic response in vitro and attempt to relate this factor to their occurrence as environmental contaminants, as a partial contribution to an assessment of their risk as endocrine disruptors.

Materials and Methods

Chemicals tested. 17ß-estradiol was purchased from Sigma, Poole, United Kingdom.

Thirty-five phthalates, encompassing a variety of structural and behavioral differences and including the major phthalates of commercial importance, were purchased from Greyhound Chemservice, Merseyside, United Kingdom (Table 1). These were of 97-99% purity.

For comparison, a number of commercial preparations were also obtained as gifts from companies as follows: dibutyl phthalate (DBP, 99.7% pure), diisobutyl phthalate (DIBP, 99.6% pure), diethyl phthalate (DEP, >99.7% pure), and dioctyl phthalate (DOP, 99.9% pure), from BP Chemical Ltd., Hull, United Kingdom; diisodecyl phthalate (DIDP, 99.9%) and diisononyl phthalate (DINP, 99.9%) from EXXON Chemical Ltd., Fareham, United Kingdom; ditridecyl phthalate (DTDP) from EXXON Chemical Ltd., Courbevoie, France; and butyl benzyl phthalate (BBP, >98.5%) from Monsanto Europe S.A., Louvain-la-Neuve, Belgium. Purity of these preparations is given as provided by the company.

Various phthalate metabolites were donated by R. Bos of the Department of Toxicology, University of Nijmegen, The Netherlands. These were mono-hexyl phthalate (MHP), mono-ethylhexyl phthalate (MEHP), mono-pentyl phthalate (MPP), mono- n -octyl phthalate (MnOP) and metabolites V, VI, and IX of DEHP ( 23 ). Also donated (by Monsanto Europe S.A.) were the primary metabolites of BBP, mono-butyl phthalate and mono-benzyl phthalate.

4-Nonylphenol, supplied by Schenectady International Inc. (Schenectady, NY), bisphenol A (Aldrich, Poole, U.K.), o , p ´-DDT (Greyhound Chemservice, Merseyside, U.K.), and genistein (Sigma, Poole, U.K.) were tested in the recombinant yeast screen only, in order to demonstrate the activity and potency of some known xenoestrogens.

o , p ´-Bisphenol A was supplied by Dow Europe S.A., Horgen, Switzerland, and was tested in the recombinant yeast screen to assess the possible significance of its presence as a contaminant in one of the phthalate samples and its effect on the apparent estrogenicity of that sample.

The recombinant yeast screen. All chemicals were assessed for estrogenic activity using a recombinant yeast screen. This is a cost-effective, sensitive, and specific process for detecting estrogenic activity. The screen has been described and extensively validated elsewhere [see Routledge and Sumpter ( 24 ) for full details]. Essentially, a gene for the human estrogen receptor has been integrated into the main yeast genome and is expressed in a form capable of binding to estrogen response elements and controlling the expression of the reporter gene lac-Z . Thus, on activation of the receptor, the lac-Z gene is expressed, producing the enzyme ß-galactosidase, which is secreted into the medium where it causes a color change of the chromogenic substance chlorophenol red-ß-d-galactopyranoside (CPRG) from yellow to red. The intensity of the red color can be measured by absorbance.

The screen is highly specific for estrogens; androgens, progesterones and corticosteroids are either completely inactive in the screen or very weakly active at very high concentrations ( 24 ).

Details of the preparation of medium components and yeast stocks have been published previously (24 ).

Growth medium was prepared by adding 5 ml 20% w/v glucose solution, 1.25 ml 4 mg/ml l-aspartic acid solution, 0.5 ml vitamin solution, 0.4 ml 24 mg/ml l-threonine solution, and 0.125 ml 20 mM copper (II) sulfate solution to 45 ml single strength minimal medium. The yeast culture was then prepared by seeding 50 ml growth medium with 125 µl yeast stock and incubating this overnight at 28°C on an orbital shaker. Assay medium contained 0.5 ml 10 mg/ml chlorophenol red-ß-d-galactopyranoside added to 50 ml growth medium seeded with 1 ml of the above yeast culture.

All glassware was thoroughly washed with solvent. Test chemicals were made up in ethanol to 2 10 -2 M (phthalates), 2 10 -4 M (4-nonylphenol, bisphenol A, genistein, o , p ´-DDT), or 2 10 -7M (17ß-estradiol) stock solutions and stored at 4°C.

Stock solutions were serially diluted in ethanol, and 10 µl of each dilution was transferred to a 96-well microtiter plate (Linbro/Titertek, ICN FLOW, Bucks, U.K.). This gave a final concentration of 10-3 M to 4.8 10 -7 M for the phthalates and their metabolites, 10 -5 M to 4.8 10 -9 M for other xenoestrogens, or 10 -8 M to 4.8 10 -12 M for 17ß-estradiol. Solvent controls were set up on each plate using 10-µl aliquots of ethanol. The ethanol was allowed to evaporate and 200-µl aliquots of assay medium (containing the yeast) was then added to each well. The plates were then sealed with autoclave tape, shaken for 2 min on a titer-plate shaker, and incubated at 32°C for 4-6 days in a naturally ventilated oven (WTB binder, BD-series; Jencons Scentific Ltd., Bedfordshire, U.K.). Plates were shaken on day 1 of incubation and again approximately 1 hr before taking absorbance readings (540 nm for color and 620 nm for turbidity), using a Titertek Multiskan MCC/340 plate reader (Life Sciences Int., Basingstoke, U.K.).

Mammalian cells. For comparison, the proliferative effects of all commercially available phthalates showing estrogenic activity in the recombinant yeast screen, as well as those that were negative but of major volume use, were tested using two estrogen-responsive human breast cancer cell lines, MCF-7 and ZR-75. As these cell lines are of human origin, they may be of particular relevance when considering the wide exposure of humans to the phthalates, which are ubiquitous in the environment ( 25 ) and can be found in such domestic products as vinyl flooring, children’s toys, printing inks, and cosmetics ( 26 ).

The phthalate samples used in these assays were the analytical standards as supplied by Greyhound Chemservice. Cells were cultured in phenol red-free medium containing 5% v/v charcoal dextran stripped serum (DCC). They were then plated in 6-well microtiter plates (Falcon, Becton Dickinson, Lincoln Park, NJ) into the aforementioned medium 3-4 days prior to commencing the experiment. For the MCF-7 cells, medium was replaced with treated medium containing either 0.1% vehicle solvent (ethanol) as a negative control, 10 -8 M 17ß-estradiol as a positive control, or 10 -5 M of each respective phthalate. Cells were trypsinized and counted using a Coulter Counter (Coulter Electronics, Harpenden, Herts, U.K.) on days 0, 2, 5, 8, and 12. Treatments were duplicated and the experiment was repeated twice. For the ZR75 cells, the treatments (control, 10 -8 M, 10 -10 M, and 10 -12 M 17ß-estradiol and 10 -5 M, 10 -6 M, and 10 -7 M of individual phthalates) were done in triplicate. Cells were counted at a single endpoint on day 11.

Results

Table 1 lists the phthalate esters tested, together with their consumption figures in Europe, to give an idea of their importance relative to one another as industrial chemicals. Some phthalates generated a dose-dependent increase in ß-galactosidase production in the yeast screen, indicating weak estrogenic activity.

Figure 1 . Estrogenic activity of some known environmental estrogens in the recombinant yeast screen. 17ß-estradiol serially diluted from 10 -8 M and ethanol were used as positive and negative controls, respectively. 4-Nonylphenol, o´p´-DDT, bisphenol A, and genistein are shown as standard curves serially diluted from 10 -5 M.

In order to relate the significance of the activity of the estrogenic phthalates to that of other environmental estrogens, we assessed the response of the yeast screen to a range of environmental estrogens. The chemicals tested were bisphenol A (an antioxidant), genistein (a phytoestrogen), 4-nonylphenol (the degradation product of a surfactant), and o , p ´-DDT (a pesticide); the results are shown in Figure 1. These chemicals were tested over a concentration range of 10 -5 M to 5 10 -9 M, and were found to have potencies varying from approximately 10 4-10 5 times less than that of the main natural estrogen, 17ß-estradiol.

Figure 2 . The estrogenic activity in the yeast screen of phthalate esters at concentrations ranging from 10 -3 M to 5 10 -7 M, compared to 17ß-estradiol (serially diluted from 10 -8 M). A) Illustrates the estrogenic activity of phthalates consumed in major volumes in Europe. B) Illustrates the estrogenic activity of DEP and DTDP, which are used commercially in Europe, and DPhP, BCHP, and IHBP, which are of negligible commercial usage. C) Portrays the lack of estrogenic activity observed in the yeast screen when the cells were incubated with certain phthalates. Abbreviations: BBP, butyl benzyl phthalate; DBP, dibutyl phthalate; DIBP, diisobutyl phthalate; DEHP, bis(2-ethylhexyl) phthalate; DIDP, diisodecyl phthalate; DINP, diisononyl phthalate; DEP, diethyl phthalate; DTDP, ditridecyl phthalate; DPhP, diphenyl phthalate; BCHP, butyl cyclohexyl phthalate; IHBP, isohexylbenzyl phthalate; DHP, dihexyl phthalate; DIHP, diisohexyl phthalate; DMP, dimethyl phthalate; DUP, diundecyl phthalate.

The estrogenic activities of the major volume usage phthalates (those exceeding 20,000 ton/annum in Europe) in the yeast screen are shown in Figure 2A. Of these six major volume use phthalates, three possessed estrogenic activity (BBP, DBP, and DIBP), two did not (DEHP and DIDP), and one (DINP) behaved unreproducibly in the screen. The former three phthalates were the most active of all those tested, and the latter three are the most extensively used in industry. Two dose-response curves were produced for DINP due to the slightly unreproducible behavior of this chemical in the yeast screen. DINP ii (Fig. 2A) shows the mean response of two standard curves in which a detectable increase in ß-galactosidase production was observed. This pattern was reproduced in three separate assays, but differed in a further three in which DINP appeared completely inactive (DINP i).

The phthalates of relatively low or negligible use in Europe (29 different ones) were assessed for estrogenic activity using the yeast screen only. Relatively few of these (five in total) possessed any estrogenic activity; all others were inactive, even at the highest concentration tested (10 -3 M) (Fig. 2B, 2C). The results obtained from the five phthalates that showed estrogenic activity are illustrated in Figure 2B. Of these, only two (DEP and DTDP) are used commercially in Europe.

Table 2 – Phthalates found to give an estrogenic response in yeast screen.

All of the phthalates that showed activity were very weak estrogens. The most potent, BBP, was approximately 1 million-fold less potent than estradiol (Table 2), making it considerably less potent than other environmental estrogens such as bisphenol A, nonylphenol, and o , p ´-DDT. When chemicals are so weakly estrogenic, it is entirely feasible that it is not the chemical (in this case the phthalate) itself which is intrinsically estrogenic, but rather that an impurity in the chemical is estrogenic. Thus, before labeling a chemical as a weak estrogen, it is necessary to exclude the possibility that the chemical is contaminated with an estrogenic impurity. One way to address this issue is to test a number of samples, of different origin, of each phthalate possessing estrogenic activity. If all samples of a phthalate possess the same degree of estrogenic activity, it is likely that that particular phthalate is intrinsically active, whereas if the different samples of a phthalate possess considerably different potencies, it is then likely that the phthalate itself is not estrogenic, but that some samples contain varying proportions of one or more contaminants that are estrogenic.

To assess this possibility–that estrogenic contaminants might be present in some phthalates–commercial preparations of all the major volume usage phthalates, including DTDP and DEP, were assessed for estrogenic activity and their potencies compared to that of their respective analytical standards (data not shown). With one exception, no differences were observed; the estrogenic activities of the commercial preparations were equivalent to those of their respective analytical standards. However, contrary to the analytical standard, the commercial preparation of DTDP failed to produce a response, even when present at 10 -3 M. Both samples of DTDP were subsequently analyzed by gel chromatography-mass spectrometry (GC-MS). The analytical standard (the active sample) was found to contain 0.5% of the ortho -isomer of bisphenol A. The inactive preparation of DTDP did not contain this chemical. A sample of o , p ´-bisphenol A was then obtained and its response in the yeast screen was compared with that of the active DTDP sample. Figure 3 shows that o , p ´-bisphenol A was about 100 times more potent than DTDP. Therefore, the presence of this chemical at just 0.5% in the DTDP sample would produce a response equivalent to that seen. Thus, it is likely that this chemical ( o , p ´-bisphenol A) was responsible for the weak activity observed in this phthalate sample (see Fig. 1); hence DTDP is not estrogenic.

Figure 3 . The activity of bisphenol A (rows A and B),o , p ´-bisphenol A (rows D and E), and DTDP (rows G and H) in the recombinant yeast screen. Bisphenol A and the ortho para isomer of this chemical were serially diluted (left to right) from 10 -5 M. DTDP was serially diluted from 10 -3 M. Rows C and F are controls (10 µl ethanol added to each of these wells).

The results shown in Figure 2A and 2B show that most of the active phthalates were unable to produce a maximal response in the yeast assay; only DTDP did so. For example, the response to BBP (the most estrogenic phthalate) reached a plateau at approximately 50% of the maximum response achieved with 17ß-estradiol. To determine whether this means that most of the phthalates are only partial estrogen agonists or whether other explanations account for the submaximal responses observed, a yeast screen containing BBP was incubated for longer than usual and the response was monitored daily. The results (Fig. 4) show that on day 4 (the usual incubation time for our yeast assays) BBP produced a shallow dose-response curve. However, by day 6, the response was greater. By day 13 the highest concentration of BBP had produced a maximal response. Note also that the dose-response curve to 17ß-estradiol moved approximately fourfold to the left between days 4 and 13 (i.e., the yeast screen became more sensitive), but the dose-response curve for BBP moved considerably further. Thus, the potency of BBP increased somewhat with time. For this reason, all the other phthalate data shown in this paper was obtained from yeast assays incubated for 6 days.

Figure 4 . Development of the butyl benzyl phthalate (BBP) standard curve over time. The BBP standard curve can be seen to be developing to an almost maximal response in this yeast assay.

To assess whether the estrogenic responses observed in the yeast assay were reproducible in other estrogen assays, active phthalates (plus the major volume use phthalates, DEHP and DIDP) were also tested for their ability to stimulate proliferation of MCF-7 and ZR-75 cells. The results from these assays (Fig. 5 and Fig. 6), which are based on human breast cancer cell lines, are mostly comparable to those obtained from the yeast screen. However, DEP and DTDP failed to induce proliferation of ZR-75 cells at 10 -5 , 10 -6, or 10 -7 M (Fig. 5B) although they had been active in the yeast screen, albeit only at higher concentrations. Using the ZR-75 cells, DINP at 10 -5 ,10 -6 , and 10 -7 M induced proliferation to a significantly greater extent than the control, which is in contrast to our findings for this chemical using the yeast screen. Growth curves for all estrogenic phthalates (i.e., those active in the yeast assay) and for DEHP and DIDP were obtained using MCF-7 cells. The results (Fig. 6) showed that BBP was considerably more mitogenic than any of the other phthalates. DTDP, DIBP, and DBP were approximately equivalent in activity, and all the other phthalates tested showed relatively little activity. All these results are consistent with those obtained using the yeast assay.

Figure 5 . The proliferation of ZR-75 cells incubated with various phthalates and controls including time = 0 (t = 0), ethanol, and 17ß-estradiol (data obtained from three separate assays). A) Cells incubated with butyl benzyl phthalate (BBP), diisobutyl phthalate (DIBP), and dibutyl phthalate (DBP). B) Cells incubated with diisononyl phthalate; (DINP), diethyl phthalate (DEP), and ditridecyl phthalate (DTDP). C) Cells incubated with bis(2-ethylhexyl) phthalate (DEHP), diisodecyl phthalate (DIDP), and dihexyl phthalate (DHP). A simple ANOVA was performed on the data, followed by the Bonferroni/Dunn test for multiple comparisons. Cell numbers significantly greater than the control are denoted by * p <0.05; ** p <0.01; # p <0.001.

Figure 6 . This figure depicts the proliferation of MCF-7 cells incubated with 10 -8 M 17ß-estradiol, 0.1% ethanol, or 10 -5 M of bis(2-ethylhexyl) phthalate (DEHP), diisodecyl phthalate (DIDP), diisobutyl phthalate (DIBP), diisononyl phthalate (DINP), butyl benzyl phthalate (BBP), dibutyl phthalate (DBP), diethyl phthalate (DEP), or ditridecyl phthalate (DTDP) over a period of 12 days.

Possible additive or synergistic effects between the most potent phthalates were investigated by incubating known concentrations of BBP, DBP, and 17ß-estradiol either individually or as simple mixtures in the yeast screen. The concentration of 17ß-estradiol used produced only a small response above background (Fig. 7), so that if additivity or synergism occurred, they could be observed within the range of the assay. Two concentrations of each of the most active phthalates (BBP and DBP) were tested alone and in combination with 17ß-estradiol. In all cases, the response obtained was very close to that expected if additivity had occurred (Fig. 7); in no case was the response significantly greater than predicted if additivity had occurred, that is, no evidence of synergism was observed.

Figure 7 . The activity observed in the yeast screen when yeast cells were incubated with single concentrations of butyl benzyl phthalate (BBP), dibutyl phthalate (DBP), and 17ß-estradiol, either individually or in simple mixtures. Abbreviations: A, 10 -11M 17ß-estradiol; B, 10 -4 M BBP; C, 10 -5 M BBP; D, 10 -4 M DBP; E, 10 -5 M DBP.

Actual absorbance represents the corrected absorbance figure (the absorbance read for the treated yeast minus that of the control). Theoretical absorbance is the corrected absorbance of the relevant individual treatments added together (the absorbance that would be expected if the two chemicals behaved in an additive manner).

The phthalate metabolites tested included 1) derivatives of the most abundant phthalate (DEHP), namely MEHP and metabolites V, VI, and IX ( 23 ); 2) MBzP and MBuP, which are primary metabolites of the most estrogenic phthalate (BBP); and 3) MHP, MnOP, and MPeP. All were serially diluted from 10 -3 M to 4.8 10 -7 M, and none showed any signs of estrogenic activity in the yeast screen (data not shown).

Table 2 summarizes the relative potency and the magnitude of the responses (compared to 17ß-estradiol) of all phthalates that were active in the yeast screen, together with their structures.

Discussion

In this paper, we investigate the possible estrogenic behavior of a large number of phthalate estersin vitro . As far as we are aware, this is the first paper to address individual estrogenic potencies for such a comprehensive spectrum of this class of chemicals.

The phthalates studied are used by industry in variable amounts, the greatest of which is for DEHP, at up to 500,000 tons/annum in Western Europe. The worldwide production of another class of chemicals, the alkylphenol polyethoxylates, was 360,000 tons/annum in the late 1980s ( 27 ), which puts into perspective the large scale use of phthalate esters as industrial chemicals, as well as their potential environmental importance.

In terms of their estrogenic behavior, it seems that those phthalates requiring further scrutiny include 1) the shorter chain phthalates, namely BBP, DBP, and DIBP, which are used by industry in smaller quantities (Table 1), but are more estrogenically active; and 2) the longer chain phthalate DINP, which although extremely weakly estrogenic in vitro , is used in large quantities (up to 200,000 tons/annum in Europe). The estrogenic behavior of the phthalates in these assays compares favorably to that previously reported (9-11), where the potency of BBP (approximately 1 millionfold less potent than estradiol in the yeast screen) was similar to that reported by Soto et al. ( 10 , 11 ) in the E-SCREEN assay (3 millionfold less potent than estradiol) and the relative strengths of the phthalates reported to be estrogenic by Jobling et al. ( 9 ) correspond to that observed in the yeast screen (BBP>DBP). It must also be noted that, generally speaking, the activities of the phthalates in the recombinant yeast screen were reproduced in the mammalian assays, thus implying that these are real estrogenic effects, and not artifactual. There were occasional discrepancies between assays: DTDP and DEP were not found to be mitogenic in the ZR-75 cell line, but they had shown slight mitogenic activity in the MCF-7 assay and a positive response in the recombinant yeast screen. The yeast cells are more robust than mammalian cells and so could be exposed to higher concentrations of phthalates with no adverse effects, hence, the observation of activity at the higher concentrations applied in the yeast screen. The reasons for discrepancy between the two mammalian assays are unclear, but may be a result of the enhanced proliferation of the MCF-7 cell line in the presence of growth factors (the identity of which is not known), as compared to the ZR-75 cell line, which is more estrogen specific.

All active chemicals, however potent, are said to be active because they cause a response above the baseline. However, for all active phthalates, only a partial dose response was observed after the usual incubation time. For example, for DINP, the most used of all the active phthalates, the maximum response was just 15% of the maximum response obtained with 17ß-estradiol. A possible explanation for results such as these, which suggest partial agonistic behavior of the phthalates, is that these chemicals were not fully solubilized in the water-based medium employed in these assays. This is a situation frequently encountered when applying highly organic compounds to in vitro assays and is entirely feasible since, generally speaking, the solubility values for phthalates are lower than the concentrations used in these trials. Thus, it is plausible that some of the phthalates tested are actually more potent than they appear to be. However, it must be noted that the chemical treatments were added to the medium of the mammalian cell assays in ethanol, thus leading to greater homogeneity throughout, and still only a partial response was observed. Conversely, contamination of a chemical with an estrogenic compound can imply a weak estrogenicity of the substance in question when it is, in fact, the contaminant that is generating the observed response and the chemical under investigation is not estrogenically active. This phenomenon was detected in the case of DTDP, where the weakly estrogenic preparation was found to be contaminated with the ortho -isomer of bisphenol A. Hence, caution must be applied when labeling a chemical a weak estrogen, particularly if the chemical is not pure (which is usually the case, especially with industrial chemicals).

It has been reported that there is a relationship between the structure of a chemical and its estrogenic behavior ( 28 ). Of the total number of phthalates tested in our study, five possessed a secondary ring structure (BBP, BCHP, DPhP, IHBP, DCHP); of these, the first four were all weakly estrogenic, albeit with varying potencies. However, by no means was this the key to estrogenicity. Of those considered to be estrogenically active, there were several that possessed alkyl side-chains, and of these, a greater maximum response was obtained with DBP, DIBP, and DEP than by those with a secondary ring structure. It appeared that the majority of the active phthalates were among the lower molecular weight species, but again there were inconsistencies with this observation, with many of the lighter phthalates being inactive in the recombinant yeast screen. It is therefore difficult to deduce, from their two-dimensional structures alone, which phthalate esters will elicit estrogenic responses.

If a chemical exhibits only weak estrogenic activity in vitro , it does not necessarily follow that the effect of the same chemical will be insignificant when applied to a whole organism. Unfortunately, results of the nature obtained here cannot be directly extrapolated to an in vivo situation. It is not known at present whether any phthalates are estrogenic in vivo , and it will be necessary to test these chemicals in vivo via different routes of exposure before reaching conclusions. Although in vitro assays give us an idea of the potential strength of a chemical as a xenoestrogen, they cannot simulate changes to the chemical within an organism and differences in the systems of individual organisms, which may influence the potency and/or bioavailability of the chemical. Metabolic processes will vary greatly, depending on the route of uptake and on the characteristics of both the chemical and the organism concerned.

Another difficulty in estimating the environmental hazard posed by phthalate esters is the lack of data documenting the exposure of humans or wildlife to these chemicals. The fact that phthalates are used in a wide variety of extensively used goods is indisputable. It is also known that they can exude from these products. For example, DBP has been found to leach from dentures ( 29 ), as has DINP from milk tubing ( 30 ). Furtmann ( 31 ) has suggested that the main source of phthalates are the consumer products themselves and that there is some justification in the inference that, following dumping or incineration of these products, there are considerable phthalate emissions into the environment. The estimated total loss of phthalate esters in Western Europe has been put at 7,740 tons/annum, or approximately 1% of total consumption ( 32 ). However, the use of such data in the analysis of environmental hazard assessment for individual chemicals is problematic because the data is generalized and estimates refer to total phthalates.

By far the most frequently reported phthalate, and that found at highest concentrations in the environment, is DEHP. This is to be expected, considering its high usage and greater likelihood of persistence relative to the shorter chain phthalates. For this reason, one would also expect DIDP and DINP to be apparent in environmental samples, but reports concerning these phthalates are sparse. Other phthalates that have been regularly documented in food ( 19 , 20 ), air ( 33 , 34 ), sediments ( 31 , 35 ), and river water ( 36 , 37 ) include the lower molecular weight phthalates such as DMP, DEP, DBP, and BBP. These are less stable as plasticizers and are therefore liable to migrate from a polymer matrix, particularly when this material is subjected to elevated temperature or surrounded by a lipophilic medium. For this reason, despite lower consumption of these phthalates compared to the higher molecular weight species, it is perhaps not surprising for them to be commonly detected, albeit at very low concentrations, in environmental samples. The solubility and environmental persistence of individual phthalates is somewhat dependent upon the chain length of the phthalate concerned. [For a more detailed discussion of the behavior of phthalates in the aquatic environment, see Furtmann ( 31 )]. It must also be considered that these chemicals are not present in isolation in environmental systems. In any one system, various mixtures of toxic organic chemicals can be found. For example, a cocktail of trace organics was documented in alligator eggs in Lake Apopka, Florida ( 38 ). Phthalates themselves have been found in environmental samples alongside polychlorinated biphenyls, p , p ´-DDT, and p , p ´-DDE ( 34 ). Certain of the PCB congeners, for example 3,4,3´,4´-tetrachlorobiphenyl, have been identified as estrogen mimics ( 39), whereas p , p ´-DDT and p , p ´-DDE have both been reported to possess antiandrogenic properties ( 40 ). In addition, various combinations of phthalates have been found to be present in environmental samples ( 37 , 41 ). With the possibility that any contaminated environmental sample will contain more than one endocrine disrupting chemical, it seems necessary to investigate whether the effect of a combination of these chemicals will be additive, more than additive, or antagonistic. This issue was addressed by incubating simple combinations of 17ß-estradiol and two estrogenic phthalates (BBP and DBP) in the recombinant yeast screen. Jobling et al. ( 9 ) found DBP and BBP, in the presence of 17ß-estradiol, to have an agonistic, as opposed to antagonistic, effect on the stimulation of transcriptional activity in transfected MCF-7 cells. We demonstrate in this paper that the activity of combinations of two phthalates, DBP and BBP, at the concentrations shown (Fig. 7) are, in fact, slightly less than additive. When these chemicals were incubated in the presence of 17ß-estradiol (with BBP at a concentration that would induce a less than maximal response), the behavior of the combination was again additive rather than synergistic.

Another factor influencing the occurrence of phthalates in the environment is their potential for persisting and accumulating in organic matrices. This would be expected to be high because phthalates are hydrophobic chemicals; thus, it might be possible to predict their environmental fate pattern based on that of other man-made organic chemicals. For example, the polychlorinated biphenyls ( 42 ) and 4-nonylphenol ( 43 ) bioaccumulate in organisms that are exposed to these chemicals over a period of time, and they also biomagnify through the food chain. However, phthalates appear to be more readily metabolized than these persistent chemicals, particularly by enzymes in the gut ( 44 ) and in sewage treatment works, although their rate of degradation does appear to be influenced by the length of their side chains ( 45 , 46 ). It is not known whether the yeast strain employed in the assays shown in this paper is capable of metabolizing complex organic chemicals, although methoxychlor has shown a positive response in the recombinant yeast screen (47 ); and it has been reported that this chemical must be metabolized before it becomes estrogenically active ( 48 ), thus suggesting that the yeast strain is capable of degrading certain organic chemicals. A small number of phthalate metabolites were tested in the recombinant yeast screen, including monobutyl phthalate (the primary metabolite of DBP and DIBP) and monobenzyl phthalate (which, with monobutyl phthalate, are the primary metabolites of BBP). All metabolites tested were inactive in this assay, suggesting that it is the parent compounds which are estrogenic. This is significant in that, as previously discussed, the phthalates appear to be metabolized following oral exposure, and hence the monoesters are more likely to be the bioavailable form of phthalates.

It is conceivable that the route of exposure of an organism to phthalates is an important parameter when considering metabolism of these chemicals in vivo . It seems probable that phthalates are readily metabolized in the gut, such that oral exposure would not lead to accumulation of high concentrations of these chemicals. However, there is little data available on the metabolism of this group of chemicals following inhalation or dermal exposure. It is perhaps necessary to investigate the fate of phthalates within an organism following administration via these routes, judging by the presence of these chemicals in a wide array of contact media. In addition, uptake via the gills, hence directly into the blood system, as occurs in fish, may elicit responses that other routes of exposure would not.

In summary, a small number of commercially available phthalate esters (BBP, DIBP, DBP, DEP, DINP) are capable of acting as extremely weak estrogens in vitro . How this is relevant to the environment cannot yet be directly estimated, partly because comprehensive data concerning the environmental fate and behavior of these individual phthalates is not available and partly due to the impracticalities involved with extrapolating in vitro data to a whole animal situation. The phthalate most widely used by the plastic industry, and that reported on with greatest frequency, is DEHP. This phthalate did not show estrogenic activity in the assays employed in this paper. Laboratory biodegradation studies, particularly of the shorter chain phthalates (that is, those which are the more potent xenoestrogens), might imply that concentrations in the environment as a whole, and within an organism, would not reach values high enough to be of significant danger. Although the potential exists for the above-mentioned chemicals to generate adverse effects when present within the system of an organism, the concentrations and the conditions of exposure required to do so are unknown. Also note that this paper has investigated one mechanism of action only, that is, the ability of phthalates to act as estrogen agonists. This may be just one of many pathways that might lead to adverse reproductive effects in animals exposed to these chemicals. The results of in vivo experiments, such as those reported by Sharpe et al. ( 12 ) and Wine et al. ( 13 ), may not be due solely to the weak estrogenic activities of the particular phthalates administered, but may involve other, and possibly more important, mechanisms of action. For example, DEHP has been recognized for many years to be a reproductive toxicant ( 49 52 ), yet this particular phthalate demonstrated no estrogenic behavior in the assays employed in this study. It may also transpire that it is not simply a matter of the response of a parent organism to the chemical concerned, whether exposure is acute or chronic, but that any effect may not be detected until subsequent generations. This possibility has been very clearly demonstrated by Wine et al. ( 13 ), who found that adverse reproductive effects induced by DBP in Sprague-Dawley rats were most pronounced in the second generation although the mechanisms generating these responses are unknown.

References

1. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. Br Med J 305:609-613 (1992).

2. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395 (1993).

3. Fry DM, Toone CK. DDT-induced feminization of gull embryos. Science 213:922-924 (1981).

4. Soto AM, Justicia H, Wray JW, Sonnenschein C. p -Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 92:167-173 (1991).

5. Jobling S, Sumpter JP. Detergent compounds in sewage effluent are weakly oestrogenic to fish: an in vitro study using rainbow trout ( Oncorhynchus mykiss ) hepatocytes. Aquat Toxicol 27:361-372 (1993).

6. White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135:175-182 (1994).

7. Jobling S, Sheahan D, Osborne JA, Matthiessen P, Sumpter JP. Inhibition of testicular growth in rainbow trout ( Oncorhynchus mykiss ) exposed to estrogenic alkylphenolic chemicals. Environ Toxicol Chem 15:194-202 (1996).

8. Harrison PTC, Humfrey CDN, Litchfield M, Peakall D, Shuker LK, eds. Environmental oestrogens: consequences to human health and wildlife. Leicester, UK:University of Leicester, Institute of Environment and Health (1995).

9. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 103:582-587 (1995).

10. Sonnenschein C, Soto AM, Fernandez MF, Olea N, Serrano FO, Ruiz-Lopez MD. Development of a marker of estrogenic exposure in human serum. Clin Chem 41(12):1888-1895 (1995).

11. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103(suppl 7):113-122 (1995).

12. Sharpe RM, Fisher JS, Millar MM, Jobling S, Sumpter JP. Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ Health Perspect 103:1136-1143 (1995).

13. Wine RN, Li L-H, Hommel Barnes L, Gulati DK, Chapin RE. The reproductive toxicity of di- n -butylphthalate in a continuous breeding protocol in Sprague-Dawley rats. Environ Health Perspect 105:102-107 (1997).

14. Autian J. Toxicity and health threats of phthalate esters: review of the literature. Environ Health Perspect 4:3-26 (1973).

15. Jaeger RJ, Rubin RJ. Migration of a phthalate ester plasticizer from polyvinyl chloride blood bags into stored human blood and its localization in human tissues. New Eng J Med 287:1114-1118 (1972).

16. Giam CS, Chan HS, Neff GS, Atlas EL. Phthalate ester plasticizers: a new class of marine pollutant. Science 199:419-421 (1978).

17. Fatoki, OS, Vernon, F. Phthalate esters in rivers of the Greater Manchester area, U.K. Sci Total Environ 95:227-232 (1990).

18. MAFF. Plasticizers: continuing surveillance. Food surveillance paper no. 30. London:Her Majesty’s Stationery Office, 1990.

19. MAFF. Phthalates in food. Food surveillance information sheet no. 82. London:Her Majesty’s Stationery Office, 1996.

20. Page BD, Lacroix GM. The occurrence of phthalate ester and di-2-ethylhexyl adipate plasticizers in Canadian packaging and food sampled in 1985-1989: a survey. Food Addit Contam 12:129-151 (1995).

21. Sharman M, Read WA, Castle L, Gilbert J. Levels of di-(2-ethyl-hexyl) phthalate and total phthalate esters in milk, cream, butter and cheese. Food Addit Contam 11:375-385 (1994).

22. Shibko SI, Blumenthal H. Toxicology of phthalic acid esters used in food-packaging material. Environ Health Perspect 3:131-137 (1973).

23. Dirven HAAM, van den Broek PHH, Arends AMM, Nordkamp HH, de Lepper AJGM, Henderson PTh, Jongeneelen FJ. Metabolites of the plasticizer di(2-ethylhexyl)phthalate in urine samples of workers in polyvinylchloride processing industries. Int Arch Occup Environ Health 64:549-554 (1993).

24. Routledge EJ, Sumpter JP. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 15:241-248 (1996).

25. Furtmann K. Phthalates in surface water–a method for routine trace level analysis. Fresenius’ J Anal Chem 348:291-296 (1994).

26. Lyons G. Phthalates in the environment. Godalming, Surrey, UK:World Wide Fund for Nature, 1995.

27. Ahel M, McEvoy J, Giger W. Bioaccumulation of the lipophilic metabolites of nonionic surfactants in freshwater organisms. Environ Pollut 79:243-248 (1993).

28. Routledge EJ, Sumpter JP. Structural features of alkylphenolic chemicals associated with estrogenic activity. J Biol Chem 272(6):3280-3288 (1997).

29. Lygre H, Solheim E, Gjerdet NR, Berg E. Leaching of organic additives from dentures in vivo . Acta Odontol Scand 51:45-51 (1993).

30. Wildbrett G. Diffusion of phthalic acid esters from PVC milk tubing. Environ Health Perspect 3:29-35 (1973).

31. Furtmann RNK. Phthalates in the aquatic environment. Report no. 6/93. Brussels:European Chemical Industry Council (European Council for Plasticisers and Intermediates), 1996.

32. ECPI. Phthalate esters used in PVC. Assessment of the release, occurrence and possible effects of plasticizers in the environment [partial copy]. Brussels:European Chemical Industry Council (European Council for Plasticisers and Intermediates), 1996.

33. Thuren A, Larsson P. Phthalate esters in the Swedish atmosphere. Environ Sci Technol 24:554-559 (1990).

34. Giam CS, Atlas E, Chan HS, Neff GS. Phthalate esters, PCB and DDT residues in the Gulf of Mexico atmosphere. Atmos Environ 14:65-69 (1980).

35. Parkman H, Remberger M. Phthalates in Swedish sediments. No. 1167. Stockholm:The Environmental Research Institute, 1995.

36. Sheldon LS, Hites RA. Organic compounds in the Delaware river. Environ Sci Technol 12:1188-1194 (1978).

37. Pirie D, Steven L, McGrory S, Best G. Survey of hormone disrupting chemicals. Glasgow, Scotland:Scottish Environmental Protection Agency, 1996.

38. Heinz GH, Percival HF, Jennings ML. Contaminants in American alligator eggs from Lake Apopka, Lake Griffin, and Lake Okeechobee, Florida. Environ Monit Assess 16:277-285 (1991).

39. Nesaretnam K, Corcoran D, Dils RR, Darbre P. 3,4,3´,4´-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo . Mol Endocrinol 10:923-936 (1996).

40. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p , p ´-DDE is a potent androgen receptor antagonist. Nature 375:581-585 (1995).

41. Tan GH. Residue levels of phthalate esters in water and sediment samples from the Klang river basin. Bull Environ Contam Toxicol 54:171-176 (1995).

42. Alcock RE, Halsall CJ, Harris CA, Johnston AE, Lead WA, Sanders G, Jones KC. Contamination of environmental samples prepared for PCB analysis. Environ Sci Technol 28:1838-1842 (1994).

43. Warhurst AM. An environmental assessment of alkylphenol ethoxylates and alkyphenols. Edinburgh:Friends of the Earth, 1995.

44. Albro PW, Lavenhar SR. Metabolism of di(2-ethylhexyl)phthalate. Drug Metab Rev 21:13-34 (1989).

45. Shelton DR, Boyd SA, Tiedje JM. Anaerobic biodegradation of phthalic acid esters in sludge. Environ Sci Technol 18:93-97 (1984).

46. O’Grady DP, Howard PH, Werner AF. Activated sludge biodegradation of 12 commercial phthalate esters. Appl Environ Microbiol 49:443-445 (1985).

47. Ashby J, Lefevre PA, Odum J, Harris CA, Routledge EJ, Sumpter JP. Synergy between synthetic oestrogens? [letter]. Nature 385:494 (1997).

48. Ousterhout J, Struck RF, Nelson JA. Estrogenic activities of methoxychlor metabolites. Biochem Pharmacol 30:2869-2871 (1981).

49. Gangolli SD. Testicular effects of phthalate esters. Environ Health Perspect 45:77-84 (1982).

50. Gray TJB, Gangolli SD. Aspects of the testicular toxicity of phthalate esters. Environ Health Perspect 65:229-235 (1986).

51. Siddiqui A, Srivastava SP. Effect of di(2-ethylhexyl)phthalate administration on rat sperm count and on sperm metabolic enzymes. Bull Environ Contam Toxicol 48:115-119 (1992).

52. Davis BJ, Maronpot RR, Heindel, JJ. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol 128:216-223 (1994).

Last Update: August 26, 1997

http://www.mindfully.org/Plastic/Estrogenic-Phthalate-Esters.htm

 

 

Phthalate leaching study of the X-TEX fabric

http://www.xextex.com/testdata/phthalate_leaching_comparison.html


Printer Friendly PDFMolecule

Phthalates are a group of chemicals used in the manufacture of plastics. They often are called plasticizers. Phthalates can prolong the life span or durability of plastics and increase the flexibility of some plastics. In addition, phthalates have been used as solvents for other materials. They are used in hundreds of products, including vinyl flooring; adhesives; detergents; lubricating oils; automotive plastics; plastic clothing, such as raincoats; and personal-care products, such as soap, shampoo, hair spray, and textiles.

The problem with phthalates is that they have been found to belong to a group of chemicals which can affect the delicate balance of the hormonal system. Their effects have been long-established in animals and are also thought to be endocrine disrupters in humans as well.


The problem is that the chemicals do not chemically bond and can therefore ‘escape’ from the product and enter the environment. Because of their widespread use for over 50 years, they are now very prevalent in the environment – found in homes, rivers, groundwater etc – and have also been found in humans. In addition, rather than biodegrading, phthalates ‘bio accumulate’ because they do not break down easily. So our exposure to them is increasing as the numbers gradually build up.

Xextex the manufacturer of X-Tex, an environmental oil sorbent recycled fabric, determined it was necessary to determine the products contribution to the phthalate problem. A comparison study was performed using the X-Tex fabric and a similar polypropylene fabric. The fabrics were submitted to Test America in Tacoma, Washington, for a TCLP leachate study per EPA method 1311, and EPA method 8270. The study was to determine if phthalates might leach from the material and be released into the environment.

Laboratory results from the testing of both products revealed that neither product produced phthalate levels above the reporting limits of the test method. However analysis of the extract concentrations produced results for comparison of the two products. The results are listed below;

Client Sample ID X-TEX


Extract Concentrations

Discussion: The X-Tex and the polypropylene fabric was extracted 18 hours per EPA Method 1311. This test subjects the fabrics to a glacial acetic buffered solution extraction which accelerates the conditions found in a landfill. It is designed to leach out organics and metals that are found in waste materials for profiling. The results from this test confirmed that non-detectable levels were obtained that were below the methods reporting level based on the instrumental method detection limits. However the extract values obtained from this analysis the X-Tex had extracted levels of phthalates that were below the level of polypropylene as illustrated in the above graph. X-Tex gives the environmental community a stellar re-cycled product that is part of the solution and not the problem to our water systems.

http://www.xextex.com/testdata/phthalate_leaching_comparison.html

 

Phthalates: The Toxic Chemicals That Might Be In Your Sex Toy

by Lynnea Dally

http://thebottomline.as.ucsb.edu/2008/03/phthalates-the-toxic-chemicals-that-might-be-in-your-sex-toy-by-lynnea-dally

Wednesday March 12, 2008

Lynnea Dally | The Bottom Line

Phthalates, a family of chemical rubber softeners used in many sex toys, might be dangerous to your health. Phthalates are generally used in a variety of things, from plastic shower curtains to blood bags and car dashboards. Typically anything that smells “plasticy” has phthalates. While people are regularly exposed to phthalates, we interact with few of these other products in quite the same, intimate way as sex toys.

Phthalates are controversial because they are considered a “probable human carcinogen,” by FDA. In high doses they cause cancer in rats and in low doses still cause serious problems. Exposure to the chemical interfered with rat genital development and fetal development, which produces stillborn rats. In humans, there has been some evidence that phthalates interfere with sperm production and possibly infant genital development. While human studies are not currently as comprehensive as the animal studies, safety groups such as the FDA and Greenpeace warn that these chemicals present a possible health risk to humans.

In 2004 the European Union banned phthalates in products intended for infants, and in America there are patches of legislation protecting infants against phthalates, such as California’s toxic toy ban bill passed by Governor Schwarzenegger this past year.

According to Greenpeace representative Bart van Opzeeland “It’s incredible that this substance can still be used in toys for adults. The last few years we’ve tested a lot of products but never before did we find such high concentrations.” So if kid’s toys are being protected, why aren’t adult toys protected? After all, kids put their toys in their mouths, and adults put their toys in more places than that. There’s a few reasons. First of all, the sex toy industry is loosely regulated. Sex toys are legally labeled as “novelty” toys, meaning that they’re intended as a gag gift and not actual use. This means there’s no government-sponsored research into whether the products are safe for human use. Thanks to the scads of embarrassed people buying these presents “as gifts” the industry continues gets away with easy-to-use but dangerous materials.

Furthermore, few customers, interest groups, and legislators want to get labeled as a “healthy sex toy advocate” so few people step up. Finally, the overall problem is not well known in America. People never suspected that their dildo, vibrator, cock ring or fake vagina could have been toxic.

So what can you do about it? Check to make sure that your products are phthalate-free, especially before you purchase. Look for a label that says phthalate-free and avoid rubber jelly products that do not list their contents. Hard plastic products are probably safe and silicone, glass, metal and wood are completely phthalate-free. There are many online sex toy stores that offer phthalate-free sections of their store. Look over the toys you have now: do they jiggle? Smell like plastic? You might want to consider trading up. Get rid of your old toys in an environmentally safe way by using a sex toy recycling program.

http://thebottomline.as.ucsb.edu/2008/03/phthalates-the-toxic-chemicals-that-might-be-in-your-sex-toy-by-lynnea-dally

Q: What do the Centers for Disease Control know about body burden?

A: The U.S. Centers for Disease Control (CDC) recently expanded their long-running annual body burden survey of U.S. citizens from two chemicals (lead and cotinine from passive tobacco smoke) to 27 classes of chemicals and heavy metals. CDC reported the results of this survey in 2001: the levels of several toxic chemicals and metals were much higher than expected. The CDC found that levels of lead in blood continue to fall, although mercury, another heavy metal that is a potent neurotoxin for fetuses, infants and children, were high.  High mercury levels in women of childbearing age were of particular concern because mercury, like lead, crosses the placenta during pregnancy and can affect the brain development of the fetus.  After birth, babies and toddlers remain more susceptible to mercury and lead because their brains and nervous systems are still developing. For more information on the health effects of mercury and lead, visit theWashington Toxics Coalition website.

Phthalates were also found at much higher concentrations than expected in women of childbearing age.  Phthalates are found in many beauty products, such as skin lotion, shampoo and nail polish, and are added to plastics to make them more pliable, such as infant feeding bottles, soft plastic toys for children and pets and some medical devices. They can be absorbed through the skin, inhaled as fumes, ingested when children bite or suck on toys, or directly administered during medical care.  Phthalates have been shown to cause organ damage and severe reproductive and developmental problems in animal studies.  The high phthalate levels found in people were enough of a concern that CDC has prioritized phthalates for further investigation. See Chemical Case Studies for more information on phthalates.

The CDC also looked for and found a number of widely used organophosphate pesticides in its study. Organophosphates pass through the body relatively quickly, so this means that the people studied were recently exposed to these pesticides. Organophosphate pesticides are used mostly as insecticides, both in agriculture and in household products. Short-term exposure can have a number of serious health effects including cancer and endocrine disruption (see www.pesticideinfo.org).

You can download the entire CDC report or view of summary of the report . The CDC plans to update this report and expand the list of chemicals it looks for annually.

Q: Are there other resources to learn more about the studies that have been done?

A: The Natural Resources Defense Council has compiled dozens of studies on its website addressing questions about chemicals in breast milk. These studies show the results of breast milk testing which has been done for years in different parts of the world. In some cases, such as in Sweden, breast milk has been systematically tested for so many years that the impact of public policies (such as banning DDT) can be seen in the test results.

Studies of chemicals in the human body and how they affect our health continue to be conducted and released in countries around the world. One of the best sources for tracking new body burden studies is the "Our Stolen Future" website , which is operated by the authors of Our Stolen Future, Dr. John Peterson Myers, Dr. Theo Colburn and Dianne Dumanoski.

In the spring of 2000, the Center for Health and Environmental Justice collected dozens of studies from around the world documenting industrial chemicals and pesticides in blood, adipose tissue and breast milk. Pesticide Action Network has compiled these studies into a database that is searchable by chemical or country, so you can find a list of all studies that have been conducted in Denmark, or a list of countries in which studies have been conducted on DDT  body burdens.  While this database is not comprehensive, it provides a glimpse of the types of studies that have been conducted for many years around the world. It will be available on-line soon atwww.panna.org .

Q: Where can I learn more about "persistent" chemicals that pass on to the next generation?

A: Some chemicals are called "persistent" because they last for a long time – in some cases decades – in the environment.  Persistent organic pollutants or "POPs" also build up in the food chain, can travel around the world in global air and water currents, and are linked to serious health problems in humans and other species.  Many organizations around the world are working to eliminate this class of POP chemicals.  The international community recently recognized that the POP chemicals did not respect national borders, and an international treaty, the Stockholm Convention, was developed.  The Convention calls for global elimination of an initial list of 12 POP chemicals, with more to be added once the treaty takes effect.  For more information about the Stockholm Convention and the many groups working to eliminate POPs, visit the International POPs Elimination Network website.

Dr. Sandra Steingraber’s recent book, Having Faith: An Ecologist’s Journey to Motherhood provides a more personal perspective on the issue.  Dr. Steingraber chronicles her pregnancy month by month, at each stage examining the potential effects of environmental contaminants on the growing fetus, including persistent chemicals that she carries in her body. She also describes the birth and breastfeeding of her daughter Faith – presenting both the wonder of the process and how those wonders are being threatened and diminished by pollutants. Dr. Steingraber’s website has excerpts from the book, information about chemicals and extensive links to organizations and information sources.

Q: Where can I learn more about chemicals that pass through our bodies quickly?

A: Some chemicals break down relatively quickly in the body, so the fact that they have been found in the body’s blood and urine means that the people tested were recently exposed to these chemicals.  Chemicals that pass quickly through our bodies can still have damaging long-term effects. In fact, the body’s process of eliminating foreign compounds often makes them more reactive, and these reactive molecules can damage delicate proteins including DNA.

When a fetus is exposed to chemicals at particular stages of development, there are often serious, irreversible effects. You can learn more about the health effects of pesticides at www.pesticideinfo.org, and about some of the links between chemical exposure and developmental effects at the "Our Stolen Future" web site and in the reports Generations at Risk and In Harms Way.

Q: Where can I learn about chemicals in my neighborhood?

A: While it would be impossible to find out exactly which chemicals you are exposed to in your house and neighborhood, there are some "right-to-know" resources that provide basic information on industrial chemical releases and pesticide applications in your state or neighborhood.

It is important to note that these resources do not capture the chemicals you are exposed to through the everyday use of many household products, pesticide residues on food, industrial by-products, and persistent pollutants that are pervasive in our environment.

Recommended Reading

www.checnet.org is a gateway to practical and accurate information for parents on how to prevent their children from being exposed to hazards in their homes.

Schettler, Ted and others. In Harm’s Way: Toxic Threats to Child Development (Greater Boston Physicians for Social Responsibility) 2000. http://www.igc.org/psr/

Solomon, Gina and Ted Schettler Generations at Risk: Reproductive Health and the Environment (MIT Press) July 1999. http://www.igc.org/psr/

Steingraber, Sandra Having Faith: An Ecologist’s Journey to Motherhood (Perseus Publishing, Cambridge, Massachusetts) 2001. www.steingraber.com

Trade Secrets home page –http://www.pbs.org/tradesecrets/problem/bodyburden.html

McDonough, William and Micheal Braungart. Cradle to Cradle/Remaking the Way We Make Things. (North Point Press) 2002.

Thornton, Joe, Michael McCally, and Jeff Howard, "Body burdens of industrial chemicals in the general population." In Life Support: The Environment and Human Health, ed. Michael McCally (MIT Press) 2002, 163-200.

http://www.chemicalbodyburden.org/learnmore.htm

Sodium Lauryl Sulfate and Sodium Laureth Sulfate

This inexpensive detergent is commonly used in cosmetic cleansers, hair shampoos, bath and shower gels, bubble baths, etc. – It is probably the most dangerous ingredient used in skin and hair-care products. In the cleaning industry SLS is used in garage floor cleaners, engine degreasers, car-wash soaps, etc. It is very corrosive and readily attacks greasy surfaces.

Sodium lauryl sulfate is used throughout the world for clinical testing as a primary skin irritant. Laboratories use it to irritate skin on test animals and humans so that they may then test healing agents to see how effective they are on the irritated skin.

A study at the University of Georgia Medical College, indicated that SLS penetrated into the eyes as well as brain, heart, liver, etc., and showed long-term retention in the tissues. The study also indicated that SLS penetrated young children’s eyes and prevented them from developing properly and caused cataracts to develop In adults.

May cause hair loss by attacking the follicle. Classified as a drug in bubble baths because it eats away skin protection and causes rashes and infection to occur.

Is potentially harmful to skin and hair. Cleans by corrosion. Dries skin by stripping the protective lipids from the surface so it can’t effectively regulate moisture.

Another extremely serious problem is the connection of SLS with nitrate contamination. SLS reacts with many types of ingredients used in skin products and forms nitrosomines (nitrates). Nitrates are potential cancer-causing carcinogenics.

Because of the alarming penetrating power of SLS, large amounts of these known carcinogens are absorbed through the skin into the body. A variation of SLS is SODIUM LAURETH SULFATE (Sodium Lauryl Ether Sulfate- SLES). It exhibits many of the same characteristics and is a higher-foaming variation of SLS.

Sodium lauryl sulfate

Not to be confused with Sodium laureth sulfate.

Sodium dodecyl sulfate

Sodium lauryl sulfate

Sodium lauryl sulfate (SLS), sodium laurilsulfate or sodium dodecyl sulfate (SDS or NaDS) (C12H25SO4Na) is an anionic surfactant used in many cleaning and hygiene products. The molecule has a tail of 12 carbon atoms, attached to a sulfate group, giving the molecule the amphiphilic properties required of a detergent.

SLS is a highly effective surfactant and is used in any task requiring the removal of oily stains and residues. For example, it is found in higher concentrations with industrial products including engine degreasers, floor cleaners, and car wash soaps. It is used in lower concentrations with toothpastes, shampoos, and shaving foams. It is an important component in bubble bath formulations for its thickening effect and its ability to create a lather.

SLS has not been proven to be carcinogenic when either applied directly to skin or consumed.[1] It has however been shown to irritate the skin of the face with prolonged and constant exposure (more than an hour) in young adults.[2] In a clinical study, SLS toothpaste was found to cause a higher frequency of canker sores than both cocoamidopropyl betaine or a detergent-free paste, on 30 patients with frequent occurrences of such ulcers.[3] However, another study comparing toothpastes with and without SLS found that it had no significant effect on ulcer patterns.[4]

 

Bottle of sodium dodecyl sulfate for use in the laboratory.

SLS is a highly effective surfactant and is used in any task requiring the removal of oily stains and residues. As such the compound is found in high concentrations in industrial products including engine degreasers, floor cleaners, and car wash soaps. In household products, SLS is used in lower concentrations with toothpastes, shampoos, and shaving foams. It is an important component in bubble bath formulations for its thickening effect and its ability to create a lather.

Research suggests that SLS could represent a potentially effective topical microbicide, which can also inhibit and possibly prevent infection by variousenveloped and non-enveloped viruses such as the Herpes simplex viruses, HIV, and the Semliki Forest Virus.[5][6]

It has recently found application as a surfactant in gas hydrate or methane hydrate formation reactions, increasing the rate of formation as much as 700 times.[7]

In medicine, sodium lauryl sulfate is used rectally as a laxative in enemas, and as an excipient on some dissolvable aspirins and other fiber therapy caplets.

Sodium lauryl sulfate is increasingly found in all kinds of common over-the-counter orally ingested drugs like aspirin as well as prescription medicines like drugs for heart problems. The reason for this is that it aids the production process by helping tablets not to stick to the mould when pressed into shape. The long term health implications of this for patients has not been the subject of any studies, and in the UK for instance it is now virtually impossible to get aspirin of any brand, standard or dispersible that does not contain sodium lauryl sulfate.

It can be used to aid in lysing cells during DNA extraction and for unraveling proteins in SDS-PAGE. Sodium lauryl sulfate, in science referred to as sodium dodecyl sulfate (SDS), is commonly used in preparingproteins for electrophoresis in the SDS-PAGE technique.[8] This compound works by disrupting non-covalent bonds in the proteins, denaturing them, and causing the molecules to lose their native shape (conformation). Also, anions of SDS bind to the main peptide chain at a ratio of one SDS anion for every two amino acid residues.[citation needed] This effectively imparts a negative charge on the protein that is proportional to the mass of that protein (about 1.4 g SDS/g protein).

This new negative charge is significantly greater than the original charge of that protein. The electrostatic repulsion that is created by binding of SDS causes proteins to unfold into a rod-like shape thereby eliminating differences in shape as a factor for separation in the gel. Sodium lauryl sulfate is probably the most researched anionic surfactant compound. Like all detergent surfactants (including soaps), sodium lauryl sulfate removes oils from the skin, and can cause skin and eye irritation. The critical micelle concentration (CMC) in pure water at 25°C is 0.0082 M,[9] and the aggregation number at this concentration is usually considered to be about 62.[10] The micelle ionization fraction (α) is around 0.3 (or 30%).[11]

There is evidence that surfactants such as sodium lauryl sulfate can act as a shark repellent at concentrations on the order of 100 parts per million. However, this does not meet the desired "cloud" deterrence level of 0.1 parts per million. [12] [13]

Synthesis

Sodium lauryl sulfate structure 

SLS is synthesized by reacting lauryl alcohol with sulfuric acid to produce hydrogen lauryl sulfate which is then neutralized through the addition of sodium carbonate.[14] Lauryl alcohol is in turn usually derived from eithercoconut or palm kernel oil by hydrolysis, which liberates their fatty acids, followed by reduction of the acid group to an alcohol.

Due to this synthesis method, SLS is actually not pure dodecyl sulfate but a mixture of alkyl sulfates with dodecyl sulfate as the main component.[15]

Toxicology

Cancer

SLS has not been proven to be carcinogenic when either applied directly to skin or consumed.[1] SLS however is a strong surfactant and some dermatological concerns regarding its role as an irritant have been raised in published reports.[16]

Sensitivity

SLS may worsen skin problems in individuals with chronic skin hypersensitivity, with some people being affected more than others.[17][18][19] SLS has also been shown to irritate the skin of the face with prolonged and constant exposure (more than an hour) in young adults.[2] In animal studies SLS appears to cause skin and eye irritation.[16]

Canker sores

A preliminary study suggested SLS in toothpaste caused the recurrence of aphthous ulcers, commonly referred to in some countries as canker sores or white sores.[20] The preliminary study "showed a statistically significant decrease in the number of aphthous ulcers from 14.3 after using the SLS-containing dentifrice to 5.1 ulcers after brushing with the SLS-free dentifrice."[20] A clinical study comparing the incidence of recurrent aphthous ulcers during the use of dentifrices with and without sodium lauryl sulfate supported the findings of an earlier independent study which suggest that use of an SLS-free dentifrice should be considered for individuals who suffer from recurrent aphthous ulcers.[21] A clinical double-blind crossover study found sodium lauryl sulfate had a significantly higher frequency of aphthous ulcers than both cocoamidopropyl betaine or a detergent-free paste, on 30 patients with frequent occurrences of recurrent aphthous ulcers.[3] The clinical double-blind crossover study suggests use of an SLS-free toothpaste for patients with recurrent aphthous ulcers would reduce recurrence.[3] A double blind crossover trial comparing toothpastes with and without SLS found that it had no significant effect on ulcer patterns.[4]

Sodium laureth sulfate

Not to be confused with Sodium lauryl sulfate.

Sodium laureth sulfate

image

Sodium laureth sulfate, or sodium lauryl ether sulfate (SLES), is a detergent and surfactant found in many personal care products (soaps, shampoos, toothpaste etc.). SLES is an inexpensive and very effective foaming agent.[1]

Chemical structure

Its chemical formula is CH3(CH2)10CH2(OCH2CH2)nOSO3Na. Sometimes the number represented by n is specified in the name, for example laureth-2 sulfate. The commercial product is heterogeneous in the number of ethoxyl groups, where n is the mean. It is common for commercial products for n= 3. SLES is prepared by ethoxylation of dodecyl alcohol. The resulting ethoxylate is converted to an half ester of sulfuric acid, which is neutralized by conversion to the sodium salt.[1] The related surfactant sodium lauryl sulfate (also known as sodium dodecyl sulfate or SLS) is produced similarly, but without the ethoxylation step. SLS and ammonium lauryl sulfate (ALS) are commonly used alternatives to SLES in consumer products.[1]

Application

SLES, SLS and ALS are surfactants that are used in many cosmetic products for their cleansing and emulsifying properties. They behave similarly to soap.

Toxicology

Irritation

Although SLES is considered safe at the concentrations used in cosmetic products, at higher concentrations it is an irritant similar to other detergents.[2] SLES has been shown to produce eye or skin irritation in experimental animals and in some human test subjects.[2] The related surfactant SLS is a known irritant,[3][4] and research suggests that SLES can also cause irritation after extended exposure in some people.[5][6]

Carcinogenicity

Toxicology research by the OSHA, NTP, and IARC supports the conclusions of the Cosmetic, Toiletry, and Fragrance Association (CTFA) and the American Cancer Society that SLES is not a carcinogen.[7] The U.S. Environmental Protection Agency classifies 1,4-dioxane to be a probable human carcinogen (having observed an increased incidence of cancer in controlled animal studies, but not in epidemiological studies of workers using the compound), and a known irritant (with a no-observed-adverse-effects level of 400 milligrams per cubic meter) at concentrations significantly higher than those found in commercial products.[8] Under Proposition 65, 1,4-dioxane is classified in the U.S. state of California to cause cancer.[9][10]

1,4-Dioxane contaminant

Some products containing SLES have been found to contain low levels of the known carcinogen 1,4-dioxane, with the recommendation from the U.S. Food and Drug Administration that these levels be monitored.[11] The FDA encourages manufacturers to remove 1,4-dioxane, though it is not required by federal law.[12]

Keys Banned Chemical Series – SLS (Sodium Laureth Sulfate)

http://keys-soap.com/keysblog/?p=688

January 19th, 2010

Dirty Dozen Chemicals: SLS

Bob Root, Keys CTO

By Bob Root

Keys Technologist

Many people that I meet ask me to describe why I do not use certain chemicals.  I tell them that my reasons are practical not political.  I generally explain in three to five pragmatic reasons why I do not use certain ingredients.  Most encourage me to offer my simplified reasons, so I am beginning to undertake why we do not use certain ingredients.  In this series of article, I will start with the Dirty Dozen.

SLS Overview:

Sodium Laureth Sulfate (SLS) is the first chemical listed on the Dirty Dozen Chemicals created by the Marin County Cancer Project.  These Dirty Dozen have been linked to elevated Cancer rates in people and their pets.

SLS has over 200 synonyms listed on the National Institutes of Health Toxnet.  Some very chemical sounding while other sound very safe and botanical.  They are fundamentally the same.  We believe that many manufacturers have chosen to create synonyms to claim that they do not use SLS.

SLS is used in cleansers, soaps, shampoos and even toothpaste.  It makes things suds, degreases and cleans.  It was introduced into the US after World War II as an engine degreaser.  Up until the 50’s it was used primarily for that purpose in the form of a product called Gunk!  Gunk is an engine degreaser that is still sold in auto parts stores to get rid of engine grime.

Companies started to use SLS in personal care products to make then foam the same in hard and soft water.  As the use grew, it became very inexpensive which broadened its appeal to companies wanting cleaning degreasing action.  Most recently, companies making “patch” based products for non-smoking or weight loss have found that SLS also help to deliver the active ingredients deeply and faster.  This is sort of the main rub I have with the ingredient, but it is only just one of the things that keeps me from using the ingredient.

Recently, Fenchem Company has published some papers that link SLS in shampoos to baldness.  This is something that we have suspected and known for quite a few years.

Why Keys Does Not Use SLS

In all the yelling and screaming about what is safe and not, I have developed a series of reasons that I do not use the Dirty Dozen Chemicals as well as others.  I have chosen this format to simplify my reasons for our customers.  When I am speaking and arguing with others in the industry my basis is much more technical.  I have chosen to over simplify my reasons here to help lay people understand my reasoning.

Reason #1  Inflammation from SLS

Chemical Inflammation aka burns!

I do not use SLS or any family of SLS surfactant because of the reactions I see with the skin.  Generally, anywhere above 0.5% of SLS, we see inflammation of the skin.  The above comment from Fenchem as bee well known to us for quite a few years, but without clinical studies, it would only be opinion and comment.  We see what they see all over the body, but it tends to manifest itself with early male pattern baldness.  What we believe is that the SLS causes inflammation of the hair follicles and causes them to close down starving off the hair growth.  We have noticed for years that men that stop using SLS based shampoos and start using Island Rx have seen renewed hair growth.  We believe it is mostly due to the switch from SLS based shampoos.  In many cases, to be an effective surfactant, SLS needs to be around 15% or higher.  This level has shown mild to severe inflammation for areas like the soft tissue around the eyes to even tougher skin on the arms and legs.  The inflammation seems to be cumulative, but reverses quickly when SLS is removed from the person regime.  Sometimes in science, taking something away results in more research facts than introducing a substance.  This is especially true when the effects of a chemical seem to be more gradual and effect other differently.

Reason #2  Stripping of Natural Oils caused by SLS

As we said, SLS began as an engine degreaser after World War II.  Even in amounts as low as 1%, SLS seems to over-clean and remove the skins natural oils.  Madison Avenue convinced us that our skin should not have any oil on it which is totally false.  Our natural oils are much of what retain our natural skin youthfulness.  In fact we believe that it is a combination of stripping these oils and unnatural dehydration caused by SLS causes skin to lose its luster.  This is why we use pharmaceutical grade natural oils in our products.  Think of it as repairing.

Skin Layers

Reason #3  Increased Skin Permeability caused by SLS

Many companies using patch therapies and many pharmaceutical products  contain SLS to increase to how it aids to penetrate the skin and small intestines.  We extrapolate that SLS in skin care products helps to increase permeability allowing hydrocarbons, bacteria, yeast and other pollutants into the skin.

Reason #4  Cellular Breakdown

In some recent test, we have seen thinning of the skin cellular wall below the epidermis in the dermal level.  The outer layer of the skin has 25 to 30 layers of dead skin cells.  Below that are living cells whose cell wall seem to be effected by SLS.  The critical word here is “seems.”  We are just beginning to look at this closer, but ”seems” is good enough for me when I add the other three primary reason

Please send me your questions and comments,  Bob Root

For those of you that want more opinion, the following description is from The Natural Health Information Center offered as their description of SLS.  This is not Keys opinion, but we do agree with much of their findings and comments

Both Sodium Laureth Sulfate (SLES) and its close relative Sodium Lauryl Sulfate (SLS) are commonly used in many soaps, shampoos, detergents, toothpastes and other products that we expect to “foam up”. Both chemicals are very effective foaming agents, chemically known as surfactants.

Unfortunately, both sodium laureth sulfate and its cousin are also very dangerous, highly irritating chemicals. Far from giving “healthy shining hair” and “beautiful skin”, soaps and shampoos containing sodium laureth sulfate can lead to direct damage to the hair follicle, skin damage, permanent eye damage in children and even liver toxicity.

Although sodium laureth sulfate is somewhat less irritating than SLS, it cannot be metabolized by the liver and its effects are therefore much longer-lasting. This not only means it stays in the body tissues for longer, but much more precious energy is used getting rid of it.

A report published in the Journal of The American College of Toxicology in 1983 showed that concentrations of SLS as low as 0.5% could cause irritation and concentrations of 10-30% caused skin corrosion and severe irritation. National Institutes of Health “Household Products Directory” of chemical ingredients lists over 80 products that contain SLS and SLES. Some soaps have concentrations of up to 30%, which the ACT report called “highly irritating and dangerous“.

Shampoos are among the most frequently reported products to the FDA. Reports include eye irritation, scalp irritation, tangled hair, swelling of the hands, face and arms and split and fuzzy hair. This is highly characteristic of sodium laureth sulfate and almost definitely directly related to its use.

Click here to learn of the possible health effects of sodium laureth sulfate

So why is a dangerous chemical like sodium laureth sulfate used in our soaps and shampoos?

The answer is simple – it is cheap. The sodium laureth sulfate found in our soaps is exactly the same as you would find in a car wash or even a garage, where it is used to degrease car engines.

On the same way as it dissolves the grease on car engines, SLES also dissolves the oils on your skin, which can cause a drying effect. It is also well documented that itdenatures skin proteins, which causes not only irritation, but also allows environmental contaminants easier access to the lower, sensitive layers of the skin.

This denaturing of skin proteins may even be implicated in skin and other cancers.

Perhaps most worryingly, sodium laureth sulfate is also absorbed into the body from skin application. Once it has been absorbed, one of the main effects of SLS is to mimic the activity of the hormone Oestrogen. This has many health implications and may be responsible for a variety of health problems from PMS and Menopausal symptoms todropping male fertility and increasing female cancers such as breast cancer, where oestrogen levels are known to be involved.

Products commonly found to contains SLS or Sodium Laureth Sulfate

oaps
Shampoos
Bubble-baths
Tooth paste
Washing-up liquid / dish soap
Laundry detergent
Children’s soaps / shampoos
Stain Remover
Carpet Cleaner
Fabric glue
Body wash
Shave cream
Mascara
Mouthwash
Skin cleanser
Moisture lotion / Moisturizer
Sun Cream

The use of sodium laureth sulfate in children’s products is particularly worrying. It is known that, whether it gets in the eyes or not, skin application DOES lead to measurable concentrations in the eyes of children. This is known to affect eye development, and the damage caused in this manner is irreversible. If you have children DO NOT USE products containing sodium laureth sulfate or SLS – they will thank you for it one day.

Do not believe that just because a product is labeled as “natural” it is free from SLS or sodium laureth sulfate. Most common brands of “Natural” or “Herbal” shampoos and cleansers still use these harmful chemicals as their main active ingredient – check your labels!

That is not to say that you can’t get sodium laureth sulfate-free shampoos, soaps, detergents and toothpastes. Some highly reputable companies have been producing such products for years. These products not only contains no sodium laureth sulfate, they are also free of other harmful chemical colorings, preservatives and even flavorings.

http://keys-soap.com/keysblog/?p=688

Aspartame

Aspartame

Aspartame (or APM) (pronounced /ˈæspərteɪm/ or /əˈspɑrteɪm/) is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages. In the European Union, it is codified as E951. Aspartame is a methyl ester of the aspartic acid/phenylalanine dipeptide. It was first synthesized in 1965.

The safety of aspartame has been the subject of several political and medical controversies, Congressional hearings and internet hoaxes since its initial approval for use in food products by the U.S. Food and Drug Administration (FDA) in 1974. A 2007 medical review on the subject concluded that "the weight of existing scientific evidence indicates that aspartame is safe at current levels of consumption as a non-nutritive sweetener".[3] However, because its breakdown products include phenylalanine, aspartame must be avoided by people with the genetic condition phenylketonuria (PKU).

Chemistry

Aspartame is a methyl ester of the dipeptide of the natural amino acids L-aspartic acid and L-phenylalanine. Under strongly acidic or alkaline conditions, aspartame may generate methanol by hydrolysis. Under more severe conditions, the peptide bonds are also hydrolyzed, resulting in the free amino acids.[4]

For some markets, aspartame is manufactured from phenylalanine produced by a genetically modified strain of E. coli,[5][6] a bacterium used commonly in laboratory research and biotechnology.[7]

Properties and use

Aspartame is an artificial sweetener and is approximately 200 times sweeter than sucrose, or table sugar. Due to this property, though aspartame upon metabolism produces 4 kilocalories per gram of energy, the quantity of aspartame needed to produce a sweet taste is so small that its caloric contribution is negligible.[3] The taste of aspartame and other artificial sweeteners differ from that of table sugar in the times of onset and how long the sweetness lasts, though aspartame comes closest amongst artificial sweeteners to sugar’s taste profile. The sweetness of aspartame lasts longer than sucrose, so it is often blended with other artificial sweeteners like acesulfame potassium to produce an overall taste more like sugar.[8]

Like many other peptides, aspartame may hydrolyze (break down) into its constituent amino acids under conditions of elevated temperature or high pH. This makes aspartame undesirable as a baking sweetener, and prone to degradation in products hosting a high-pH, as required for a long shelf life. The stability of aspartame under heating can be improved to some extent by encasing it in fats or in maltodextrin. The stability when dissolved in water depends markedly on pH. At room temperature, it is most stable at pH 4.3, where its half-life is nearly 300 days. At pH 7, however, its half-life is only a few days. Most soft-drinks have a pH between 3 and 5, where aspartame is reasonably stable. In products that may require a longer shelf life, such as syrups for fountain beverages, aspartame is sometimes blended with a more stable sweetener, such as saccharin.[9]

Aspartame’s major decomposition products are its cyclic dipeptide (diketopiperazine form), the de-esterified dipeptide (aspartyl-phenylalanine), and its constituent components, phenylalanine,[10] aspartic acid,[11]and methanol.[12] At 180° C, aspartame undergoes decomposition to form a diketopiperazine (DKP) derivative.[13]

In products such as powdered beverages, the amine in aspartame can undergo a Maillard reaction with the aldehyde groups present in certain aroma compounds. The ensuing loss of both flavor and sweetness can be prevented by protecting the aldehyde as an acetal.

Descriptive analyses of solutions containing aspartame report a sweet aftertaste as well as bitter and off-flavour aftertastes.[14]

Discovery and approval

Aspartame was discovered in 1965 by James M. Schlatter, a chemist working for G.D. Searle & Company. Schlatter had synthesized aspartame in the course of producing an antiulcer drug candidate. He accidentally discovered its sweet taste when he licked his finger, which had become contaminated with aspartame.[15]

In 1975, prompted by issues regarding Flagyl and Aldactone, a U.S. FDA task force team reviewed 25 studies submitted by the manufacturer, including 11 on aspartame. The team reported “serious deficiencies in Searle’s operations and practices".[16] The FDA sought to authenticate 15 of the submitted studies against the supporting data, in 1979 the Center for Food Safety and Applied Nutrition (CFSAN) concluded that, as any problems with the aspartame studies were minor and did not affect the conclusions, the studies could be used to assess aspartame’s safety.[16]

In 1980, the FDA convened a Public Board of Inquiry (PBOI) consisting of independent advisors charged with examining the purported relationship between aspartame and brain cancer. The PBOI concluded that aspartame does not cause brain damage, but it recommended against approving aspartame at that time, citing unanswered questions about cancer in laboratory rats.[16][17]

Citing data from a Japanese study that had not been available to the members of the PBOI,[18] and after seeking advice from an expert panel that found fault with statistical analyses underlying the PBOI’s hesitation, yet argued against approval,[19] FDA commissioner Hayes approved aspartame for use in dry goods.[20] In 1983, the FDA further approved aspartame for use in carbonated beverages, and for use in other beverages, baked goods, and confections in 1993. In 1996, the FDA removed all restrictions from aspartame, allowing it to be used in all foods.

In 1984, Monsanto Company bought G.D. Searle—and the aspartame business became a separate Monsanto subsidiary, the NutraSweet Company. On May 25, 2000, Monsanto sold it to J.W. Childs Equity Partners II L.P.[21] The U.S. patent on aspartame expired in 1992. Since then, the company has competed for market share with other manufacturers, including Ajinomoto, Merisant and the Holland Sweetener Company. The latter stopped making the chemical in late 2006 because "global aspartame markets are facing structural oversupply, which has caused worldwide strong price erosion over the last five years", making the business "persistently unprofitable".[22]

Several European Union countries approved aspartame in the 1980s, with EU-wide approval in 1994. The European Commission Scientific Committee on Food reviewed subsequent safety studies and reaffirmed the approval in 2002. The European Food Safety Authority reported in 2006 that the previously established Acceptable Daily Intake was appropriate, after reviewing yet another set of studies.[23]

Metabolism and phenylketonuria

Upon ingestion, aspartame breaks down into natural residual components, including aspartic acid, phenylalanine, methanol,[24] and further breakdown products including formaldehyde[25] and formic acid, accumulation of the latter being suspected as the major cause of injury in methanol poisoning. Human studies show that formic acid is excreted faster than it is formed after ingestion of aspartate. In some fruit juices, higher concentrations of methanol can be found than the amount produced from aspartame in beverages.[11]

High levels of the naturally-occurring essential amino acid phenylalanine are a health hazard to those born with phenylketonuria (PKU), a rare inherited disease that prevents phenylalanine from being properly metabolized. Since individuals with PKU must consider aspartame as an additional source of phenylalanine, foods containing aspartame sold in the United States must state "Phenylketonurics: Contains Phenylalanine" on their product labels.[26]

In the UK, foods that contain aspartame are legally required by the country’s Food Standards Agency to list the chemical among the product’s ingredients and carry the warning "Contains a source of phenylalanine" – this is usually at the foot of the list of ingredients. Manufacturers are also required to print ‘"with sweetener(s)" on the label close to the main product name’ on foods that contain "sweeteners such as aspartame" or "with sugar and sweetener(s)" on "foods that contain both sugar and sweetener".[27]

Marketing

Equal, NutraSweet, and Canderel are ingredients of approximately 6,000 consumer foods and beverages sold worldwide, including (but not limited to) diet sodas and other soft drinks, instant breakfasts, breath mints, cereals, sugar-free chewing gum, cocoa mixes, frozen desserts, gelatin desserts, juices, laxatives, chewable vitamins supplements, milk drinks, pharmaceutical drugs and supplements, shake mixes, tabletop sweeteners, teas, instant coffees, topping mixes, wine coolers and yogurt. It is provided as a table condiment in some countries. Aspartame is less suitable for baking than other sweeteners, because it breaks down when heated and loses much of its sweetness. Aspartame is also one of the main sugar substitutes used by people with diabetes.

Ajinomoto

In 2004 the market for aspartame, in which the company Ajinomoto, the world’s largest aspartame manufacturer, had a 40 percent share, was 14,000 metric tons a year, and consumption of the product was rising by 2 percent a year.[28] Ajinomoto acquired its aspartame business in 2000 from Monsanto for $67M.[29]

In 2008, Ajinomoto sued British supermarket chain Asda, part of Wal-Mart, for a malicious falsehood action concerning its aspartame product when the chemical was listed as excluded from the chain’s product line, along with other "nasties".[30] In July 2009, a British court found in favour of Asda.[31] In June 2010, an appeal court reversed the decision, allowing Ajinomoto to pursue a case against Asda to protect aspartame’s reputation.[32] Asda said that it would continue to use the term "no nasties" on its own-label products.[33]

In November 2009, Ajinomoto announced a new brand name for its aspartame sweetener — AminoSweet.[34][35]

Competition

Because sucralose, unlike aspartame, retains its sweetness after being heated, and has at least twice the shelf life of aspartame, it has become more popular as an ingredient.[36] This, along with differences in marketing and changing consumer preferences, caused aspartame to lose market share to sucralose.[37][38] In 2004, aspartame traded at about $30/kg and sucralose, which is roughly three times sweeter by weight, at around $300/kg.[39].

Safety controversy

Main article: Aspartame controversy

Aspartame has been the subject of several controversies and hoaxes since its initial approval by the U.S. Food and Drug Administration (FDA) in 1974. Critics allege that conflicts of interest marred the FDA’s approval of aspartame, question the quality of the initial research supporting its safety,[40][41][42] and postulate that numerous health risks may be associated with aspartame.

The validity of these claims has been examined and dismissed.[43][44][45] In 1987, the U.S. Government Accountability Office concluded that the food additive approval process had been followed properly for aspartame.[40][46] Aspartame has been found to be safe for human consumption by more than ninety countries worldwide,[47][48] with FDA officials describing aspartame as "one of the most thoroughly tested and studied food additives the agency has ever approved" and its safety as "clear cut".[49] The weight of existing scientific evidence indicates that aspartame is safe at current levels of consumption as a non-nutritive sweetener.[3]

 

The artificial sweetener aspartame has been the subject of several controversies and hoaxes since its initial approval by the U.S. Food and Drug Administration (FDA) in 1974. Critics allege that conflicts of interest marred the FDA’s approval of aspartame, question the quality of the initial research supporting its safety,[1][2][3] and postulate that numerous health risks may be associated with aspartame.

The validity of these claims has been examined and dismissed.[4][5][6] In 1987, the U.S. Government Accountability Office concluded that the food additive approval process had been followed properly for aspartame.[1][7] Aspartame has been found to be safe for human consumption by more than ninety countries worldwide,[8][9] with FDA officials describing aspartame as "one of the most thoroughly tested and studied food additives the agency has ever approved" and its safety as "clear cut".[10] The weight of existing scientific evidence indicates that aspartame is safe at current levels of consumption as a non-nutritive sweetener.[11]

History of approval and safety

The controversy over aspartame safety originated in perceived irregularities in the aspartame approval process during the 1970s and early 1980s, including allegations of conflicts of interest and claims that aspartame producer G.D. Searle had withheld safety data. In 1996, the controversy reached a wider audience with a 60 Minutes report[12] on concerns that aspartame could cause brain tumors in humans. Around the same time, an unidentified anti-aspartame activist wrote about the subject under a pen name, creating the basis for a misleading and unverifiable hoax chain letter that was spread over the Internet.[5]

Approval in the United States

Aspartame was originally approved for use in dry foods in 1974 by then FDA Commissioner Alexander Schmidt after review by the FDA’s Center for Food Safety and Applied Nutrition. Searle had submitted 168 studies[1]:20 on aspartame, including seven animal studies that were considered crucial by the FDA.[1]:21 Soon afterwards, John Olney, a professor of psychiatry and prominent critic of MSG, along with James Turner, a public-interest lawyer and author of an anti-food-additive book, filed a petition for a public hearing, citing safety concerns.[1]:38[13]:63-4 Schmidt agreed, pending an investigation into alleged improprieties in safety studies for aspartame and several drugs. The Department of Justice instituted grand jury proceedings against Searle for fraud in one of its drug studies. In December 1975, the FDA placed a stay on the aspartame approval, preventing Searle from marketing aspartame.[1]:28

In 1977 and 1978, an FDA task force and a panel of academic pathologists reviewed 15 aspartame studies by Searle, and concluded that, although minor inconsistencies were found, they would not have affected the studies’ conclusions.[1]:4 In 1980, a Public Board of Inquiry (PBOI) heard testimony from Olney and disagreed with his claims that aspartame could cause brain damage, including in the developing fetus.[1]:40-41 The board decided that further study was needed on a postulated connection between aspartame and brain tumours, and revoked approval of aspartame.[1]:47

In 1981, FDA Commissioner Arthur Hull Hayes sought advice on the issue from a panel of FDA scientists and a lawyer. The panel identified errors underlying the PBOI conclusion that aspartame might cause brain tumours, and presented arguments both for and against approval.[1]:53 Hayes approved the use of aspartame in dry foods. Hayes further justified his approval with a Japanese brain tumor study,[14] the results of which, the PBOI chairman later said, would have resulted in an "unqualified approval" from the PBOI panel.[15] Several objections followed, but all were denied.[1]:13 In November 1983, a little more than a year after approving aspartame Hayes left the FDA and joined public-relations firm Burson-Marsteller as a senior medical advisor.[7]Because Burson-Marsteller was Searle’s public relations agency at the time, this decision would later fuel conspiracy theories.[16]

Because of the approval controversy, Senator Howard M. Metzenbaum requested an investigation by the U.S. Government Accountability Office (GAO) of aspartame’s approval. In 1987, the GAO reported that protocol had been followed and provided a timeline of events in the approval process.[1]:13 At that time, of 67 scientists who responded to a questionnaire, 12 had major concerns about Aspartame’s safety, 26 were somewhat concerned but generally confident in Aspartame safety, and 29 were very confident in Aspartame safety.[1]:16,76-81

Approval outside the US

Food additive safety evaluations by many countries have led to approval of aspartame, citing the general lack of adverse effects following consumption in reasonable quantities.[17] Food safety authorities worldwide have set acceptable daily intake (ADI) values for aspartame at 40 mg/kg of body weight based on a 1980 Joint FAO/WHO Expert Committee on Food Additives recommendation.[9] JECFA re-confirmed its evaluation in a later addendum to its monograph[18]) and the same value was approved in a December 2002 evaluation of all aspartame research by the European Commission’s Scientific Committee on Food.[9] The FDA has set its ADI for aspartame at 50 mg/kg.[19]

Based on government research reviews and recommendations from advisory bodies such as those listed above, aspartame has been found to be safe for human consumption by more than ninety countries worldwide.[8][9]

Alleged conflict of interest prior to 1996

In 1976, the FDA notified then-U.S. attorney for Chicago, Sam Skinner, of the ongoing investigation of Searle, and in January 1977, formally requested that a grand jury be convened. In February, 1977, Searle’s law firm, Sidley & Austin offered Skinner a job and Skinner recused himself from the case.[20] Mr. Skinner’s successor was in place several months later, and the statute of limitations for the alleged offenses expired in October 1977. Despite complaints and urging from DOJ in Washington, neither the interim US attorney for Chicago, William Conlon, nor Skinner’s successor, Thomas Sullivan, convened a grand jury.[21] In December, 1977, Sullivan ordered the case dropped for lack of evidence, and Conlon was later hired by Searle’s law firm. Concern about conflict of interest in this case inflamed the controversy, and Senator Metzenbaum investigated in 1981 Senate Hearings.[1] In 1989, the US Senate approved the nomination of Sam Skinner to be Secretary of Transportation, noting that both Sullivan and Senator Metzenbaum had concluded that Skinner had not acted improperly.[20]

Ralph G. Walton, a psychologist at Northeastern Ohio Universities College of Medicine, claims that funding sources may have affected the conclusions of aspartame-related research. Walton alleges that researchers with ties to industry find no safety problems, while many of those without ties to aspartame find toxicities.[16][22] In a rebuttal to Walton’s statements, the ‘Aspartame Information Service’ (a service provided by Ajinomoto, a producer of aspartame and supplier to well known food and drink makers), reviews the publications Walton cites as critical of aspartame, finding that most of them do not involve aspartame or do not draw negative conclusions, are not peer-reviewed, are anecdotal, or are duplicates.[23]

Internet rumors

An elaborate hoax disseminated through the Internet attributes deleterious medical effects to aspartame. This conspiracy theory claims that the FDA approval process of aspartame was tainted[4][5][24] and cites as its source an email based upon a supposed talk by a "Nancy Markle" at a "World Environmental Conference."[4][5][25] Specifically, the hoax websites allege that aspartame is responsible for multiple sclerosis, systemic lupus, and methanol toxicity, causing "blindness, spasms, shooting pains, seizures, headaches, depression, anxiety, memory loss, birth defects" and death.[6]

The dissemination of the Nancy Markle letter was considered so notable that the Media Awareness Network featured one version of it in a tutorial on how to determine the credibility of a web page. The tutorial implied that the Markle letter was not credible and stated that it should not be used as an authoritative source of information.[6] Betty Martini, who posted similar messages to Usenet newsgroups in late 1995 and early 1996,[5] claims that an unknown person combined her original letter with other information and redistributed it as Nancy Markle.[26][27] She believes that there is a conspiracy between the FDA and the producers of aspartame. This conspiracy theory has become a canonical example discussed on several Internet conspiracy theory andurban legend websites.[5][28][29] Although most of the allegations of this theory contradict the bulk of medical evidence,[4] this misinformation has spread around the world as chain emails since mid-December 1998,[5] influencing many websites[28] as anurban legend that continues to scare consumers.[4]

Government action and voluntary withdrawals

In 1997, due to public concerns the UK government introduced a new regulation obliging food makers who use sweeteners to state clearly next to the name of their product the phrase "with sweeteners".[30]

In 2007, the Indonesian government considered banning Aspartame.[31] In the Philippines, the small political party Alliance for Rural Concerns introduced House Bill 4747 in 2008 with the aim of having aspartame banned from the food supply.[32] The US state of New Mexico introduced a bill to ban aspartame in 2007,[33][34][35] and Hawaiian legislators signed a 2009 resolution asking the FDA to rescind approval.[36] In March 2009, the California OEHHA identified aspartame as a chemical for consultation by its Carcinogen Identification Committee, in accordance with California state Proposition 65.[37]

In 2007, the UK supermarket chains Sainsbury’s,[38] M&S,[39] and Wal-Mart subsidiary Asda,[40] announced that they would no longer use aspartame in their own label products.[41] In April 2009, Ajinomoto Sweeteners Europe, the makers of Aspartame in Europe, responded to Asda’s ‘no nasties’ campaign by filing a complaint of malicious falsehood against Asda in the English courts.[42][43] In July 2009, Asda won the legal case after the trial judge construed the ‘no nasties’ labelling to "not mean that aspartame was potentially harmful or unhealthy", though it might be appealed.[44][45]

In 2009, the South African retailer Woolworths announced it was removing aspartame from its own-brand foods.[46]

In 2010, the British Food Standards Agency launched an investigation into aspartame amid claims that some people experience side-effects after consuming the substance.[47]

Consumption

A 12 ounce can of diet soda contains 180 mg of aspartame,[48] and one liter of aspartame-sweetened soda contains 600 mg aspartame.[49] U.S. diet beverage consumers average approximately 200 mg of daily aspartame consumption.[48] For a 75 kilograms (165 lb) adult, it takes approximately 21 cans of diet soda to consume the 3,750 mg of aspartame that would surpass the FDA’s 50 milligrams per kilogram of bodyweight ADI of aspartame.[48] Surveys of aspartame intake, particularly via diet soda, indicate that even consumers with high aspartame intake are typically "well below" the EFSA‘s 40 mg/kg ADI.[50][51][52] The European Commission’s Scientific Committee on Food concluded in 2002 that, while some minor effects on health may occur at very high doses, no effects are expected at normal levels of consumption.[53][54]

Safety and analysis

Large scale analyses by scientists and government bodies have concluded that aspartame is safe for dietary consumption by humans. A 2007 study, published in Annals of Oncology of the European Society for Medical Oncology, reviewed Italian studies of instances of cancer from 1991 and 2004 and concluded a "lack of association between saccharin, aspartame and other sweeteners and the risk of several common neoplasms".[55]

In 2006, the US National Cancer Institute concluded in a study of over 470,000 men and women aged 50 to 69 that there was no statistically significant link between aspartame consumption and leukemias, lymphomas or brain tumors.[56] The study compared how much of 4 types of aspartame-sweetened beverages the subjects said they had drunk in 1995 or 1996 to how likely they were to have developed these cancers during the following five years.[57] This conclusion was questioned in letters to the editors[58][59] which pointed out that the study did not consider non-beverage consumption of aspartame, did not estimate the subjects’ long-term use of aspartame, and did not include any subjects who had consumed aspartame since childhood (as the subjects were all over 49 and aspartame beverages had only been on the market for 15 years). The letters concluded that the study design was inappropriate to test the stated hypothesis.

In two widely criticised and later discounted studies,[11][60] the European Ramazzini Foundation of Oncology and Environmental Sciences (ERF) reported[61] what they claimed was a dose-independent, statistically significant increase in several malignancies of rats, concluding that aspartame is a potential carcinogen at normal dietary doses. After reviewing the foundation’s claims, the European Food Safety Authority (EFSA)[62] the U.S. Food and Drug Administration (FDA)[63] discounted the study results and found no reason to revise their previously established acceptable daily intake levels for aspartame. Other reported flaws included: comparing cancer rates of older aspartame-consuming rats to younger control rats; unspecified composition of the "Corticella" diet and method of adding aspartame, leading to possible nutritional deficiencies; unspecified aspartame storage conditions; lack of animal randomization; overcrowding and a high incidence of possibly carcinogenic infections; and the U.S. National Toxicology Program’s finding that the ERF had misdiagnosed hyperplasias as malignancies.[11] The U.S. FDA requested the study’s data and offered to review tissue slides, but the Ramazzini Foundation did not send all of the data and withheld its pathology slides. From the materials received, the FDA found that the data did not support the researcher’s published conclusions.[63]

Several other scientists support the most recent ERF study.[64] Two scientists referred to the newer study in their comments regarding the potential risks to workers who produce aspartame and are exposed to it under long-term conditions. They proposed that the FDA "should consider sponsoring a prospective epidemiologic study of aspartame workers."[65]

The New Zealand Food Safety Authority (NZFSA) also questioned the validity and significance of the Ramazzini studies, stating, "These studies were conducted in a way that could not possibly have provided any information about the toxicity of aspartame – or in fact anything else in the rats’ diet. … In fact, the only conclusion that can be drawn from the results is that aspartame appears to be safe because the studies showed that those rats fed it (even at very high doses) lived as long (if not longer) as untreated rats, despite consuming up to more than 100 times the ADI every day of their lives. If aspartame was as horrendously toxic as is being claimed, it would be logical to expect the rats dosed with it to have shortened life-spans. The conclusions drawn by the researchers were clearly not backed up by their own data."[66]

Scientific studies of aspartame ingestion by humans have found no adverse effects,[55][67][68][69][70][71] but several scientists have recommended further research into postulated connections between aspartame and an increase in malignant brain tumorsfrom 1982 to 1992[72] and in lymphoma.[61] Although some reports have proposed a connection between aspartame and headache or migraine in susceptible individuals,[73][74] the overall scientific evidence indicates that aspartame does not cause headaches.[75]

Hypotheses of adverse health effects have focused on three metabolites of aspartame. A review of the effects of those metabolites has established that aspartame and its metabolites are safe and that there are no adverse reactions.[62]

Methanol and formaldehyde

Approximately 10% of aspartame (by mass) is broken down into methanol in the small intestine. Most of the methanol is absorbed and quickly converted into formaldehyde and then to formic acid.[76] Some opponents of aspartame have falsely claimed that this causes metabolic acidosis.[28] The metabolism of aspartame does not damage the body because: (a) the quantity of methanol produced is too small to disrupt normal physiological processes;[75] (b) methanol and formaldehyde are natural by-products of human metabolism and are safely processed by various enzymes;[75] (c) there is more methanol in some natural fruit juices and alcoholic beverages than is derived from aspartame ingestion;[75][77] and (d) even large doses of pure methanol have been shown in non-human primate studies to lead to ample accumulation of formic acid (as formate), while no formaldehyde was detected.[78]

In experiments on rodents given radiolabeled aspartame, labeled protein and DNA accumulated in the brain, liver, kidneys and other tissues after ingestion of either 20 mg/kg or 200 mg/kg of aspartame.[76] However, these scientists were not directly measuring formaldehyde, but simply measuring levels of some by-product of the methanol from aspartame.[75]

Phenylalanine

Fifty percent of aspartame by mass is broken down into phenylalanine, one of the nine essential amino acids commonly found in foods and a precursor to tyrosine. A rise in blood plasma phenylalanine is negligible in typical use of aspartame[79] and their studies show no significant effects on neurotransmitter levels in the brain or changes in seizure thresholds.[80][81][82] Adverse effects of phenylalanine on fetuses have been observed only when blood phenylalanine levels remain at high levels as opposed to spiking occasionally.[83]

Aspartic acid

40% of aspartame by mass is broken down into aspartic acid (aspartate), an amino acid. At high concentrations, aspartate can act as an excitotoxin, inflicting damage on brain and nerve cells.[84][85]

Humans and other primates are not as susceptible to excitotoxins as rodents; therefore, it is problematic to make conclusions about human safety from high-dose excitoxin response in rodent studies.[86][87] Increases in blood plasma levels of aspartic acid after ingestion of aspartame are insufficient to cause concern for human subjects researchers.[88][89]

Aspartylphenylalanine diketopiperazine

Aspartylphenylalanine diketopiperazine, a type of diketopiperazine (DKP), is created in products as aspartame breaks down over time. For example, researchers found that 6 months after aspartame was put into carbonated beverages, 25% of the aspartame had been converted to DKP.[49]

Concern among some scientists has been expressed that this form of DKP would undergo a nitrosation process in the stomach producing a type of chemical that could cause brain tumors.[72][90] However, the nitrosation of aspartame or the DKP in the stomach likely does not produce chemicals that cause brain tumors.[75] In addition, only a minuscule amount of the nitrosated chemical can be produced.[91] There are very few human studies on the effects of this form of DKP. However, a (one-day) exposure study showed that the DKP was tolerated without adverse effects.[92]

Insulin resistance

Some aspartame critics, particularly those in weight loss communities, claim that aspartame contributes to weight gain and obesity due to purported spikes in the insulin level.[93] The argument holds that aspartame causes the body to secrete excess insulin. If true, this could lead to insulin resistance, weight gain, and possibly type II diabetes — health outcomes that consumers may be trying to prevent by using diet foods and sodas. However, recent studies have shown that aspartame does not increase glucose nor insulin blood levels and cannot be directly linked to insulin resistance or diabetes.[94]

Flight performance

A 1991 study published in the medical journal Aviation, Space, and Environmental Medicine reported that there were anecdotal concerns about aspartame and the cognitive performance of pilots; however, its double-blind study found no detectable effect of aspartame on pilot performance.[95] In 1992, the US Air Force magazine Flying Safety published an article which expressed such anecdotal concerns and warned that a few pilots who drink diet sodas containing aspartame could be more susceptible to conditions ranging from flicker vertigo to gradual loss of vision.[96]

Depression

In 1994, a double-blind study was halted by the institutional review board when eight patients with acute depression exhibited an increased expression of their symptoms after they consumed aspartame. On this basis, the authors of the study recommended that patients with unipolar depression avoid the sweetener.[97] Independent authors commenting on the study have cautioned against drawing conclusions from the uncontrolled study considering the everyday experience of depressed people exposed to aspartame. The authors also addressed issues of publication bias, "Potential for positive publication bias in studies funded by manufacturers undoubtedly exists, but this can also apply to studies designed by those seeking to prove a strong belief about hazards of food components."[98]

Aspartame2

Aspartame is, by far, the most dangerous substance on the market that is added to foods.

http://www.mercola.com/article/aspartame/dangers.htm

Aspartame is the technical name for the brand names NutraSweet, Equal, Spoonful, and Equal-Measure. It was discovered by accident in 1965 when James Schlatter, a chemist of G.D. Searle Company, was testing an anti-ulcer drug.

Aspartame was approved for dry goods in 1981 and for carbonated beverages in 1983. It was originally approved for dry goods on July 26, 1974, but objections filed by neuroscience researcher Dr John W. Olney and Consumer attorney James Turner in August 1974 as well as investigations of G.D. Searle’s research practices caused the U.S. Food and Drug Administration (FDA) to put approval of aspartame on hold (December 5, 1974). In 1985, Monsanto purchased G.D. Searle and made Searle Pharmaceuticals and The NutraSweet Company separate subsidiaries.

Aspartame accounts for over 75 percent of the adverse reactions to food additives reported to the FDA. Many of these reactions are very serious including seizures and death.(1) A few of the 90 different documented symptoms listed in the report as being caused by aspartame include: Headaches/migraines, dizziness, seizures, nausea, numbness, muscle spasms, weight gain, rashes, depression, fatigue, irritability, tachycardia, insomnia, vision problems, hearing loss, heart palpitations, breathing difficulties, anxiety attacks, slurred speech, loss of taste, tinnitus, vertigo, memory loss, and joint pain.

According to researchers and physicians studying the adverse effects of aspartame, the following chronic illnesses can be triggered or worsened by ingesting of aspartame:(2) Brain tumors, multiple sclerosis, epilepsy, chronic fatigue syndrome, parkinson’s disease, alzheimer’s, mental retardation, lymphoma, birth defects, fibromyalgia, and diabetes.

Aspartame is made up of three chemicals: aspartic acid, phenylalanine, and methanol. The book "Prescription for Nutritional Healing," by James and Phyllis Balch, lists aspartame under the category of "chemical poison." As you shall see, that is exactly what it is.

What Is Aspartame Made Of?

Aspartic Acid (40 percent of Aspartame)

Dr. Russell L. Blaylock, a professor of neurosurgery at the Medical University of Mississippi, recently published a book thoroughly detailing the damage that is caused by the ingestion of excessive aspartic acid from aspartame. Blaylock makes use of almost 500 scientific references to show how excess free excitatory amino acids such as aspartic acid and glutamic acid (about 99 percent of monosodium glutamate (MSG) is glutamic acid) in our food supply are causing serious chronic neurological disorders and a myriad of other acute symptoms.(3)

How Aspartate (and Glutamate) Cause Damage

Aspartate and glutamate act as neurotransmitters in the brain by facilitating the transmission of information from neuron to neuron. Too much aspartate or glutamate in the brain kills certain neurons by allowing the influx of too much calcium into the cells. This influx triggers excessive amounts of free radicals, which kill the cells. The neural cell damage that can be caused by excessive aspartate and glutamate is why they are referred to as "excitotoxins." They "excite" or stimulate the neural cells to death.
Aspartic acid is an amino acid. Taken in its free form (unbound to proteins) it significantly raises the blood plasma level of aspartate and glutamate. The excess aspartate and glutamate in the blood plasma shortly after ingesting aspartame or products with free glutamic acid (glutamate precursor) leads to a high level of those neurotransmitters in certain areas of the brain.

The blood brain barrier (BBB), which normally protects the brain from excess glutamate and aspartate as well as toxins, 1) is not fully developed during childhood, 2) does not fully protect all areas of the brain, 3) is damaged by numerous chronic and acute conditions, and 4) allows seepage of excess glutamate and aspartate into the brain even when intact.

The excess glutamate and aspartate slowly begin to destroy neurons. The large majority (75 percent or more) of neural cells in a particular area of the brain are killed before any clinical symptoms of a chronic illness are noticed. A few of the many chronic illnesses that have been shown to be contributed to by long-term exposure to excitatory amino acid damage include:

  • Multiple sclerosis (MS)
  • ALS
  • Memory loss
  • Hormonal problems
  • Hearing loss
  • Epilepsy
  • Alzheimer’s disease
  • Parkinson’s disease
  • Hypoglycemia
  • AIDS
  • Dementia
  • Brain lesions
  • Neuroendocrine disorders

The risk to infants, children, pregnant women, the elderly and persons with certain chronic health problems from excitotoxins are great. Even the Federation of American Societies for Experimental Biology (FASEB), which usually understates problems and mimics the FDA party-line, recently stated in a review that:

"It is prudent to avoid the use of dietary supplements of L-glutamic acid by pregnant women, infants, and children. The existence of evidence of potential endocrine responses, i.e., elevated cortisol and prolactin, and differential responses between males and females, would also suggest a neuroendocrine link and that supplemental L-glutamic acid should be avoided by women of childbearing age and individuals with affective disorders."(4)

Aspartic acid from aspartame has the same deleterious effects on the body as glutamic acid.

The exact mechanism of acute reactions to excess free glutamate and aspartate is currently being debated. As reported to the FDA, those reactions include:(5)

  • Headaches/migraines
  • Nausea
  • Abdominal pains
  • Fatigue (blocks sufficient glucose entry into brain)
  • Sleep problems
  • Vision problems
  • Anxiety attacks
  • Depression
  • Asthma/chest tigShtness.

One common complaint of persons suffering from the effect of aspartame is memory loss. Ironically, in 1987, G.D. Searle, the manufacturer of aspartame, undertook a search for a drug to combat memory loss caused by excitatory amino acid damage. Blaylock is one of many scientists and physicians who are concerned about excitatory amino acid damage caused by ingestion of aspartame and MSG.

A few of the many experts who have spoken out against the damage being caused by aspartate and glutamate include Adrienne Samuels, Ph.D., an experimental psychologist specializing in research design. Another is Olney, a professor in the department of psychiatry, School of Medicine, Washington University, a neuroscientist and researcher, and one of the world’s foremost authorities on excitotoxins. (He informed Searle in 1971 that aspartic acid caused holes in the brains of mice.)

Phenylalanine (50 percent of aspartame)

Phenylalanine is an amino acid normally found in the brain. Persons with the genetic disorder phenylketonuria (PKU) cannot metabolize phenylalanine. This leads to dangerously high levels of phenylalanine in the brain (sometimes lethal). It has been shown that ingesting aspartame, especially along with carbohydrates, can lead to excess levels of phenylalanine in the brain even in persons who do not have PKU.

This is not just a theory, as many people who have eaten large amounts of aspartame over a long period of time and do not have PKU have been shown to have excessive levels of phenylalanine in the blood. Excessive levels of phenylalanine in the brain can cause the levels of seratonin in the brain to decrease, leading to emotional disorders such as depression. It was shown in human testing that phenylalanine levels of the blood were increased significantly in human subjects who chronically used aspartame.(6)

Even a single use of aspartame raised the blood phenylalanine levels. In his testimony before the U.S. Congress, Dr. Louis J. Elsas showed that high blood phenylalanine can be concentrated in parts of the brain and is especially dangerous for infants and fetuses. He also showed that phenylalanine is metabolised much more effeciently by rodents than by humans.(7)

One account of a case of extremely high phenylalanine levels caused by aspartame was recently published the "Wednesday Journal" in an article titled "An Aspartame Nightmare." John Cook began drinking six to eight diet drinks every day. His symptoms started out as memory loss and frequent headaches. He began to crave more aspartame-sweetened drinks. His condition deteriorated so much that he experienced wide mood swings and violent rages. Even though he did not suffer from PKU, a blood test revealed a phenylalanine level of 80 mg/dl. He also showed abnormal brain function and brain damage. After he kicked his aspartame habit, his symptoms improved dramatically.(8)

As Blaylock points out in his book, early studies measuring phenylalanine buildup in the brain were flawed. Investigators who measured specific brain regions and not the average throughout the brain notice significant rises in phenylalanine levels. Specifically the hypothalamus, medulla oblongata, and corpus striatum areas of the brain had the largest increases in phenylalanine. Blaylock goes on to point out that excessive buildup of phenylalanine in the brain can cause schizophrenia or make one more susceptible to seizures.

Therefore, long-term, excessive use of aspartame may provid a boost to sales of seratonin reuptake inhibitors such as Prozac and drugs to control schizophrenia and seizures.

Methanol (aka wood alcohol/poison) (10 percent of aspartame)

Methanol/wood alcohol is a deadly poison. Some people may remember methanol as the poison that has caused some "skid row" alcoholics to end up blind or dead. Methanol is gradually released in the small intestine when the methyl group of aspartame encounter the enzyme chymotrypsin.

The absorption of methanol into the body is sped up considerably when free methanol is ingested. Free methanol is created from aspartame when it is heated to above 86 Fahrenheit (30 Centigrade). This would occur when aspartame-containing product is improperly stored or when it is heated (e.g., as part of a "food" product such as Jello).

Methanol breaks down into formic acid and formaldehyde in the body. Formaldehyde is a deadly neurotoxin. An EPA assessment of methanol states that methanol "is considered a cumulative poison due to the low rate of excretion once it is absorbed. In the body, methanol is oxidized to formaldehyde and formic acid; both of these metabolites are toxic." They recommend a limit of consumption of 7.8 mg/day. A one-liter (approx. 1 quart) aspartame-sweetened beverage contains about 56 mg of methanol. Heavy users of aspartame-containing products consume as much as 250 mg of methanol daily or 32 times the EPA limit.(9)

Symptoms from methanol poisoning include headaches, ear buzzing, dizziness, nausea, gastrointestinal disturbances, weakness, vertigo, chills, memory lapses, numbness and shooting pains in the extremities, behavioral disturbances, and neuritis. The most well known problems from methanol poisoning are vision problems including misty vision, progressive contraction of visual fields, blurring of vision, obscuration of vision, retinal damage, and blindness. Formaldehyde is a known carcinogen, causes retinal damage, interferes with DNA replication and causes birth defects.(10)

Due to the lack of a couple of key enzymes, humans are many times more sensitive to the toxic effects of methanol than animals. Therefore, tests of aspartame or methanol on animals do not accurately reflect the danger for humans. As pointed out by Dr. Woodrow C. Monte, director of the food science and nutrition laboratory at Arizona State University, "There are no human or mammalian studies to evaluate the possible mutagenic, teratogenic or carcinogenic effects of chronic administration of methyl alcohol."(11)

He was so concerned about the unresolved safety issues that he filed suit with the FDA requesting a hearing to address these issues. He asked the FDA to "slow down on this soft drink issue long enough to answer some of the important questions. It’s not fair that you are leaving the full burden of proof on the few of us who are concerned and have such limited resources. You must remember that you are the American public’s last defense. Once you allow usage (of aspartame) there is literally nothing I or my colleagues can do to reverse the course. Aspartame will then join saccharin, the sulfiting agents, and God knows how many other questionable compounds enjoined to insult the human constitution with governmental approval."(10) Shortly thereafter, the Commissioner of the FDA, Arthur Hull Hayes, Jr., approved the use of aspartame in carbonated beverages, he then left for a position with G.D. Searle’s public relations firm.(11)

It has been pointed out that some fruit juices and alcoholic beverages contain small amounts of methanol. It is important to remember, however, that methanol never appears alone. In every case, ethanol is present, usually in much higher amounts. Ethanol is an antidote for methanol toxicity in humans.(9) The troops of Desert Storm were "treated" to large amounts of aspartame-sweetened beverages, which had been heated to over 86 degrees F in the Saudi Arabian sun. Many of them returned home with numerous disorders similar to what has been seen in persons who have been chemically poisoned by formaldehyde. The free methanol in the beverages may have been a contributing factor in these illnesses. Other breakdown products of aspartame such as DKP (discussed below) may also have been a factor.

In a 1993 act that can only be described as "unconscionable," the FDA approved aspartame as an ingredient in numerous food items that would always be heated to above 86 degree F (30 degree C).

Diketopiperazine (DKP)

DKP is a byproduct of aspartame metabolism. DKP has been implicated in the occurrence of brain tumors. Olney noticed that DKP, when nitrosated in the gut, produced a compound that was similar to N-nitrosourea, a powerful brain tumor causing chemical. Some authors have said that DKP is produced after aspartame ingestion. I am not sure if that is correct. It is definitely true that DKP is formed in liquid aspartame-containing products during prolonged storage.

G.D. Searle conducted animal experiments on the safety of DKP. The FDA found numerous experimental errors occurred, including "clerical errors, mixed-up animals, animals not getting drugs they were supposed to get, pathological specimens lost because of improper handling," and many other errors.(12) These sloppy laboratory procedures may explain why both the test and control animals had sixteen times more brain tumors than would be expected in experiments of this length.

In an ironic twist, shortly after these experimental errors were discovered, the FDA used guidelines recommended by G.D. Searle to develop the industry-wide FDA standards for good laboratory practices.(11)

DKP has also been implicated as a cause of uterine polyps and changes in blood cholesterol by FDA Toxicologist Dr. Jacqueline Verrett in her testimony before the U.S. Senate.(13)

http://www.mercola.com/article/aspartame/dangers.htm

Aspartame: Sweet Misery A Poisoned World

1:29:54 – 1 year ago

This is the movie that Pepsi and Coca Cola don’t want you to see.

New Health Canada Data on Bisphenol A (BPA) Strongly Supports Safety of Bottled-Water, Baby-Food and Infant-Formula Products

Who We Are

This web site is sponsored by the Polycarbonate/BPA Global Group, which is organized regionally at the American Chemistry Council,PlasticsEurope, and the Japan Chemical Industry Association.

Bisphenol A (BPA) Information, Research & News

http://www.bisphenol-a.org/whatsNew/20090709.html

July 9, 2009

The following statement can be attributed to Steven G. Hentges, Ph.D. of the American Chemistry Council’s (ACC) Polycarbonate/BPA Global Group. Dr. Hentges’ comments are in regard to the recently released reports from Health Canada on its survey of bisphenol A (BPA) in bottled water, baby food, and infant formula products.

ARLINGTON, VA (July 9, 2009) —“Reports released today by Health Canada on research conducted by its scientists confirm that the levels of bisphenol A (BPA) in bottled water, baby food and infant formula are extremely low. These new government data confirm Health Canada’s previous conclusion that exposure to BPA through food packaging uses is not expected to pose a health risk to the general population, including newborns and young children.

“As noted by Health Canada, an adult would have to drink approximately 1,000 liters (or 264 gallons) of water from polycarbonate water cooler bottles every day to approach the science-based safe intake limit for BPA recently established in Canada.

“No BPA was detected in any of the canned powdered infant formula samples tested. The level of BPA found in baby food packaged in jars clearly indicates that exposure to BPA through consumption of these products is extremely low. Health Canada noted that the nutritional benefits of baby food products far outweigh any possible risk.

“Health Canada’s new data provides further support for recent assessments from eleven regulatory bodies around the world that determined BPA is safe for use in food contact products. These regulatory bodies include: the European Food Safety Authority, German Federal Institute for Risk Assessment, Danish Environmental Protection Agency, French Food Safety Authority, Swiss Office for Public Health, and Food Standards Australia-New Zealand.

“Polycarbonate plastic and epoxy resins, both made from BPA, are widely used in food packaging to protect the safety and integrity of foods and beverages. Clear, shatter-resistant polycarbonate water cooler bottles are also lightweight and reusable over many cycles. Epoxy resin coatings prevent corrosion of metal cans and lids and contamination of foods and beverages. ACC and its member companies have long-supported research to advance scientific understanding about chemicals, and we are committed to providing the compounds and plastics integral to products that help protect public health and safety.”

Survey of Bisphenol A in Baby Food Products Prepackaged in Glass Jars
http://www.hc-sc.gc.ca/fn-an/pubs/securit/bpa_survey-enquete-eng.php

Survey of Bisphenol A in Canned Powdered Infant Formula Products
http://www.hc-sc.gc.ca/fn-an/pubs/securit/bpa_survey-enquete-pow-pou-eng.php

Survey of Bisphenol A in Bottled Water Products
http://www.hc-sc.gc.ca/fn-an/securit/packag-emball/bpa/bpa_survey-enquete-bot-bou-eng.php

http://www.bisphenol-a.org/whatsNew/20090709.html

Government of Canada Takes Action on Another Chemical of Concern: Bisphenol A

http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2008/2008_59-eng.php

Bisphenol A

News Release
2008-59
April 18, 2008
For immediate release

OTTAWA – The Honourable Tony Clement, Minister of Health, and the Honourable John Baird, Minister of the Environment, today announced that the Government is taking action to protect the health of Canadians and the environment from another chemical of concern.

Canada is the first country in the world to complete a risk assessment of bisphenol A in consultation with industry and other stakeholders, and to initiate a 60 day public comment period on whether to ban the importation, sale and advertising of polycarbonate baby bottles which contain bisphenol A.

The comment period will begin on April 19, 2008, once the Government publishes a summary notice of its assessment findings in Canada Gazette, Part 1.

“Canada has been the first country in the world to conduct risk assessments on a number of chemicals of concern, as a result of a new initiative announced by the Prime Minister on December 8, 2006 known as the Chemicals Management Plan,” said Minister Clement.“We have immediately taken action on bisphenol A, because we believe it is our responsibility to ensure families, Canadians and our environment are not exposed to a potentially harmful chemical.”

Health Canada’s screening assessment of bisphenol A primarily focused on its impacts on newborns and infants up to 18 months of age; however, health risks for Canadians of all ages were considered in the screening.

It was determined that the main source of exposure for newborns and infants is through the use of polycarbonate baby bottles when they are exposed to high temperatures and the migration of bisphenol A from cans into infant formula. The scientists concluded in this assessment that bisphenol A exposure to newborns and infants is below levels that may pose a risk, however, the gap between exposure and effect is not large enough.

To be prudent, the Government of Canada is proposing to reduce bisphenol A exposure in infants and newborns by proposing a number of actions: to ban polycarbonate baby bottles; to develop stringent migration targets for bisphenol A in infant formula cans; to work with industry to develop alternative food packaging and develop a code of practice; and to list bisphenol A under Schedule 1 of the Canadian Environmental Protection Act.

Environment Canada scientists also found that at low levels, bisphenol A can harm fish and aquatic organisms over time. Studies indicate that it can currently be found in wastewater and sludge treatment plants.

“When it comes to Canada’s environment, you can’t put a price on safety,” said Minister Baird. “Not only are we finding out about the health impacts of bisphenol A, but the environmental impacts as well. That’s why our Government will be moving forward and will work with the provinces and stakeholders to keep bisphenol A out of our environment, and take the necessary measures to ensure its safe use and disposal.”

For more information, please visit the Next link will take you to another Web site Chemical’s Management Web site or call 1-866-891-4542.

http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2008/2008_59-eng.php

Health Canada bisphenol A announcement imminent

http://www.cbc.ca/consumer/story/2008/04/15/bisphenol.html
CBC News

Health Canada is expected to classify bisphenol A as a dangerous substance as early as Wednesday, which could lead to regulations on the increasingly controversial chemical.

The move would make the department the first regulatory body anywhere in the world to rule that bisphenol A (BPA) endangers people and the environment, according to a report in the Globe and Mail.

When contacted by the CBC Tuesday afternoon, Health Canada spokesman Alastair Sinclair would not comment on whether an announcement is imminent.

BPA, which is used to make many hard plastic toys, bottles and food containers, is thought to mimic the hormone estrogen. Recent independent studies link the chemical to breast cancer, obesity, infertility and insulin-resistance in rodents.

Conversely, the plastics industry vigorously defends the chemical, noting it has been used widely for 50 years.

The Health Canada evaluation of bisphenol A was launched last year as part of a study about 200 chemicals the federal government has designated for more careful research.

Once the department, along with Environment Canada, releases its draft assessment of BPA, a 60-day public comment period will follow. Ottawa then has a year in which to issue a report outlining how it will control exposure, assuming that no new information comes out of the public comment period.

But some retailers aren’t waiting for an official announcement.

Canada’s largest sporting-goods retailer said Tuesday it is pulling all water bottles that contain BPA from its more than 500 stores.

Bob Sartor, chief executive officer of Forzani Group, said the company began removing the bottles early Tuesday, after reports Health Canada is about to designate BPA as dangerous. He says Forzani Group stores, which include Sport Check, Athlete’s World and Coast Mountain Sports, will provide refunds for any bottles with receipts.

In December, Vancouver-based Mountain Equipment Co-op became the first major Canadian retailer to pull polycarbonate containers from its store shelves. Lululemon Athletica Inc., also Vancouver-based, announced plans later the same month to stop selling plastic water bottles that contain bisphenol A.

With files from the Canadian Press

Read more: http://www.cbc.ca/consumer/story/2008/04/15/bisphenol.html#ixzz0yJy4NbYi

http://www.cbc.ca/consumer/story/2008/04/15/bisphenol.html

Cash receipts pose risk for BPA exposure: Study

BY BRETT RUSKIN, POSTMEDIA NEWS AUGUST 30, 2010

http://www.vancouversun.com/health/Cash+receipts+pose+risk+exposure+Study/3459858/story.html

A series of recent studies have found high levels of the toxin in an unlikely but ubiquitous place: cash register receipts.

A series of recent studies have found high levels of the toxin in an unlikely but ubiquitous place: cash register receipts.

Photograph by: Photos.com, canada.com

OTTAWA — The next plastic water bottle you buy won’t have bisphenol A in it, but the receipt might. A series of recent studies have found high levels of the toxin in an unlikely but ubiquitous place: cash register receipts.

One study found that touching a receipt for five seconds with a single fingertip wiped off up to 23 micrograms of bisphenol A (BPA). The chemical could then find its way onto food and be ingested. The amount wiped off increases tenfold when all fingers contact the paper and “by an order of magnitude,” scientists say, when the paper is crumpled in one’s palm.

The full article appears in the September issue of Analytical and Bioanalytical Chemistry, a German scientific journal.

BPA has been in the news since 2007 when some retailers pulled hard plastic bottles from their shelves. There was concern that trace amounts of the chemical were seeping into the water. A year later the federal government announced that Canada would be the first country to ban BPA from plastic food containers.

All calculations that deal with BPA levels are intangibly small, measured in micrograms and parts-per-billion. Health Canada says it is dangerous to consume more than 25 micrograms per kilogram of body mass per day. But levels even lower than that may be too much. A 2009 research group found “long-term adverse reproductive and carcinogenic effects” in mice given only one microgram per kilogram of body mass.

There is much discussion on the effect of BPA on humans, but no conclusive testing has been done to support or rebut detrimental claims. One certainty is that there is a lot of BPA in cash receipts.

Receipts, and theatre and concert tickets are all printed on thermal paper. The dye is already part of the paper, which makes for an inexpensive and reliable printing process. When heat is applied, a solvent in the paper melts and allows dye to mix with BPA and darken, which produces the desired text.

Scientists in Boston have analysed the chemicals in thermal paper. In July, researchers from the Warner Babcock Institute took receipts from 10 businesses and extracted all the BPA. They found between 3,000 and 19,000 micrograms in the 30-centimetre strips.

That much BPA is more than 12 times Health Canada’s limit for a 60-kilogram person, although it’s unlikely that the entire amount would wipe off in normal use.

“Ideally, there wouldn’t be any at all,” said Janelle Witzel of Environmental Defence, a group lobbying against harmful chemicals.

“One of our main concerns is potential ingestion,” she said. “After handling a receipt or before a meal, like everything else, just be sure to wash your hands.”

Other suggestions include keeping receipts away from children and toddlers, and separate from unpackaged foods in grocery bags.

It’s difficult to avoid BPA in receipts.

“Anywhere you go now, minus a few mom-and-pop stores, you look at your receipt and it’s thermal paper,” said Jesse Gonzalez, an employee at Wedge Paper Products.

The Mississauga, Ont.-based company distributes cash register paper rolls to businesses across North America. “The quickest way to tell is by taking your fingernail and scratching it. It’ll leave a mark and that’s how you can tell it’s thermal paper.”

Gonzalez said BPA-free thermal paper is more expensive to produce.

However, he said right now about half of his company’s shipments are BPA-free, because customers are requesting it.

Prior to the receipt studies, scientists had focused on BPA exposure from food packaging.

In 2009, Health Canada measured the amount of BPA that seeped into canned soft drinks from the cans’ inner lining. On average, 0.2 micrograms of BPA were ingested with each soft drink — a fraction of the amount wiped off a receipt.

In animal tests, BPA has been linked to ovarian and prostate cancer, obesity and diabetes, among other illnesses. Earlier this month, Statistics Canada released a study estimating that 91 per cent of Canadians had measurable levels of BPA in their urine.

Ottawa Citizen

© Copyright (c) The Ottawa Citizen

Read more:http://www.vancouversun.com/health/Cash+receipts+pose+risk+exposure+Study/3459858/story.html#ixzz0yJybcT6q

http://www.vancouversun.com/health/Cash+receipts+pose+risk+exposure+Study/3459858/story.html

Health Canada makes it official: BPA is health hazard

http://www.canada.com/vancouversun/news/story.html?id=e81a7270-aec9-48cb-aad3-b74df38feec0

Canada on Saturday will become the first country to formally declare bisphenol A hazardous to human health and officially inform the baby-product industry it will no longer be able to use the chemical in baby bottles.

BY CANWEST NEWS SERVICE OCTOBER 16, 2008

OTTAWA – Canada on Saturday will become the first country to formally declare bisphenol A hazardous to human health and officially inform the baby-product industry it will no longer be able to use the chemical in baby bottles.
Canada’s announcement comes six months after Health Minister Tony Clement surprised the chemical industry by announcing the government’s plan to place bisphenol A on its list of toxic substances and ban its use in baby bottles.
In unveiling the “precautionary and prudent” move, Clement proposed a limited ban of the widely used chemical, also found in hard plastic sports bottles and the lining of food cans.
Most Canadians “need not be concerned” about the health effects of bisphenol A, Clement said at the time. “This is not the case for newborns and infants.”
The government’s final decision will appear in the Canada Gazette, which publishes the official regulations of the government.
Rick Smith, executive director of Environmental Defence and co-author of the forthcoming book Slow Death by Rubber Duck: How the Toxic Chemistry of Everyday Life Affects Our Health, said the expected declaration is a “good start.”
But he said new evidence continues to pile up, pointing to the detrimental health effects of bisphenol A on adults.
“There’s new science coming out on a weekly basis pointing to this chemical being a health concern for adults. Baby bottles are a good start, but the government now needs to take a look at getting this chemical out of the lining in cans.”
The latest research, the first large BPA study in humans published last month by the prestigious Journal of the American Medical Association, found a “significant relationship” between exposure to the ubiquitous estrogenic chemical and heart disease, diabetes and liver problems.
Meanwhile, the U.S. Food and Drug Administration is under fire after determining last month in a draft report that BPA was safe for food storage. On Thursday, the Washington Post published an editorial arguing the FDA’s final recommendation, expected this month, could be “seen as less than fully independent.”
The influential newspaper cited the recent donation of $5 million to the University of Michigan’s Risk Science Center from Charles Gelman, the retired head of a medical device manufacturing company and outspoken proponent of bisphenol A.
The acting director of the university centre is Martin Philbert, a toxicologist who is also head of the FDA advisory panel poised to deliver its risk assessment of BPA.
Philbert did not disclose the gift to the agency as part of the disclosure process when he was appointed to the panel; he told the Milwaukee Journal Sentinel he did not need to, since he does not stand to gain from it. The FDA is looking into a possible conflict of interest.

© (c) CanWest MediaWorks Publications Inc.

http://www.canada.com/vancouversun/news/story.html?id=e81a7270-aec9-48cb-aad3-b74df38feec0

NEW STUDY CONCLUDES NO EFFECTS FROM BPA ON NERVOUS SYSTEM

Study Helps Answer Key Research Questions

February 17, 2010

ARLINGTON, VA (Feb. 17,  2010) — The American Chemistry Council (ACC) today commented on a significant study published online in the scientific journal Toxicological Sciences. Quotes below may be attributed to Steven G. Hentges, Ph.D., ACC’s Polycarbonate/BPA Global Group:

“This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development.  The robust study was conducted by highly qualified researchers at WIL Research Laboratories.

“This study follows on the heels of a recent low-dose study by EPA that also explored the potential effects of BPA at very early stages of life in rodents and that found even low doses of BPA did not affect the brain, reproduction or development.  Both of these studies – examining potential effects on brain development and behavior at low doses – address the areas of “some concern” which the National Toxicology Program had previously identified as appropriate for additional research.

“Regulatory agencies from around the world have concluded that the science supports the safety of BPA for people of all ages in its current uses.  Plastics made with BPA contribute to the safety and convenience of everyday life because of their durability, clarity and shatter-resistance.  Can liners made with BPA are essential components to help to protect the safety of packaged foods and preserve products from spoilage and contamination.”

Background on the study
The study is titled “Developmental Neurotoxicity Study of Dietary Bisphenol A in Sprague-Dawley Rats,” (Donald G. Stump, et al.).  In the study, pregnant female rats were exposed to BPA via direct consumption of the diet at dosage levels that spanned the range from low doses, as used in some published studies reporting developmental neurotoxicity, to a high dose that was anticipated to result in systemic toxicity in the pregnant rat (0, 0.01, 0.1, 5, 50, and 150 mg/kg/day).  The offspring, exposed to BPA in utero, via milk while nursing and via direct consumption through the diet once they started to feed, were studied for functional or morphological effects on their nervous systems.  The study concluded that there were no neurologic or neurobehavioral effects related to BPA at any dose tested.

Bisphenol A from Wikipedia

Bisphenol A, commonly abbreviated as BPA, is an organic compound with two phenol functional groups used to make polycarbonate plastic and epoxy resins, along with other applications.
Known to be estrogenic since the mid 1930s, concerns about the use of bisphenol A in consumer products were regularly reported in the news media in 2008 after several governments issued reports questioning its safety, thus prompting some retailers to remove products containing it from their shelves. A 2010 report from the United States Food and Drug Administration (FDA) raised further concerns regarding exposure of fetuses, infants, and young children.

Bisphenol A Chart 1Bisphenol A Chart 1a

Synthesis

Bisphenol A was first reported by A.P. Dianin in 1891.
It is prepared by the condensation of acetone (hence the suffix A in the name) with two equivalents of phenol. The reaction is catalyzed by an acid, such as hydrochloric acid (HCl) or a sulfonated polystyrene resin. Typically, a large excess of phenol is used to ensure full condensation:
(CH3)2CO + 2 C6H5OH → (CH3)2C(C6H4OH)2 + H2O
A large number of ketones undergo analogous condensation reactions. Commercial production of BPA requires distillation – either extraction of BPA from many resinous byproducts under high vacuum, or solvent-based extraction using additional phenol followed by distillation.

Use

Further information: Polycarbonate

Bisphenol -A 2d chart

Bisphenol A is used primarily to make plastics, and products containing bisphenol A-based plastics have been in commerce for more than 50 years. It is a key monomer in production of epoxy resins and in the most common form of polycarbonate plastic. Polycarbonate plastic, which is clear and nearly shatter-proof, is used to make a variety of common products including baby and water bottles, sports equipment, medical and dental devices, dental fillings and sealants, eyeglass lenses, CDs and DVDs, and household electronics. BPA is also used in the synthesis of polysulfones and polyether ketones, as an antioxidant in some plasticizers, and as a polymerization inhibitor in PVC. Epoxy resins containing bisphenol A are used as coatings on the inside of almost all food and beverage cans, however, due to BPA health concerns, in Japan epoxy coating was mostly replaced by PET film. Bisphenol A is also a precursor to the flame retardant tetrabromobisphenol A, and was formerly used as a fungicide. Bisphenol A is a preferred color developer in carbonless copy paper and thermal paper, with the most common public exposure coming from some thermal point of sale receipt paper. BPA-based products are also used in foundry castings and for lining water pipes.
Global production of bisphenol A was estimated to be over 2 million tonnes in 2003, and more than 2.2 Mt in 2009. In the U.S., it is manufactured by Bayer MaterialScience, Dow Chemical Company, SABIC Innovative Plastics (formerly GE Plastics), Hexion Specialty Chemicals, and Sunoco Chemicals. In 2004, these companies produced just over 1 million t of bisphenol A, up from just 7,260 t in 1991. In 2003, annual U.S. consumption was 856,000 t, 72% of which was used to make polycarbonate plastic and 21% going into epoxy resins. In the US less than 5% of the BPA produced is used in food contact applications.

Identification in plastics
Main article: Resin identification code

07

03

There are seven classes of plastics used in packaging applications. Type 7 is the catch-all “other” class, and some type 7 plastics, such as polycarbonate (sometimes identified with the letters “PC” near the recycling symbol) and epoxy resins, are made from bisphenol A monomer.
Type 3 (PVC) can also contain bisphenol A as an antioxidant in plasticizers. This is particularly true for “flexible PVC”, but not true for PVC pipes.
Type 6 (polystyrene) neither contains, nor does it break down into bisphenol A, according to the Styrene Information and Research Center, a not for profit organization whose membership represents approximately 95% of the North American styrene industry.

Health effects

Bisphenol A is an endocrine disruptor, which can mimic the body’s own hormones and may lead to negative health effects. Early development appears to be the period of greatest sensitivity to its effects. Regulatory bodies have determined safety levels for humans, but those safety levels are currently being questioned or under review as a result of new scientific studies.
In 2009 the The Endocrine Society released a scientific statement expressing concern over current human exposure to BPA.

Previous studies

In 2007, a consensus statement by 38 experts on bisphenol A concluded that average levels in people are above those that cause harm to many animals in laboratory experiments. A panel convened by the U.S. National Institutes of Health determined that there was “some concern” about BPA’s effects on fetal and infant brain development and behavior. A 2008 report by the U.S. National Toxicology Program (NTP) later agreed with the panel, expressing “some concern for effects on the brain, behavior, and prostate gland in fetuses, infants, and children at current human exposures to bisphenol A,” and “minimal concern for effects on the mammary gland and an earlier age for puberty for females in fetuses, infants, and children at current human exposures to bisphenol A.” The NTP had “negligible concern that exposure of pregnant women to bisphenol A will result in fetal or neonatal mortality, birth defects, or reduced birth weight and growth in their offspring.”

Obesity

A 2008 review has concluded that obesity may be increased as a function of BPA exposure, which “merits concern among scientists and public health officials”. A 2009 review of available studies has concluded that “perinatal BPA exposure acts to exert persistent effects on body weight and adiposity”. Another 2009 review has concluded that “Eliminating exposures to (BPA) and improving nutrition during development offer the potential for reducing obesity and associated diseases”. Other reviews have come with similar conclusions.

Neurological issues
A panel convened by the U.S. National Institutes of Health determined that there was “some concern” about BPA’s effects on fetal and infant brain development and behavior. A 2008 report by the U.S. National Toxicology Program (NTP) later agreed with the panel, expressing “some concern for effects on the brain”. In January 2010 the FDA expressed the same level of concern.
A 2007 review has concluded that BPA, like other xenoestrogens, should be considered as a player within the nervous system that can regulate or alter its functions through multiple pathways. A 2007 review has concluded that low doses of BPA during development have persistent effects on brain structure, function and behavior in rats and mice. A 2008 review concluded that low-dose BPA maternal exposure causes long-term consequences at the level of neurobehavioral development in mice. A 2008 review has concluded that neonatal exposure to Bisphenol-A (BPA) can affect sexually dimorphic brain morphology and neuronal adult phenotypes in mice. A 2008 review has concluded that BPA altered long-term potentiation in the hippocampus and even nanomolar dosage could induce significant effects on memory processes. A 2009 review raised concerns about BPA effect on anteroventral periventricular nucleus.
A 2008 study by the Yale School of Medicine demonstrated that adverse neurological effects occur in non-human primates regularly exposed to bisphenol A at levels equal to the United States Environmental Protection Agency’s (EPA) maximum safe dose of 50 µg/kg/day. This research found a connection between BPA and interference with brain cell connections vital to memory, learning and mood.
Highly controversial claims have been made that BPA could be involved in attention-deficit hyperactivity disorder (ADHD)
A 2010 study with rats prenatally exposed to 40 microg/kg bw BPA has concluded that corticosterone and its actions in the brain are sensitive to the programming effects of BPA.

Disruption of the dopaminergic system

A 2005 review concluded that prenatal and neonatal exposure to BPA in mice can potentiate the central dopaminergic systems, resulting in the supersensitivity to the drugs-of-abuse-induced reward effects and hyperlocomotion.
A 2008 review has concluded that BPA mimics estrogenic activity and impacts various dopaminergic processes to enhance mesolimbic dopamine activity resulting in hyperactivity, attention deficits, and a heightened sensitivity to drugs of abuse.
A 2009 study on rats has concluded that prenatal and neonatal exposure to low-dose BPA causes deficits in development at dorsolateral striatum via altering the function of dopaminergic receptors. Another 2009 study has found associated changes in the dopaminergic system.

Thyroid function

A 2007 review has concluded that bisphenol-A has been shown to bind to thyroid hormone receptor and perhaps have selective effects on its functions.
A 2009 review about environmental chemicals and thyroid function, raised concerns about BPA effects on triiodothyronine and concluded that “available evidence suggests that governing agencies need to regulate the use of thyroid-disrupting chemicals, particularly as such uses relate exposures of pregnant women, neonates and small children to the agents”.
A 2009 review summarized BPA adverse effects on thyroid hormone action.

Cancer research

According to the WHO’s INFOSAN, “animal studies have not provided convincing evidence of risk of cancer from BPA exposure.”
Neither the U.S. Environmental Protection Agency nor the International Agency for Research on Cancer has evaluated bisphenol A for possible carcinogenic activity.
A 2010 review concluded that Bisphenol A may increase cancer risk.

Breast cancer

Further information: Risk factors of breast cancer#Bisphenol A
A 2008 review has concluded that “perinatal exposure to (…) low doses of (..) BPA, alters breast development and increases breast cancer risk”.
Another 2008 review concluded that ” animal experiments and epidemiological data strengthen the hypothesis that foetal exposure to xenoestrogens may be an underlying cause of the increased incidence of breast cancer observed over the last 50 years”.
A 2009 in vitro study has concluded that BPA is able to induce neoplastic transformation in human breast epithelial cells. Another 2009 study concluded that maternal oral exposure to low concentrations of BPA during lactation increases mammary carcinogenesis in a rodent model.
A 2010 study with the mammary glands of the offspring of pregnant rats treated orally with 0, 25 or 250 µg BPA/kg body weight has found that key proteins involved in signaling pathways such as cellular proliferation were regulated at the protein level by BPA.
A 2010 study has found that BPA may reduce sensitivity to chemotherapy treatment of specific tumors.

Neuroblastoma

In vitro studies have suggested that BPA can promote the growth of neuroblastoma cells. A 2010 in vitro study has concluded that BPA potently promote invasion and metastasis of neuroblastoma cells through overexpression of MMP-2 and MMP-9 as well as downregulation of TIMP2.

Prostate development and cancer

A 1997 study in mice has found that neonatal BPA exposure of 2 μg/kg increased adult prostate weight. A 2005 study in mice has found that neonatal BPA exposure at 10 μg/kg disrupted the development of the fetal mouse prostate. A 2006 study in rats has shown that neonatal bisphenol A exposure at 10 μg/kg levels increases prostate gland susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis. A 2007 in vitro study has found that BPA within the range of concentrations currently measured in human serum is associated with permanently increase in prostate size. A 2009 study has found that newborn rats exposed to a low-dose of BPA (10 µg/kg) increased prostate cancer susceptibility when adults.

DNA methylation

Bisphenol A suppress DNA methylation (by increased hypomethylation) which is linked to epigenetic changes.

Reproductive system and sexual behavior research
A series of studies made in 2009 found:
Mouse ovary anomalies from exposure as low as 1 µg/kg, concluded that BPA exposure causes long-term adverse reproductive and carcinogenic effects if exposure occurs during prenatal critical periods of differentiation.
Neonatal exposure of as low as 50 µg/kg disrupts ovarian development in mice.
Neonatal BPA exposition of as low as 50 µg/kg permanently alters the hypothalamic estrogen-dependent mechanisms that govern sexual behavior in the adult female rat.
Prenatal exposure to BPA at levels of (10 μg/kg/day) affects behavioral sexual differentiation in male monkeys.
In placental JEG3 cells in vitro BPA may reduce estrogen synthesis.
BPA exposure disrupted the blood-testis barrier when administered to immature, but not to adult, rats.
Exposure to BPA in the workplace was associated with self-reported adult male sexual dysfunction.
A rodent study, funded by EPA and conducted by some of its scientists, concluded that, compared with ethinyl estradiol, low-dose exposures of bisphenol A (BPA) showed no effects on several reproductive functions and behavioral activities measured in female rats. That study was criticized as flawed for using polycabornate cages in the experiment and the claimed resistance of the rats to estradiol but that claim was contested by the authors and others.
A 2010 study with mice concluded that BPA exposure in utero leads to permanent DNA alterations in sensitivity to estrogen.

General research

At an Endocrine Society meeting in 2009, new research reported data from animals experimentally treated with BPA. Studies presented at the group’s annual meeting show BPA can affect the hearts of women, can permanently damage the DNA of mice, and appear to be entering the human body from a variety of unknown sources.
A 2009 in vitro study on cytotrophoblasts cells has found cytoxic effects in exposure of BPA doses from 0.0002 to 0.2 micrograms per millilitre and concluded this finding “suggests that exposure of placental cells to low doses of BPA may cause detrimental effects, leading in vivo to adverse pregnancy outcomes such as preeclampsia, intrauterine growth restriction, prematurity and pregnancy loss”
A 2009 study in rats concluded that BPA, at the reference safe limit for human exposure, was found to impact intestinal permeability and may represent a risk factor in female offspring for developing severe colonic inflammation in adulthood.
A 2010 study on mice has concluded that perinatal exposure to 10 micrograms/mL of BPA in drinking water enhances allergic sensitization and bronchial inflammation and responsiveness in an animal model of asthma.

Studies on humans

Lang study and heart disease
The first large study of health effects on humans associated with bisphenol A exposure was published in September 2008 by Iain Lang and colleagues in the Journal of the American Medical Association.[19][94] The cross-sectional study of almost 1,500 people assessed exposure to bisphenol A by looking at levels of the chemical in urine. The authors found that higher bisphenol A levels were significantly associated with heart disease, diabetes, and abnormally high levels of certain liver enzymes. An editorial in the same issue notes that while this preliminary study needs to be confirmed and cannot prove causality, there is precedent for analogous effects in animal studies, which “add[s] biological plausibility to the results reported by Lang et al.”
A later similar study performed by the same group of scientists, published in January 2010, confirmed, despite of lower concentrations of BPA in the second study sample, an associated increased risk for heart disease but not for diabetes or liver enzymes.

Other studies

Studies have associated recurrent miscarriage with BPA serum concentrations, oxidative stress and inflamattion in postmenopausal women with urinary concentrations, externalizing behaviors in two-year old children, especially among female children, with mother’s urinary concentrations, altered hormone levels in men and declining male sexual function with urinary concentrations.

Historical studies

The first evidence of the estrogenicity of bisphenol A came from experiments on rats conducted in the 1930s, but it was not until 1997 that adverse effects of low-dose exposure on laboratory animals were first reported.

Low dose exposure in animals
Low dose exposure in animals

The current U.S. human exposure limit set by the EPA is 50 µg/kg/day.

Xenoestrogen

There is evidence that bisphenol A functions as a xenoestrogen by binding strongly to estrogen-related receptor γ (ERR-γ). This orphan receptor (endogenous ligand unknown) behaves as a constitutive activator of transcription. BPA seems to bind strongly to ERR-γ (dissociation constant = 5.5 nM), but not to the estrogen receptor (ER). BPA binding to ERR-γ preserves its basal constitutive activity. It can also protect it from deactivation from the selective estrogen receptor modulator 4-hydroxytamoxifen.
Different expression of ERR-γ in different parts of the body may account for variations in bisphenol A effects. For instance, ERR-γ has been found in high concentration in the placenta, explaining reports of high bisphenol A accumulation in this tissue.

Human exposure sources

“    The problem is, BPA is also a synthetic estrogen, and plastics with BPA can break down, especially when they’re washed, heated or stressed, allowing the chemical to leach into food and water and then enter the human body. That happens to nearly all of us; the CDC has found BPA in the urine of 93% of surveyed Americans over the age of 6. If you don’t have BPA in your body, you’re not living in the modern world.    ”
—The Perils of Plastic, http://www.time.com/time/specials/packages/article/0,28804,1976909_1976908_1976938-2,00.html

TIME Magazine

Bisphenol A has been known to be leached from the plastic lining of canned foods and, to a lesser degree,[citation needed] polycarbonate plastics, especially those that are cleaned with harsh detergents or used to contain acidic or high-temperature liquids. A recent Health Canada study found that the majority of canned soft drinks it tested had low, but measurable levels of bisphenol A. This exposure through metal cans is due to the fact that BPA is an ingredient in the internal coating of food and beverage metal cans used to protect the food from direct contact with metal. While most human exposure is through diet, exposure can also occur through air and through skin absorption.
Free BPA is found in high concentration in thermal paper and carbonless copy paper, which would be expected to be more available for exposure than BPA bound into resin or plastic. Popular uses of thermal paper include airline tickets, event and cinema tickets, labels, and point of sale applications (receipts). While there is little concern for dermal absorption of BPA, free BPA can readily be transferred to skin and residues on hands can be ingested.
Studies by the CDC found bisphenol A in the urine of 95% of adults sampled in 1988–1994 and in 93% of children and adults tested in 2003–04. Infants fed with liquid formula are among the most exposed, and those fed formula from polycarbonate bottles can consume up to 13 micrograms of bisphenol A per kg of body weight per day (μg/kg/day; see table below). The most sensitive animal studies show effects at much lower doses, while the EPA considers exposures up to 50 µg/kg/day to be safe. In 2009, a study found that drinking from polycarbonate bottles increased urinary bisphenol A levels by two thirds, from 1.2 micrograms/gram creatinine to 2 micrograms/gram creatinine.
11 of 13 thermal printing papers contained 8 – 17 g/kg Bisphenol A (BPA). Upon dry finger contact with a thermal paper receipt, roughly 1 μg BPA (0.2 – 6 μg) was transferred to the forefinger and the middle finger. For wet or greasy fingers approximately 10 times were more transferred. Extraction of BPA from the fingers were possible up to 2 hours after exposure.
Consumer groups recommend that people wishing to lower their exposure to bisphenol A avoid canned food and polycarbonate plastic containers (which shares resin identification code 7 with many other plastics) unless the packaging indicates the plastic is bisphenol A-free. The National Toxicology Panel recommends avoiding microwaving food in plastic containers, putting plastics in the dishwasher, or using harsh detergents, to avoid leaching.
A 2009 small US study funded by the EWG has detected an average of 2.8 ng/mL BPA in the blood of 9 out of the 10 umbilical cords tested.
In the US and Canada, BPA has been found in infant liquid formula in concentrations varying from 0.48 to 11 ng/g.[133][134] BPA has been rarely found in infant powder formula (only 1 of 14).
In the US consumption of soda, school lunches, and meals prepared outside the home was statistically significantly associated with higher urinary BPA.
A 2010 study of Austrian, Swiss and German population has suggested polycarbonate (PC) baby bottles as the most prominent role of exposure for infants, and canned food for adults and teenagers.

Estimated daily bisphenol A intake μg-kg-day

Pharmacokinetics

There’s no agreement between scientists of a physiologically-based pharmacokinetic (PBPK) BPA model for humans. The effects of BPA on an organism depends on how much free BPA is available and for how long cells are exposed to it. Glucuronidation in the liver, by conjugation with glucuronic acid to form the metabolite BPA-glucuronide (BPAG), reduces the amount of free BPA, however BPAG can be deconjugated by beta-glucuronidase, an enzyme present in high concentration in placenta and other tissues. Free BPA can also be inactivated by sulfation, a process that can also be reverted by arylsulfatase C.
The best test methods for studying BPA effects are currently under discussion with scientists sharing different opinions.
A 2010 review of 80+ biomonitoring studies concluded that the general population is internally exposed to significant amounts of unconjugated BPA (in the ng/ml blood range). Using GC/MS on 20 samples, BPA was detected in 100% of urine samples with a median of 1.25 ng.ml, and 10% of blood samples (LOD 0.5 ng/ml).
A 2009 research has found that some drugs, like naproxen, salicylic acid, carbamazepine and mefenamic acid can, in vitro, significantly inhibit BPA glucuronidation.
A 2010 study on rats embryos has found that genistein may enhance developmental toxicity of BPA.

Environmental risk

In general, studies have shown that BPA can affect growth, reproduction and development in aquatic organisms. Among freshwater organisms, fish appear to be the most sensitive species. Evidence of endocrine-related effects in fish, aquatic invertebrates, amphibians and reptiles has been reported at environmentally relevant exposure levels lower than those required for acute toxicity. There is a widespread variation in reported values for endocrine-related effects, but many fall in the range of 1μg/L to 1 mg/L.
BPA can contaminate the environment either directly or through degradation of products containing BPA, such as ocean-borne plastic trash.
As an environmental contaminant this compound interferes with nitrogen fixation at the roots of leguminous plants associated with the bacterial symbiont Sinorhizobium meliloti. Despite a half-life in the soil of only 1–10 days, its ubiquity makes it an important pollutant. According to Environment Canada, “initial assessment shows that at low levels, bisphenol A can harm fish and organisms over time. Studies also indicate that it can currently be found in municipal wastewater.”
A 2009 review of the biological impacts of plasticizers on wildlife published by the Royal Society with a focus on annelids (both aquatic and terrestrial), molluscs, crustaceans, insects, fish and amphibians concluded that BPA have been shown to affect reproduction in all studied animal groups, to impair development in crustaceans and amphibians and to induce genetic aberrations.
A large 2010 study of two rivers in Canada found that areas contaminated with hormone-like chemicals including bisphenol A showed females made up 85 per cent of the population of a certain fish, while females made up only 55 per cent in uncontaminated areas.

Government and industry response

World Health Organization

Arguing uncertainty of possible adverse health effects of low dose BPA exposure, especially on the nervous system and on behaviour, and also the differences of exposure of very young children, the WHO announced in November 2009 that it would organize an expert consultation in 2010 to assess BPA safety.

Australia and New Zealand

The Australia and New Zealand Food Safety Authority (Food Standards Australia New Zealand) does not see any health risk with bisphenol A baby bottles if the manufacturer’s instructions are followed. Levels of exposure are very low and do not pose a significant health risk. It added that “the move by overseas manufacturers to stop using BPA in baby bottles is a voluntary action and not the result of a specific action by regulators.” It suggests the use of glass baby bottles if parents have any concerns.

Canada

In April 2008, Health Canada concluded that, while adverse health effects were not expected, the margin of safety was too small for formula-fed infants and proposed classifying the chemical as “‘toxic’ to human health and the environment.”
After the release of that assessment, Canadian Health Minister Tony Clement announced Canada’s intent to ban the import, sale, and advertisement of polycarbonate baby bottles containing bisphenol A due to safety concerns, and investigate ways to reduce BPA contamination of baby formula packaged in metal cans. While the agency concluded that human exposures were less than levels believed to be unsafe, the margin of safety was not high enough for formula-fed infants. Around the same time, Wal-Mart announced that it was immediately ceasing sales in all its Canadian stores of food containers, water and baby bottles, sippy cups, and pacifiers containing bisphenol A, and that it would phase out baby bottles made with it in U.S. stores by early 2009. Nalgene also announced it will stop using the chemical in its products, and Toys-R-Us said it too will cease selling baby bottles made from it. Subsequent news reports showed many retailers removing polycarbonate drinking products from their shelves.

The federal government has formally declared bisphenol A a hazardous substance as of October 2008 and is now placed on its list of toxic substances. Health officials wrote in Canada Gazette that “It is concluded that bisphenol A be considered as a substance that may be entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.”The federal ministries of health and the environment announced they would seek to restrict imports, sales and advertising of polycarbonate baby bottles containing BPA.
In its statement Gc.ca released on 18 October 2008, Health Canada noted that “bisphenol A exposure to newborns and infants is below levels that cause effects” and that the “general public need not be concerned”.
On Aug. 25, 2010, Environment Canada confirmed they are in the process of adding bisphenol-A to its list of toxic substances.[ref]http://www.thestar.com/article/852096–in-historic-move-canada-to-list-bpa-as-toxic

Europe

European Union

The updated 2008 European Union Risk Assessment Report on bisphenol A, published in June 2008 by the European Commission and European Food Safety Authority (EFSA) concluded that bisphenol A-based products, such as polycarbonate plastic and epoxy resins, are safe for consumers and the environment when used as intended.[159] By October 2008, after the Lang Study was published, the EFSA issued a statement concluding that the study provided no grounds to revise the current TDI (Tolerable Daily Intake) level for BPA of 0.05 mg/kg bodyweight.
A 2009 scientific study criticized the European risk assessment processes of endocrine disruptors, including BPA.
On 22 December 2009 the EU Environment ministers released a statement expressing concerns over recent studies showing adverse effects of exposure to endocrine disrupters.
The EFSA is scheduled to release another opinion on BPA by May 2010.

Denmark

In May 2009, the Danish parliament passed a resolution to ban the use of BPA in baby bottles, which has not been enacted by April 2010. In March 2010 a temporary ban was declared by the Health Minister

Belgium

On March 2010, senator Philippe Mahoux proposed legislation to ban BPA in food contact plastics.

France

On 5 February 2010, the French Food Safety Agency (AFSSA) questioned the previous assessments of the health risks of BPA, especially in regard to behavioral effects observed in rat pups following exposure in utero and during the first months of life. On April 2010 the AFFSA suggested the adoption of better labels for food products containing BPA.

On 24 March 2010 French Senate unanimously approved a proposition of law to ban BPA from baby bottles, the proposition still depends of Assembly approval.

Germany

On 19 September 2008, the German Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR) stated that there was no reason to change the current risk assessment for bisphenol A on the basis of the Lang Study.
In October, 2009, the German environmental organization Bund für Umwelt und Naturschutz Deutschland requested a ban on BPA for children’s products, especially pacifiers,[171] and products that make contact with food. In response, some manufacturers voluntarily removed the problematic pacifiers from the market.

Netherlands

On 6 November 2008, the Dutch Food and Consumer Product Safety Authority (VWA), stated in a newsletter that baby bottles made from polycarbonate plastic do not release measurable concentrations of bisphenol A and therefore are safe to use.

Switzerland

In February 2009 the Swiss Federal Office for Public Health, based on reports of other health agencies, stated that the intake of bisphenol A from food represents no risk to the consumer, including newborns and infants. However, in the same statement it advised for proper use of polycarbonate baby bottles and listed alternativesSweden
By May 2010 the Swedish Chemicals Agency asked for a BPA ban in baby bottles but the Swedish Food Safety Authority prefers to await the expected European Food Safety Authority’s updated review. The Minister of Environment said to wait for the EFSA review but not for too long.

UK

In December 2009 responding to a letter from a group of seven scientists that urged the UK Government to ‘adopt a standpoint consistent with the approach taken by other Governments who have ended the use of BPA in food contact products marketed at children’ the UK Food Standards Agency reaffirmed in January 2009 their view that ‘exposure of UK consumers to BPA from all sources, including food contact materials, was well below levels considered harmful

Japan

Between 1998 and 2003, the canning industry voluntarily replaced their BPA-containing epoxy resin can liners with BPA-free polyethylene terephthalate (PET) in many of their products. For other products, they switched to a different epoxy lining that yielded much less migration of BPA into food than the previously used resin. In addition, polycarbonate tableware for school lunches was replaced by BPA-free plastics. As a result of these changes, Japanese risk assessors have found that virtually no BPA is detectable in canned foods or drinks, and blood levels of BPA in people have declined dramatically (50% in one study).

United States

September 2008
In September, the National Toxicology Program finalized their report on bisphenol A, finding “some concern”, mid-point of a five-level scale, that infants were at risk from exposure to the chemical.[32]
At that time, the FDA reassured consumers that current limits were safe, but convened an outside panel of experts to review the issue. The Lang study was also released that month, and David Melzer, a co-author of the study, presented the results of the study before the FDA panel.
The editorial accompanying the Lang study’s publication in JAMA criticized the FDA’s assessment of bisphenol A: “A fundamental problem is that the current ADI [acceptable daily intake] for BPA is based on experiments conducted in the early 1980s using outdated methods (only very high doses were tested) and insensitive assays. More recent findings from independent scientists were rejected by the FDA, apparently because those investigators did not follow the outdated testing guidelines for environmental chemicals, whereas studies using the outdated, insensitive assays (predominantly involving studies funded by the chemical industry) are given more weight in arriving at the conclusion that BPA is not harmful at current exposure levels.”

March 2009
Sunoco, a producer of gasoline and chemicals, is now refusing to sell the chemical to companies for use in food and water containers for children younger than 3, saying it can’t be certain of the compound’s safety. Sunoco plans to require its customers to guarantee that the chemical will not be used in children’s food products.
The six largest US companies which commercialize baby bottles decided to stop using bisphenol A in their products. Suffolk County, New York banned baby beverage containers made with bisphenol A.
On March 13 leaders from the House and Senate proposed legislation to ban bisphenol A.
In the same month, Rochelle Tyl, author of two studies used by FDA to assert BPA safety in August 2008, said those studies didn’t claim that BPA is safe since they weren’t designed to cover all aspects of the chemical’s effects.

May 2009
The first US jurisdictions to pass regulations limiting or banning BPA were Minnesota and Chicago. Minnesota’s regulation takes effect in 2010, “manufacturers of … children’s products containing BPA may not sell them in the state after Jan. 1, 2010. The ban extends to all retailers in the state a year later.” The products impacted are known as sippy cups and baby bottles. The City of Chicago adopted a similar ban shortly thereafter. Coverage of Chicago’s ban in the news showed a relentless opposition by the industry. A Chicago Tribune article noted an up-hill battle while passing legislation, “[industry officials] used FDA’s position on the issue when they tried to block the city’s measure.”
In May 2009 the Washington Post accused the manufacturers of food and beverage containers and some of their biggest customers of trying to devise a public relations and lobbying strategy to block government BPA bans.

June 2009
In June 2009, the FDA announced the decision to reconsider the BPA safety levels.
Connecticut was the first US state to ban bisphenol A from infant formula and baby food containers, as well from any reusable food or beverage container.

July 2009
The California Environmental Protection Agency’s Developmental and Reproductive Toxicant Identification Committee unanimously voted against placing Bisphenol A on the state’s list of chemicals that are believed to cause reproductive harm. The panel, although concerned over the growing scientific research showing BPA’s reproductive harm in animals, found that there was insufficient data of the effects in humans. Critics point out that the same panel failed to add second-hand smoke to the list until 2006, and only one chemical was added to the list in the last three years.

August 2009
On August 3, Massachusetts’ Department of Public Health advised mothers to take certain actions to prevent possible health impact in children. Mothers with children up to two years old were advised to limit exposure by avoiding products that might contain BPA, such as plastic drinking bottles and other plastic materials with recycling codes of 7 or 3.
The Milwaukee Journal Sentinel, as part of an ongoing investigative series into BPA and its effects, revealed plans by the Society of the Plastics Industry to execute a major public relations blitz to promote BPA, including plans to attack and discredit those who report or comment negatively on the monomer and its effects.

September 2009
On September 29, the U.S. Environmental Protection Agency announced that it is evaluating BPA, and another five chemicals, for action plan development.

October 2009
On October 28, the NIH announced $30,000,000 in stimulus grants to study the health effects of BPA. This money is expected to result in many peer-reviewed publications.

November 2009
The Consumer Reports magazine published an analysis of BPA content in some canned foods and beverages, where in specific cases the content of a single can of food could exceed the current FDA Cumulative Exposure Daily Intake.

January 2010
On January 15 the FDA expressed “some concern”, the middle level in the scale of concerns, about the potential effects of BPA on the brain, behavior, and prostate gland in fetuses, infants, and young children and announced it was taking reasonable steps to reduce human exposure to BPA in the food supply. However, the FDA is not recommending that families change the use of infant formula or foods, as it sees the benefit of a stable source of good nutrition as outweighing the potential risk from BPA exposure.
On the same date the U.S. Department of Health & Human Services released information to help parents to reduce children’s BPA exposure.

February 2010
According to The Milwaukee Journal Sentinel, which supports a BPA ban, after lobbyists for the chemical industry met with administration officials, the EPA delayed BPA regulation and did not include the chemical in an action plan released December 30, 2009.
Many US states are considering some sort of BPA ban.

March 2010
On March 29, the EPA declared BPA a “chemical of concern”.

April 2010
The 2008–2009 Annual Report of the President’s Cancer Panel declared: “because of the long latency period of many cancers, the available evidence argues for a precautionary approach to these diverse chemicals, which include (…) bisphenol A”

Meanwhile, as of April, General Mills has announced that they have found a BPA-free alternative can liner that apparently works even with tomatoes, a highly acidic product that has long baffled the industry in terms of finding a suitable substitute. They say with the next tomato harvest, they will begin using it in tomato products sold by their organic foods subsidiary, Muir Glen. Thus far, there has been no word on whether General Mills will use BPA-free alternatives on any of its other canned products.

Lead Mercury and Bisphenol-A  Levels in the blood of Canadian People

http://www.statcan.gc.ca/daily-quotidien/100816/dq100816a-eng.htm

2007 to 2009

New data from the Canadian Health Measures Survey (CHMS) show that blood lead concentrations in the Canadian population have fallen dramatically since they were last measured 30 years ago. Furthermore, 91% of Canadians aged 6 to 79 had detectable concentrations of bisphenol A (BPA) in their urine and 88% had detectable concentrations of total mercury in their blood. The CHMS analyzed blood and urine samples for indicators of more than 80 environmental contaminants and chemical substances, most of which were measured for the first time in a representative sample of Canadians.

Lead

Blood lead concentrations were measured at the national level for the first time in 30 years by the CHMS from 2007 to 2009. Less than 1% of Canadians aged 6 to 79 had concentrations of lead at or above the intervention level of 10 micrograms per decilitre of blood.

The geometric mean concentration of blood lead for Canadians aged 6 to 79 was 1.34 micrograms per decilitre.

Blood lead concentrations were higher in adults than in children. Older adults (aged 60 to 79) had the highest concentrations. Children aged 6 to 11 and teens aged 12 to 19 had the lowest.

Controlling for age group and sex, higher concentrations of lead in the blood were associated with lower household income, being born outside Canada, living in a dwelling that was at least 50 years old, current or former smoking, and drinking alcohol at least once a week.

Although lead was detected in 100% of the population, concentrations have fallen dramatically over the past 30 years. The geometric mean lead concentration for people aged 6 to 79 measured by the CHMS between 2007 and 2009 was about one-third of the concentration measured in the 1978/1979 Canada Health Survey for the same age group.

In 1978/1979, about 27% of Canadians aged 6 to 79 had blood lead concentrations at or above the intervention level, compared with less than 1% from 2007 to 2009.

Note to readers

This third release of data from the Canadian Health Measures Survey (CHMS) includes information on more than 80 environmental contaminants and chemical substances that were measured in the Canadian population from 2007 to 2009. These baseline data on the presence of environmental chemicals in the population will help track trends as data from subsequent cycles of the CHMS become available.

This release provides information on laboratory measures related to the environment, such as heavy metals (lead, mercury and cadmium), pesticides, herbicides, PCBs and perfluorinated compounds. These indicators were collected from March 2007 to February 2009 from a representative sample of about 5,600 Canadians aged 6 to 79 years at 15 sites across the country.

Lead is a heavy metal that occurs naturally in the environment. People can be exposed to lead from air, water, food, dust, consumer products and certain occupations and hobbies. High lead levels can increase the risk of nervous system and kidney damage.

Bisphenol A (BPA) is an industrial chemical used primarily in the production of polycarbonate plastic and epoxy resins for food containers, water bottles and protective linings for canned food and beverages. It does not occur naturally in the environment. Some studies on animals suggest that low levels of exposure to BPA very early in life can affect neural development and behaviour; however, there is some uncertainty in interpreting how these findings might be relevant to human health.

Mercury is found throughout the environment. The general population is exposed primarily through consuming fish and seafood. Chronic exposure to elevated levels may cause a number of health effects, including numbness and tingling in the extremities, blurred vision, deafness and intellectual impairment. Prenatal exposure may cause neurological and developmental delays.

Micrograms per litre and micrograms per decilitre are measures of concentration that reflect the number of molecules per litre or decilitre of blood or urine.

A geometric mean is a type of average that is less influenced by extreme values than the traditional arithmetic mean. The geometric mean provides a better estimate of central tendency for highly skewed data. This type of data is common in the measurement of environmental chemicals in blood and urine.

This decline reflects the removal of major sources of lead from the environment. Since the 1970s, lead has no longer been added to automotive gasoline or used as solder in food cans, and lead limits in paint have been reduced.

Bisphenol A (BPA)

Bisphenol A (BPA) concentrations were measured for the first time at a national level in Canada by the CHMS from 2007 to 2009.

Canadians aged 6 to 79 had a geometric mean concentration of urinary BPA of 1.16 micrograms per litre. This is consistent with results from international studies reporting mean or median concentrations of 1 to 3 micrograms per litre.

Concentrations of BPA in urine based on volume were higher for children aged 6 to 11 than they were for adults aged 40 to 79. Moreover, the highest concentrations were measured in teens aged 12 to 19.

Mercury

The CHMS measured total mercury in blood samples provided by participants aged 6 to 79. From 2007 to 2009, total blood mercury was detected in 88% of Canadians in this age group.

The geometric mean concentration across this population was 0.69 micrograms per litre. Mercury concentrations were lower for children and teens aged 6 to 19 than for adults aged 20 to 79.

Definitions, data sources and methods: survey number 5071.

The article “Lead and bisphenol A concentrations in the Canadian population,” which is part of today’s Health Reports, Vol. 21, no. 3 (82-003-X, free), online release, is now available. From the Key resource module of our website, choose Publications.

Fact sheets on lead, bisphenol A and mercury are also available in Health Fact Sheets(82-625-X, free).

The publication Canadian Health Measures Survey: Cycle 1 Data Tables, 2007 to 2009, no. 2 (82-623-X, free), is now available from the Key resource module of our website under Publications.

For more information about the Canadian Health Measures Survey, 2007 to 2009, or to enquire about the concepts, methods or data quality of this release, contact Media Relations (613-951-4636), Communications and Library Services Division.

http://www.statcan.gc.ca/daily-quotidien/100816/dq100816a-eng.htm

Ground Zero Islamic center’s funding leads to CFR

n49700570_31141164_1043

Jerry Mazza
Online Journal
August 31, 2010

My first whiff of the news was an unsettling email from a reader of my article, ‘Ground Zero Mosque’ inflating Islamophobia, indicating The Council on Foreign Relations, i.e. the Rockefeller Globalist cabal, had a hand in this. The writer was annoyed at my not considering it.

I hadn’t considered it since my focus had been on the fact that the destruction of 9/11 was not perpetrated by Muslim nations as stated categorically by the New York Post, ignoring the very possible involvement of Israel, which has a history of false-flag attacks.

I received a second email from the Corbett Report, a video report whose Sunday stories were the Ground Zero Mosque Distraction, Israel Lobby, Apple and Orwell, the first with some fascinating information about Imam Faisal Abdul Rauf, who heads up the Cordoba Initiative, i.e., the building of the Ground Zero Islamic center. Eureka!

The Cordoba Initiative, and Imam Rauf, Corbett went on to say, were affiliated with the United Nations Alliance of Civilizations and support for that came from fellow Council on Foreign Relations’ members. Imam Rauf himself was on the Council on Foreign Relations’ Religious Advisory Committee. The Cordoba initiative’s website cited “Christian support for the Cordoba House” from a Christian publication, “Sojourners,” which is owned by evangelical Christian writer and political activist Jim Wallis, also a sitting member of the CFR’s Religious Advisory Committee. Wow!

print_head_logo

At some point, the American Society for Muslim Advancement (asma.org) was shown on the screen along with: “Our Supporters: U.S. Foundations.” After wincing, I froze the frame and downloaded the list, which included the Carnegie Corporations of New York, Rockefeller Brothers, Rockefeller Philanthropy, Rockefeller Brothers Fund, the Henry Luce Foundation, and Hunt Alternatives, to mention a few of the globalist pack.

n5845627667_196429_2737

There was also a clip of David Rockefeller speechifying at the CFR and welcoming back Dick Cheney to a meeting. Of course, Cheney remarked that he was happy to be there, was once “director” of the organization though he didn’t mention it when he was running for Congress from his native Wyoming. This drew a big laugh from the elite insiders present.

Next Corbett referred to Nancy Pelosi, who had recently questioned who was funding the Cordoba Initiative given how it was being politicized (at Democratic expense given Obama’s “for it but not where” statements). We cut to a call from Pelosi for an investigation. We cut back to Corbett who pointed out that it was rather embarrassing for her and others when the information above was revealed; that this money was not coming from Muslims or Middle Eastern nations.

This despite a scene, in which a Cordoba employee claimed to an inquiring reporter that the money came from Muslims, corporations, and interested groups, and that it wasn’t really necessary for everyone to know who contributed.

Corbett, having discredited the claim of Muslim funding rather thoroughly, moved on to several related stories, including Israel’s spending some $35 million dollars to control articles favorable to it in the US press and to tamp down the negative press on Dimona and Palestine.

He also mentioned the $50,000 given to the Atlantic monthly to write an attack piece on Iran, because it was the “greatest threat to Israel since Hitler.” Parenthetically, the writer was a former member of the Israel Defense Force, which might account for the hyperbole, seeing how it is Israel that has hundreds of nuclear warheads at their nuclear facility at Dimona in the Negev desert.

Corbett’s last piece focused on ideas for coming advancements in Apple i-Pods and i-Phones that seemed to be straight out of Orwell’s 1984, forecasting coming police-friendly improvements/intrusions on every conceivable form of personal privacy from Apple.

I also took a step back to corroborate Rauf’s deep ties to the CFR, seeing how the NY Post had painted him more as a co-conspirator with al-Qaeda, writing, “Clearly, though this is a complicated issue. The 9/11 mass murder, after all, was committed in the name of Islam.”

That explosive statement was followed by a quote from a letter by Dan Senor of the Council on Foreign Relations in the Wall Street Journal (also owned by Rupert Murdoch, owner of the New York Post) that whatever the stated goals of the Islamic center and Rauf, “in the minds of many who are swayed by the most radical interpretations of Islam . . . it will be celebrated as a Muslim monument erected on the site of a great Muslim ‘military victory.’” And . . .”that’s why the question of who precisely will pay to build the $100 million project is so compelling.” Amazing!

cfr

Here is a CFR member, whose organization is bankrolling the Islamic center with one hat on, switches hats and demands to know precisely who will pay to cough up the $100 million. Well, Dan, it’s your very own CFR sponsors who are picking up the tab. And if you think Corbett and I are the only ones who caught you with your two hats on, and your pants down, let me go to writer Steve Watson of PrisonPlanet.com, who wrote pretty much the same thing in Ground Zero Mosque Imam is Globalist Stooge.

“The Imam of the now infamous “ground zero mosque” is a member of the ultra elitist Council On Foreign Relations and receives financial backing from powerful globalist sources including the Rockefellers, the Carnegie Corporation and the Ford Foundation.

“This information provides a compelling backdrop to the theory that the move to establish the mosque is a deliberate attempt to further stoke religious tensions and and divert attention away from the real enemy of free humanity, the corporate globalist elite who continue to profit from global war and division.”

_twin_towers_cnn

Meanwhile, Americans all over the country, especially in lower New York City, are out in droves screaming at each other in fear over Muslim appropriation of the building site, feeling as if Muslims were at their doors with scimitars, when, in fact, it’s our own Council on Foreign Relations whipping up the synthetic terror. Doesn’t that point, too, to CFR involvement in the 9/11 event, producing the same feelings?

As to the “Globalist stooge” Rauf, I’m sure there’s a special place in hell for him, betraying his Muslim community to the danger of angry Americans to the synthetic terror threat, and frightening the latter to even more debilitating scare tactics. Let’s hope this doesn’t spill into the 9/11 commemoration ceremonies or the coinciding 9/11 As Inside Job rally that parallels them. Perhaps, if Rauf and the CFR are sufficiently exposed, that claim will have more meaning for more people than ever.

Jerry Mazza is a freelance writer and life-long resident of New York City. Reach him atgvmaz@verizon.net. His new book, State Of Shock: Poems from 9/11 on” is available atwww.jerrymazza.com, Amazon or Barnesandnoble.com. He has also written hundreds of articles on American and world politics as an Associate Editor of Online Journal.

National debate intensifies over plans to build mosque near Ground Zero

By Summer Hortillosa

TUESDAY AUGUST 17, 2010

Mosque_proximity_to_wtc

Photographer: National Oceanic and Atmospheric Administration

An aerial view of Park51’s proximity to Ground Zero.

The American Society for Muslim Advancement (ASMA) and The Cordoba Initiative (CI) intend to build a 13-story mosque and community center named Park51 two blocks from Ground Zero, the location of the 9/11 terrorist attacks. According to the Wall Street Journal, ASMA’s executive director Daisy Khan said the symbolism of the site added to the appeal of the property. “We decided we wanted to look at the legacy of 9/11 and do something positive…[and] reverse the trend of extremism and the kind of ideology that the extremists are spreading.”

Others, however, see the location choice differently. Some have held protests against the mosque and attempted to mark one of the buildings currently at 45-51 Park Place as a landmark in order to prevent demolition. This attempt failed when the Landmarks Preservation Commission decided that it was not worthy of landmark status. The vote was supported by some, like New York City Mayor Michael Bloomberg and opposed by others like Newt Gingrich, Sarah Palin and the Anti-Defamation League.

The most prominent figure in the debate is President Barack Obama, who recently announced his position on the issue. Obama equates allowing the mosque to be built with upholding America’s founding principles and said, “This is America, and our commitment to religious freedom must be unshakable.”

freedom-tower-hudson

The debate surrounding this single Muslim community center has echoed throughout the United States. For example, the issue has brought to light the fear of Muslims that many Americans still hold after the 9/11 attacks. These feelings have manifested in protests against the building and in the expansion of or even the current existence of mosques in communities all over the country. The outcome of this debate certainly has the potential to affect how Muslims and non-Muslims in America interact and to raise some very important questions. Will the tension between Muslim and Western cultures ever decrease or dissipate? Will Americans ever be able to minimize their fear of Muslims since 9/11? Is there a way to find balance and peace for both cultures?

The New Anti-Semitism, Continued

Park51’s Khan sees resonance with Islamophobia

http://www.nextbookpress.com/scroll/43369/the-new-anti-semitism-continued/

BY MARC TRACY | Aug 23, 2010

Spencer Platt/Getty Images

Yesterday, Daisy Khan, the wife of Imam Abdul Feisal Rauf (who himself was profiled in theNew York Times this weekend), compared opposition to her Cordoba Initiative’s plans for an Islamic center in lower Manhattan to “a metastasized anti-Semitism.” She added, “That’s what we feel right now. It’s not even Islamophobia, it’s beyond Islamophobia. It’s hate of Muslims. And we are deeply concerned.”

Separately, contributing editor Jeffrey Goldbergnotes, “Anti-Muslim sentiment in America today has many of the hallmarks of the anti-Semitism of yesteryear. American Jews should be able to see that.”

One American Jew who did see that was Daniel Luban, writing in Tablet Magazine last week about “The New Anti-Semitism”:

Is the Ground Zero Mosque Moving?

Many of the tropes of classic anti-Semitism have been revived and given new force on the American right. Once again jingoistic politicians and commentators posit a religious conspiracy breeding within Western society, pledging allegiance to an alien power, conspiring with allies at the highest levels of government to overturn the existing order. Because the propagators of these conspiracy theories are not anti-Semitic but militantly pro-Israel, and because their targets are not Jews but Muslims, the ADL and other Jewish groups have had little to say about them. But since the election of President Barack Obama, this Islamophobic discourse has rapidly intensified

http://www.nextbookpress.com/scroll/43369/the-new-anti-semitism-continued/

FBI paid informant in Bronx synagogue bomb plot $97K, who provided terror suspects with fake bombs

BY ROBERT GEARTY
DAILY NEWS STAFF WRITER

Wednesday, August 25th 2010, 5:24 PM

Suspect Laguerre Payen in a courtroom sketch from 2009.

Hagen for News

Suspect Laguerre Payen in a courtroom sketch from 2009.

The jury in the Bronx synagogue bomb plot case was told Wednesday that the informant who provided the four suspects with phony bombs and missiles was paid $97,000 by the FBI.

The FBI gave Pakistani immigrant Shahed Hussain $44,000 for expenses and $53,000 for “his services” over a three-year period, agent Robert Fuller said.

Fuller, the first prosecution witness in the trial that started Tuesday, showed the jury one of the unexploded bombs the would-be terrorists planned to use to blow up one of two Riverdale synagogues.

Defense lawyers contend that without the informant – who they say entrapped the suspects – their bumbling clients would never have tried to blow up two synagogues in Riverdale and shoot down missiles.

James Cromitie, 44, and co-defendants David Williams, 29, Onta Williams, 34, and Laguerre Payen, 28, were caught in May 2009.

Hussain met them at an upstate mosque, where he was sent by the feds. The trial continues today in Manhattan Federal Court. The four suspects face life in prison if convicted.

Read more: http://www.nydailynews.com/ny_local/2010/08/25/2010-08-25_fbi_paid_informant_in_bronx_synagogue_bomb_plot_97k_who_provided_terror_suspects.html#ixzz0yIoaDOwa

Orwellian DoubleThink: Rights are Privileges

Activist Post
August 31, 2010

Rights are Privileges (Freedom is Slavery): The primary duty of all public officials is to protect the rights of citizens as defined in the Constitution, where they shall not make or enforce any laws that violate those rights.  In fact, the “checks and balances” were put in place to assure that rights of citizens are not being trampled by one branch of the government. After 9-11, President Bush and other public officials proclaimed that their most important job was protecting the safety of the American people, which basically put an end to our rights coming first.

If the corporate-government fear campaign fails to scare the rights away from citizens, they try to convince the public that rights are now privileges and charge a fee or a tax for the “right” to engage in a certain activity.

Here are a few recent examples where rights are eroding into privileges:

050110top2

  • Air travel has become a privilege since 9-11.  We must now forfeit all rights to our physical being by submitting to naked body scanners that emit unhealthy levels of radiation, or open-palm invasive frisking.  Everyone is assumed to be guilty until thoroughly cavity checked for explosives.
  • Free-speech Blogging on the Internet is now the target of taxes and licensing fees — the trial financial assault before free speech is ultimately killed with the end of net neutrality. Philadelphia is seeking a blog tax, while South Carolina has attempted to require all controversial speech groups to register, of course with a fee attached.

blog_logo

Gun control isn't about guns Its about control_cropped

  • Gun rights are under continued pressure by the government and the media to make us believe it is a privilege to own guns.
  • Capital rights, or the freedom to spend or invest our own money, are now under assault withcapital controls.
  • Property rights erode every time property taxes are jacked up because the Fed creates inflation.  We own less and less of our property each day the dollar devalues. Property rights also erode as more strict zoning regulations continually pass.

Spy satelite

Will ‘Machete’ release spark racial violence?

Alex Jones & Aaron Dykes
Infowars.com
September 1, 2010

With the violent and racially-charged film ‘Machete’ about to hit theaters Friday, Alex Jones has once again questioned the film’s potential to heighten tensions in the immigration debate or even fuel riots or attacks. Though the production crew has downplayed fears of a ‘race war’ message, recent sightings of bloody ‘Machete’ promo posters plastered throughout Latin America suggest that this violent film may still stir controversy and strong reactions.

We only hope director Robert Rodriguez and his production crew have thought carefully about what they are putting out on the big screen.

The image of a bloody machete in a clenched fist, now plastered across the Latin American world to promote ‘Machete’– spotted recently by a listener in Puerto Rico– holds a double meaning. “Todos con Machete” is more than just a rally cry to join the hero of this Mexploitation film; the machete is the common symbol for peasant uprising in Mexico, Central and South America– the weapon of a disarmed population.

The image of a bloody machete in a clenched fist now plastered across the Latin American world to promote ‘Machete’– spotted recently by a listener in Puerto Rico — holds a double meaning. “Todos con Machete” is more than just a rally cry to join the hero of this Mexploitation film; the machete is the common symbol for peasant uprising in Mexico, Central and South America– the weapon of a disarmed population.

The justified anger evoked by the “machete” is then fueled into the film’s “war” on immigration, as the crazed patriot senator played by Robert DeNiro declares, and Machete’s pursuit of revenge killing. In reality, the imagery this film puts forward plays into the hands of the globalists who are using “pressure populations” like the underprivileged of Latin America to neutralize the sovereignty of the United States andamalgamate the region into the North American Union and larger world government.

The message of ‘Machete’ became politicized back in May shortly after director Robert Rodriguez leaked a trailer with a special “message to Arizona” that stirred fierce debate about the film. Rodriguez backed off of the fiery rhetoric however, after scenes from the script and warnings from Hispanic members of the film’s crew confirmed its overt racial overtones and prejudiced violence. Rodriguez told Ain’t It Cool News that he simply had ‘too much tequila‘ and that many of the most controversial scenes would be cut. We hope this will prove true in the final edit premiering Sept. 3.

Nevertheless, many dubious statements have been issued from the ‘Machete’ camp. Producer Elizabeth Avellan told the Austin American-Statesman Saturday that:

“There were a lot of things that people misconstrued… without even knowing the script and pretending they have a script.”

The reference was clearly to Jones, who issued a video response to the very real script given to him in May by a high level source within the production team. Rodriguez himself admitted the quoted scenes were authentic, but claimed it was not from a final draft. Alex Jones told the Statesman that he doesn’t mind Rodriguez having cinematic freedom, but objects to the portrayal of white people as a “bunch of blood-thirsty, foaming-at-the-mouth killers,” adding that it “reflects bad on Texas.”

Early ‘Machete’ reviews, however, suggest the film maintains its political fury. In an exposé titled, How ‘Machete’ Inflames Immigration Debate,” The Hollywood Reporteraccuses the film of ‘skewering’ the notorious Sheriff Joe Arpaio in a particularly nasty near-likeness, wherein Don Johnson leads a band of murderous border vigilantes who shoot illegals on sight:

“Among ‘Machete’s’ more provocative elements are border vigilantes led by Don Johnson as a kind of avatar for Maricopa County’s Sheriff Joe Arpaio and fake political ads for an incumbent senator whose platform is built on his ‘hard line against (inappropriate term)’ and a description of them as ‘parasites.’ That the two characters murder a pregnant Mexican woman to prevent her baby from being born in America and then shoot her distraught husband while uttering the line, ‘Welcome to America,’ underlines the point.”

Arpaio denied the likeness, but the larger portrayal is more than provoking; it’s backwards. It is border-area law enforcement like Arpaio and Sheriff Babeu in Pinal County whose lives have been threatened. The portrayal of border & law enforcement and volunteer minute men as murderous, vicious and heartless– as written in the script and according to screening reports– is wrong indeed. In reality, the violence at the border is carried out almost exclusively by the Mexican drug gangs, backed by CIA and Wall Street banks, who use desperate immigrants for drug mules or play them into the hands of kidnappers, extortionists or human trafficking.Mexico is collapsing, and border regions in Arizona have fallen to drug lord control. The 72 migrants from Central and South America murdered by Las Zetas drug members should be a stark reminder of where the violence is coming from.

Despite the controversy over the film’s message, Alex Jones, who lead early criticism of the film after learning what the script contained, has maintained that Rodriguez has a right to put out any film he wants.

“I support tax incentives for industry and for film and the arts,” Jones said. “Robert Rodriguez has a right to make any movie he wants. If he’s putting out this hardcore, race war film– if he’s releasing it the way the script states– I think it should get its funding, but they had better remove any controls off of any other films. If they let this go forward and give it funding but then block other things, it’s outrageous.”

The Texas Film Commission, a division of Governor Rick Perry’s office, has been criticized for its selective funding and rejection of certain projects. The film ‘Waco’ was rejected and its filmmakers were reportedly told not to apply for tax incentives because the commission allegedly objected to its depiction of the massacre at the Branch Davidian church in Waco in 1993. Now funding for ‘Machete’ could fall under greater scrutiny.

While Rodriguez maintains the blood-soaked film is just for fun, its violent scenes are not only ‘torn from the headlines’ but all too likely to provoke real hatred and animosity between different racial groups. We only hope the indicators of a divisive message prove overblown as its producers have reassured us over and over again.

Machete – Trailer – Machete is based on the fake trailer in Robert Rodriguez’s 2007 Grindhouse, featuring Danny Trejo and Jeff Fahey reprising their original roles.
The feature version of the trailer finds Machete (Trejo) a renegade former Mexican Federale, roaming the streets of Texas after a shakedown from drug lord Torrez (Steven Seagal). Reluctantly, Machete takes an offer from spin doctor Benz (Fahey) to assassinate McLaughlin (Robert De Niro) a corrupt Senator. Double crossed and on the run Machete braves the odds with the help of Luz (Michelle Rodriguez), a saucy taco slinger, Padre (Cheech Marin) his “holy” brother, and April (Lindsay Lohan) a socialite with a penchant for guns. All while being tracked by Sartana (Jessica Alba), a sexy ICE agent with a special interest in the blade slinger.

Investors Spooked As Glitch Sends Gold To $3400

Some speculate error was secret signal to indicate where precious metal is really heading

Investors Spooked As Glitch Sends Gold To $3400 010910top
Photograph: Giorgio Monteforti

Paul Joseph Watson
Prison Planet.com
Wednesday, September 1, 2010

Investors were briefly panicked yesterday when the Yahoo Finance website indicated that gold had soared to over $3400 dollars an ounce, an instant jump of 175 per cent. Possible reasons for the shocking spike ranged from a simple mistake to a secret signal being communicated to insiders as to where the commodity was really heading.

Just after 11am eastern time, the Yahoo Finance website gold graph indicated that the precious metal had jumped from $1235.60 an ounce to a whopping $3401.50 an ounce in the space of minutes. The commodity then quickly returned to its previous level almost immediately.

The only event that could precede such a massive and instantaneous jump in gold would have to be something on the scale of a nuclear war or a sudden and total collapse of the U.S. dollar.

Investors Spooked As Glitch Sends Gold To $3400 010910top2
Click for enlargement.

Since the apparent glitch was only registered on the Yahoo website, many have attributed it to an in-house error. But that didn’t stop financial forums raging with speculation as to whether the snafu wasn’t some kind of hidden message being put out to insiders as to when gold will really hit such a level.

“This is one of those secret messages to traders in the know that tell the brokers when gold will be at a certain level,” claimed a Kitco forum member.

Indeed, numerous investment analysts speculated last year that gold was heading towards the $3500 range as a result of a deflationary collapse of the U.S. economy.

“Did it really do that, and I wonder if someone knew and cashed in bigtime only to re-invest it after it dropped back down. If they did, they made some major moola!,” commented a poster at DailyPaul.com.

Was this a ‘tell’ to let insiders know that gold is about to soar? Or was it nothing more meaningful than a technical glitch?

————————————————————————————————————-

With the current economic conditions you cannot afford to be uninformed. Bob Chapman’s International Forecaster is the foremost in financial and economic newsletters. Published twice a month by surface mail or 6-8 times a month by e-mail, you won’t want to miss a single issue of this newsletter. For a limited time Midas Resources and The Alex Jones Show are offering to you a chance to get a FREE one year subscription to the International Forecaster!

When you purchase the Gold Franc containing a fifth ounce of gold, at an exceptional price from Midas Resources, you will also receive a full one year subscription of the International Forecaster ( $159.95 value) FREE!

Call Midas Resources to get this special limited offer today at 1-800-686-2237 and tell them you got the email offer from Alex Jones or purchase it now by visiting the GCN website.

Investors Spooked As Glitch Sends Gold To $3400 040310gold